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Obesity is a major public health problem in the general adult population.
1
 The prevalence of 
obesity worldwide has more than doubled in the last decades. The World Health Organization 
(WHO) estimated that 13% of the world´s adult population were obese in 2014.
1
 Overweight 
and obesity have been considered the fifth leading global risk for mortality in the world.
2
 
Common health consequences of overweight and obesity include cardiometabolic diseases 
(e.g., mainly diabetes, stroke and heart diseases), musculoskeletal disorders and certain types 
of cancers such as breast and colon cancer.
3
 Globally, the burden of diabetes, ischemic heart 
disease and certain cancers is about 44%, 23% and 7-41% attributable to overweight and 
obesity, respectively.
2
  
 Concurrent with this, the prevalence of overweight and obesity in childhood is also 
reaching alarming levels worldwide. The WHO estimated that 41 million children worldwide 
under the age of 5 years were overweight or obese in 2014.
4
 Childhood obesity is associated 
with a higher risk of obesity, cardiovascular disease, premature death and disability in 
adulthood.
5
 In addition to increased future risks, obese children experience breathing 
difficulties, increased risk of fractures, early markers of cardiovascular disease (e.g., 
hypertension, non-alcoholic fatty liver disease, adverse lipid profile, insulin resistance), 
depression and other psychological effects.
5
 
In the past few decades, there has been mounting evidence suggesting that obesity and 
cardiometabolic diseases in childhood and adulthood at least partly originate in fetal or early 
postnatal life.
6-11
 The Developmental Origins of Health and Disease (DOHaD) hypothesis 
proposes that alterations in the intrauterine environment during critical periods of cellular 
proliferation and differentiation can affect the developing fetus leading to structural and 
functional alterations in cells, tissues and organ systems. These alterations may have lifelong 
consequences for body composition and cardiometabolic health in later life.
6
 Maternal 
adiposity during pregnancy, among other lifestyle prenatal factors, has been identified as an 
important risk factor that might lead, through intrauterine programming, to obesity and 
cardiometabolic dysfunction in the offspring.
6
 Along with intrauterine life, infancy seems 
also to be a critical period for the development of obesity and cardiometabolic diseases.
7
 A 
large body of evidence has suggested that nutrition and growth in infancy are related to 
obesity and cardiovascular disease risk in later life.
9-11
 In particular, rapid weight gain in 
infancy is associated with an adverse cardiovascular profile in adulthood.
8
 
 Assessing the contribution of maternal adiposity during pregnancy and infant 
adiposity to later adverse body composition and cardiometabolic risk status broadens the 
understanding on their short- and long-term health consequences. Furthermore, this may help 
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to develop future preventive strategies aimed at improving body composition and 
cardiovascular health throughout the life course and in future generations. Therefore, studies 
included in this thesis were designed to clarify the adiposity and cardiovascular health related 
consequences of maternal and infant adiposity (Figure 1.1). 
 
 
Figure 1.1 Overview of the assessed associations in this thesis 
 
 
 
 
 
 
 
 
 
 
 
 
Maternal adiposity during pregnancy 
Obesity in women of reproductive age is increasing in prevalence worldwide.
12
 Maternal pre-
pregnancy obesity is an important risk factor for pregnancy and birth complications.
13-16
 In 
addition to short-term adverse health effects, maternal obesity seems also to affect long-term 
health of the offspring. A meta-analysis of published studies showed an increased risk of 
overweight in offspring of mothers with overweight and obesity, as compared to offspring of 
mothers with normal weight.
17
 Next to maternal obesity, excessive gestational weight gain 
also seems to be associated with an increased risk of childhood obesity.
18-20
 Gestational 
weight gain is a complex trait, which reflects multiple components including maternal 
Maternal adiposity during pregnancy 
Pre-pregnancy body mass index, gestational weight gain 
 
Infant adiposity 
Body mass index, subcutaneous fat (skinfold thicknesses) 
Childhood adiposity 
Body mass index, anthropometric indices based on waist 
circumference, total, abdominal and organ fat (bioelectric 
impedance, dual-energy X-ray absorptiometry, ultrasound and 
magnetic resonance imaging) 
Childhood cardiovascular 
risk factors 
Blood pressure, blood lipids 
and insulin 
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nutritional status, the fetus, amniotic fluid, placenta, uterine and mammary tissue expansion, 
increased blood volume, and extracellular fluid.
21
 Intrauterine programming might be 
involved in the associations of maternal obesity and excessive gestational weight gain with a 
greater risk of obesity in later life. It has been suggested that a maternal obesogenic 
environment during pregnancy leads to higher maternal plasma concentrations of glucose, 
amino acids and free fatty acids that are transferred to the developing fetus and might cause 
permanent changes in the development of adipocytes, and in the appetite control system.
6
 
Maternal pre-pregnancy body mass index and gestational weight gain are important 
modifiable factors that might greatly impact maternal health and health of the offspring. 
Thus, obtaining a better understanding of the influence of maternal pre-pregnancy body mass 
index and gestational weight gain on more detailed offspring fat measures, such as abdominal 
and organ fat, already from early infancy onwards and their underlying mechanisms is of 
utmost importance for development of preventive strategies.   
 
Infant adiposity 
Infant growth patterns, such as rapid postnatal weight gain, are recognized as critical for the 
development of overweight and obesity and for an adverse body fat distribution in later 
life.
7,9,11,22,23
 Also, infant overweight and obesity are important risk factors for overweight 
and obesity in childhood.
24,25
 Besides the effect on adiposity, early infant growth seems also 
to affect cardiovascular disease risk throughout the life course. Rapid weight gain in the first 
3 months of life has been associated with an unfavorable cardiovascular and metabolic health 
profile in adulthood.
8
  
Infancy seems to be characterized by a specific body fat development. During the first 
4 months of life approximately 90% of body fat is located subcutaneously,
26
 and 
preperitoneal fat mass seems to increase only from the second year of life onwards.
27
 
Skinfold thickness, which is a valid measurement of total and regional subcutaneous fat,
28
 
might be particularly relevant in infancy due to the pattern of fat deposition observed in this 
period.  
Altogether, these studies suggest that infancy may be a critical period that influences 
the development of an adverse body fat profile and cardiovascular disease in later life. Thus, 
obtaining a better understanding of the influence of more detailed fat mass measures during 
infancy on fat mass measures and cardiovascular risk factors later in life helps to further 
understand the stability of body fat measures across the life course and to identify early 
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critical periods of fat development important for the risk of cardiovascular disease in 
adulthood.  
 
Childhood adiposity and cardiovascular risk factors 
The majority of studies addressing the adiposity related consequences of maternal adiposity 
during pregnancy and infant adiposity have used body mass index, which is a safe, 
inexpensive and an easy to obtain population-level diagnostic tool for defining general 
adiposity. However, body mass index is a suboptimal measure of body fat mass, especially in 
children, and provides no information about body fat distribution.
29
  
 Previous studies have suggested that body fat distribution, rather than body mass 
index, is related to the risk of cardiovascular and metabolic diseases.
30
 Waist circumference 
and other indices based on waist circumference, such as waist-to-height ratio and waist-to-hip 
ratio, have been used in clinical practice to estimate abdominal fat. However, waist 
circumference has been more strongly correlated with body mass index and total body fat 
than with abdominal visceral fat,
31,32
 raising doubts about its use and the use of waist-to-
height ratio for assessing abdominal fat. Waist-to-hip ratio has been suggested to be a good 
predictor of cardiovascular disease risk because it includes a measurement of hip 
circumference, which has been negatively associated with diabetes, cardiovascular disease 
and mortality.
33,34
 In line with this, in a meta-regression analysis of 15 prospective studies, 
waist-to-hip ratio tended to be more strongly associated with cardiovascular events than waist 
circumference.
35
 Although easier to obtain and cheaper, anthropometric measurements are 
more likely to be affected by measurement error. As an alternative, dual-energy X-ray 
absorptiometry is an imaging technique that quantifies total and regional body fat content 
with high precision.
28
  
These measures do not give any insight into the amount of subcutaneous, visceral and 
organ fat compartments, which have been described as better indicators of cardiometabolic 
risk.
30,36,37
 Large cohort studies such as the Framingham Heart Study and the Jackson Heart 
Study have reported that excess visceral adiposity and ectopic fat deposition (such as excess 
heart, liver and intrathoracic fat) is related to various cardiometabolic abnormalities, 
independently of total or subcutaneous fat.
38-44
 Magnetic resonance imaging is a high quality 
imaging and gold standard technique for the measurement of intra-abdominal and organ fat 
deposition.
45-48
 Abdominal ultrasound is also a valid method to estimate subcutaneous fat 
mass and preperitoneal fat mass, as a proxy for visceral fat mass.
46,49
 Overall, the 
cardiometabolic risk associated with adipose tissue seems to be mainly related to abdominal 
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and organ fat and thus it is important to gain more knowledge on the associations of early life 
factors with these measures of adiposity later in life. 
 Cardiovascular disease events are more frequent from the fifth decade of life onwards 
but the precursors of cardiovascular disease seem to originate in childhood. Previous studies 
have shown that increased blood pressure levels during childhood strongly predict 
hypertension in young adulthood.
50
 Also, a long exposure to raised concentrations of low-
density lipoprotein (LDL)-cholesterol increases the risk of cardiovascular events.
51
 In line 
with this, an adverse cardiovascular risk profile characterized by high levels of LDL-
cholesterol, systolic blood pressure, body mass index and cigarette smoking in 12- to 18-
year-old adolescents was associated with carotid intima media thickness in adulthood, 
independently of current risk factors.
52
 Higher glucose, insulin and insulin resistance in 
childhood have also been associated with a higher risk of diabetes and an adverse 
cardiovascular profile in adulthood.
53,54
 Exposure to cardiovascular risk factors early in life 
may contribute to the development of cardiovascular disease events in adulthood and thus it 
is important to obtain further insight into their determinants and underlying mechanisms. 
 
General aim  
The general aim of this thesis was to assess the adiposity and cardiovascular health related 
consequences of maternal and infant adiposity. 
 
Specific aims 
The specific aims of this thesis are addressed in the studies presented in Chapter 2 and 
Chapter 3. In Chapter 2, studies on the influence of maternal adiposity during pregnancy on 
infant and childhood outcomes are described. In Chapter 2.1, we reviewed the childhood 
cardiometabolic, respiratory and cognitive-related health consequences of maternal obesity 
during pregnancy. In Chapter 2.2, we studied the influence of maternal body mass index, 
and gestational weight gain on body mass index and subcutaneous fat at the ages of 1.5, 6 and 
24 months. In Chapter 2.3, we addressed the associations of maternal gestational weight 
gain, diabetes and smoking on total and regional adiposity at the age of 7 years and explored 
whether these associations were through direct intrauterine mechanisms or through birth 
weight. The associations of maternal body mass index, and gestational weight gain on body 
mass index, and total, abdominal, pericardial and liver fat at the age of 10 years are described 
in Chapter 2.4. In Chapter 3, studies on the influence of infant adiposity on childhood 
outcomes are described. In Chapter 3.1, we examined the accuracy of single and combined 
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anthropometric indices for assessing body fat and clarified the use of indices based on waist 
circumference as measures of adiposity in children. The influence of infant body mass index 
and subcutaneous fat on childhood adiposity and cardiovascular risk factors is studied in 
Chapter 3.2 and Chapter 3.3, respectively. 
 
General design 
The studies presented in this thesis were embedded in the Generation XXI, Porto, Portugal 
and in the Generation R Study, Rotterdam, the Netherlands. 
 
Generation XXI 
The Generation XXI is a population-based birth cohort assembled in Porto, Portugal.
55
 The 
Generation XXI was designed to chart the growth and development of children born at the 
dawn of the new millennium seeking to better understand health during childhood and later in 
adolescence and adulthood, thereby contributing to health gains among the population. 
Mothers resident in the catchment area who delivered a live-born child, with a gestational 
age≥24 weeks, in one of the public maternity units covering the metropolitan area of Porto, 
between April 2005 and August 2006, were eligible for enrolment in this study. Mothers were 
invited to participate, 24 to 72 hours after delivery, and of the invited mothers, 91% accepted 
to participate. A total of 8647 children and 8495 mothers were enrolled at baseline. Follow-
up evaluations at ages 6, 15 and 24 months were restricted to sub-samples of children. Re-
evaluations of the entire cohort were conducted at 4 years old (between 2009 and 2011; 86% 
of all children re-evaluated) and at 7 years old (between 2012 and 2014; 80% of all children 
re-evaluated). Currently, they are being evaluated at 10 years old. The Generation XXI has 
been collecting parental and child data through interviewer- and self-administered 
questionnaires and diaries, performing detailed physical examinations and collecting 
biological samples. The studies presented in this thesis used data from enrolment and from 
the 7-year-old re-evaluation. 
 
Generation R Study 
The Generation R Study is a population-based prospective cohort study from fetal life until 
young adulthood in Rotterdam, the Netherlands.
56
 The Generation R Study was designed to 
identify early environmental and genetic determinants of growth, development and health in 
fetal life and childhood. All pregnant women living in the study area with a delivery date 
between April 2002 and January 2006 were eligible for enrolment in this study. Enrolment 
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was aimed at early pregnancy, but was possible until the birth of the child. In total, 9778 
mothers were enrolled in the study, of whom 8880 (91%) were included during pregnancy. 
Assessments were planned in early-, mid-, and late-pregnancy (<18, 18-25 and ≥25 weeks of 
gestation, respectively) and included parental physical examinations, blood and urine 
collection, fetal ultrasound examinations, and self-administered questionnaires. Assessments 
of the newborn at birth included a physical examination and cord blood tests. Additional 
detailed assessments of fetal and postnatal growth and development were conducted in a 
subgroup of Dutch mothers and their children from late pregnancy onwards. From birth to 4 
years of age, data on growth, development and health of the participating children were 
obtained by questionnaires and visits to the routine child health care centers. At the age of 6 
and 10 years, all children were invited to participate in detailed body composition and 
cardiovascular follow-up measurements. Currently, they are being evaluated at 13 years old. 
The studies presented in this thesis used data from pregnancy, birth, infancy and 6 and 10-
year-old re-evaluations. 
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Abstract  
 
Background: Obesity is a major public health problem among women of reproductive age. 
In a narrative review, we examined the influence of maternal obesity during pregnancy on 
fetal outcomes and childhood adiposity, cardio-metabolic, respiratory and cognitive-related 
health outcomes. We discuss results from recent studies, the causality and potential 
underlying mechanisms of observed associations and challenges for future epidemiological 
studies. 
 
Summary: Evidence from observational studies strongly suggests that maternal pre-
pregnancy obesity and excessive gestational weight gain are associated with increased risks 
of fetal pregnancy complications and adverse childhood cardio-metabolic, respiratory and 
cognitive-related health outcomes. It remains unclear whether these associations are due to 
intrauterine mechanisms or explained by confounding family-based sociodemographic, 
lifestyle and genetic factors. The underlying mechanisms have mainly been assessed in 
animal studies and small human studies, and are yet to be further explored in large human 
studies.  
 
Key Message: Maternal obesity is an important modifiable factor during pregnancy that is 
associated with a variety of adverse offspring health outcomes. Further studies are needed to 
explore the causality and underlying mechanisms of the observed associations. Ultimately, 
preventive strategies focused on reducing maternal obesity and excessive weight gain during 
pregnancy may reduce common diseases in future generations.  
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Introduction 
Obesity is a major public health problem worldwide.
1
 The World Health Organization 
estimated that 11% men and 15% women of the world’s adult population were obese in 
2014.
1
 The strong increase in obesity prevalence also affected women of reproductive age. 
Over time, studies from the US and UK showed an increase in maternal obesity at the start of 
pregnancy from approximately 10% around 1990 to approximately 16-22% in the early 
2000s.
2, 3
 To date, the obesity prevalence rate in pregnant women is estimated to be as high as 
30% in Western countries.
4-7
 In these countries, an even higher percentage of women gain an 
excessive amount of weight during pregnancy based on the US Institute of Medicine (IOM) 
guidelines, which define optimal ranges of maternal weight gain during pregnancy according 
to a mother’s pre-pregnancy body mass index (BMI) based on evidence from observational 
studies (Table 1).
5, 8-11 
An accumulating body of evidence suggests that maternal obesity and 
excessive weight gain during pregnancy are not only associated with adverse maternal and 
fetal pregnancy outcomes, but also have a long-term adverse influence on common health 
outcomes in the offspring.
11, 12
  
In this narrative review, we provide a review update of the findings from recent 
observational studies and meta-analyses focused on the associations of maternal obesity and 
excessive weight gain during pregnancy with fetal outcomes and offspring adiposity, cardio-
metabolic, respiratory and cognitive-related health outcomes throughout childhood.
11, 12
 We 
also discuss the causality and potential mechanisms underlying the observed associations as 
well as challenges for future research.  
 
Fetal outcomes 
Maternal pre-pregnancy obesity and excessive gestational weight gain are important risk 
factors for multiple adverse fetal outcomes (Figure 1).
11-13
 Several large meta-analyses have 
shown that a higher maternal pre-pregnancy or early pregnancy BMI is associated with 
increased risks of fetal death, stillbirth, neonatal death and the development of various 
congenital anomalies.
14, 16
 Thus far, increased gestational weight gain seems not to be 
associated with fetal death or still birth. Both higher maternal pregnancy BMI and increased 
gestational weight gain are well-known risk factors for delivering large size for gestational 
age infants. A meta-analysis among 13 studies showed that, as compared to normal maternal 
pre-pregnancy weight, maternal pre-pregnancy obesity was associated with a 2-fold higher 
risk of delivering a large size for gestational age infant.
17
 Similarly, a meta-analysis among 
15 cohort and case-control studies showed that excessive gestational weight gain based on the 
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IOM criteria was associated with a 2-fold higher risk of macrosomia.
18
 Based on studies that 
assessed the associations of gestational weight gain during specific periods of pregnancy, it 
appears that especially higher second and third trimester maternal weight gain are associated 
with an increased risk of delivering a large size for gestational age infant.
19, 20
 Also, both 
maternal pre-pregnancy BMI and gestational weight gain seem to be associated with common 
adverse neonatal outcomes, such as preterm birth, a low Apgar score, neonatal hypoglycemia 
and referral to the neonatal intensive care unit, with stronger and more consistent associations 
for maternal pre-pregnancy BMI than for gestational weight gain.
20-25
  
Thus, both maternal pre-pregnancy obesity and excessive gestational weight gain lead 
to increased risks of fetal complications throughout pregnancy. Overall, the associations for 
maternal pre-pregnancy obesity with adverse fetal outcomes seem to be more consistent and 
stronger than for excessive gestational weight gain.
13, 20
   
 
Childhood outcomes 
An accumulating body of evidence suggests that maternal obesity during pregnancy 
adversely affects a variety of childhood health outcomes.
11
 Most studies that assessed the 
influence of maternal gestational obesity on common childhood health outcomes focused on 
childhood adiposity and cardio-metabolic development (Figure 1).
12
 Across studies from 
different countries, maternal pre-pregnancy obesity and excessive gestational weight gain are 
associated with an increased risk of obesity throughout childhood.
26
 Two meta-analyses 
based on results from observational studies showed that both maternal pre-pregnancy obesity 
and excessive gestational weight gain according to the IOM criteria were associated with a 3-
fold higher risk of childhood obesity, as compared to normal weight women and to a 
recommended amount of gestational weight gain, respectively.
27, 28
 However, during 
childhood, BMI might not be an appropriate measure of fat mass because an increase in BMI 
may reflect an increase in lean mass instead of fat mass.
29, 30
 It has been shown that detailed 
fat mass measures, such as total body fat mass and abdominal fat mass, are more strongly 
associated with cardio-metabolic risk factors in childhood and adulthood and the risk of 
mortality in later life.
31-33
 Several studies also showed that a higher maternal pre-pregnancy 
BMI and total gestational weight gain are independently associated with a higher childhood 
waist circumference, total body fat mass and abdominal fat mass levels, although the 
associations for total gestational weight gain are less consistent.
10, 34-39
 Maternal weight gain 
in early pregnancy appears to be a specific critical period for the development of adiposity in 
childhood.
12
 Three population-based prospective cohort studies showed that especially 
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maternal gestational weight gain in early pregnancy was associated with a higher childhood 
BMI, total body fat mass and abdominal fat mass from the age of 4−9 years.10, 19, 35 These 
associations appeared to be independent from maternal pre-pregnancy BMI and weight gain 
later in pregnancy.  
Both maternal pre-pregnancy obesity and excessive gestational weight gain are 
associated with a suboptimal childhood cardio-metabolic profile.
12
 In the Generation R 
Study, a population based prospective cohort study in Rotterdam, the Netherlands, we 
observed that a higher maternal pre-pregnancy BMI was associated with a higher childhood 
systolic blood pressure, left ventricular mass, aortic root diameter and insulin levels, and 
lower high-density lipoprotein (HDL)-cholesterol levels at the age of 6 years.
34, 40
 As 
compared to children from normal weight mothers, children from obese mothers had a 3-fold 
higher risk of an adverse childhood cardio-metabolic risk profile, which included high 
abdominal fat mass, high blood pressure, high insulin and triglycerides levels and low HDL-
cholesterol level.
34
 Similarly, higher maternal early pregnancy weight gain, but not weight 
gain later in pregnancy, was associated with an increased risk of an adverse childhood cardio-
metabolic risk profile.
35
 Another Dutch study among 1,459 mothers and their 5-6 year old 
children showed that a higher maternal pre-pregnancy BMI was associated with higher 
childhood systolic blood pressure and overall metabolic score, as a measure of a metabolic 
syndrome like phenotype, but not with childhood sympathetic drive, parasympathetic drive or 
heart rate.
39, 41
 A study among 5,154 UK mother-offspring pairs showed that higher maternal 
pre-pregnancy weight and gestational weight gain in mid-pregnancy were associated with 
higher childhood levels of triglycerides, HDL-cholesterol, apolipoprotein A1 and interleukin 
(IL)-6 at the age of 9 years.
10
 A study among 1,090 mother-child pairs participating in a pre-
birth cohort in the USA showed that a higher maternal pre-pregnancy BMI was associated 
with higher mid-childhood leptin, high sensitivity C-reactive protein and IL-6 levels, and 
lower adiponectin levels, whereas a higher total gestational weight gain was only associated 
with higher mid-childhood leptin levels.
36
 Across different studies, these associations with 
cardio-metabolic risk factors are not explained by birth weight, but seem to be largely 
mediated by childhood BMI.
12 
 
A higher maternal pre-pregnancy BMI and increased gestational weight gain may 
affect respiratory outcomes throughout childhood (Figure 1). A meta-analysis among 14 
European birth cohort studies showed that maternal overweight and obesity during pregnancy 
were associated with the risk of ever wheezing and recurrent wheezing until the age of 2 
years.
42
 Accordingly, a more recent meta-analysis among 14 studies with over 108,000 
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mother–child pairs showed that maternal obesity during pregnancy was associated with a 
31% increased risk of asthma or ever wheezing in children aged 14 months to 16 years.
43
 
Each 1-kg/m
2
 increase in maternal BMI led to a 3% increased risk of childhood asthma.
43
 
High gestational weight gain was associated with a 16% higher risk of ever asthma or 
wheeze, but not with current asthma or wheeze.
43
 In both meta-analyses, the observed 
associations could not be explained by multiple socioeconomic, lifestyle and birth 
characteristics or by the child’s BMI at the time of assessment of the outcome.42, 43 Asthma is 
partly considered an atopic disorder. However, thus far, the associations of maternal pre-
pregnancy obesity with other atopic disorders including allergic rhinitis, hay fever, atopic 
dermatitis or inhalant and food allergen sensitization are inconsistent.
44-48
 In addition, only 
few studies assessed the associations with more detailed childhood lung function 
measurements directly and have shown inconsistent results.
45, 46
  
Less is known about the associations of maternal obesity during pregnancy with 
cognitive outcomes in the offspring (Figure 1).
49-59
 Several studies showed that maternal pre-
pregnancy obesity is associated with a lower cognitive function in children, but results are not 
consistent.
49-57 
Total weight gain during pregnancy seems not be associated with childhood 
cognitive function.
54, 56, 60
 However, a study among 5,191 mother-offspring pairs restricted to 
term deliveries from the UK showed small positive associations of maternal weight gain in 
each trimester of pregnancy with IQ scores at 8 years of age, without remarkable differences 
in strength of the effect estimates for different periods of maternal weight gain.
61
 Similarly, a 
study among normal weight Scandinavian mothers and their children, showed that maternal 
third trimester weight gain was only associated with child IQ scores at 5 years of age when 
the sample was limited to term deliveries.
62
 In a meta-analysis among 5 observational studies, 
maternal obesity during pregnancy was associated with a 1.5-fold higher risk of childhood 
autism spectrum disorder.
63
 A Swedish study among 333,057 participants also showed that 
both low and high maternal gestational weight gain were associated with an increased risk of 
autism spectrum disorder in children.
64
 A combined study among 12,556 school-aged 
children and their mothers from 3 prospective Scandinavian cohorts showed that maternal 
pre-pregnancy obesity was associated with an increased risk of childhood attention deficit 
hyperactivity disorder (ADHD) symptoms rated by teachers.
65
 No associations of maternal 
gestational weight gain with ADHD symptoms seem to be present.
66 
 
Thus, in line with the risks of adverse fetal outcomes, maternal pre-pregnancy obesity 
and excessive gestational weight gain also lead to increased risks of adverse adiposity, 
cardio-metabolic, respiratory and cognitive-related outcomes in childhood. Most consistent 
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associations have been reported for childhood adiposity outcomes, whereas especially the 
associations with childhood cognitive outcomes seem to be weaker and less consistent across 
studies. The observed associations seem not to be restricted to obesity or excessive 
gestational weight gain only, but present across the full range of BMI and gestational weight 
gain.   
 
Causality or confounding 
It remains unclear whether the associations of maternal obesity during pregnancy with 
common childhood outcomes are explained by direct intrauterine mechanisms or confounded 
by environmental, lifestyle or genetic characteristics.
11, 12
 Most previous observational studies 
adjusted their analyses for a variety of pregnancy-related characteristics and maternal and 
offspring socio-demographic, nutrition and lifestyle-related characteristics.
11, 12
 Despite 
adjustment for potential confounding factors in these observational studies, residual 
confounding may still be a major issue to consider.
11, 12
 As described previously, several 
methods in epidemiological research can be used to better control for confounding 
characteristics in observational studies.
11, 12
 
Multiple studies have compared the strength of associations of maternal and paternal 
BMI with childhood outcomes as an aid to further disentangle underlying mechanisms.
12
 
Stronger associations for maternal BMI suggest direct intrauterine mechanisms, whereas 
similar or stronger associations for paternal BMI suggest a role for shared genetic or family-
based, lifestyle-related characteristics.
12
 Stronger associations of maternal pre-pregnancy 
BMI with birth weight have been reported than for paternal BMI.
67
 Although studies 
comparing associations of maternal and paternal BMI with childhood BMI have shown 
conflicting results,
68
 studies examining these associations with more detailed childhood fat 
mass measures and other cardio-metabolic risk factors have shown that maternal pre-
pregnancy BMI tends to be more strongly associated with childhood total fat mass, 
android/gynoid fat mass ratio and clustering of cardio-metabolic risk factors than paternal 
BMI.
34, 69
 A study among 940 Swedish children and 873 adolescents showed that higher 
maternal BMI was more strongly associated with offspring cardiorespiratory fitness, after 
taking offspring fatness into account, than paternal BMI.
70
 No such studies have yet been 
performed with other childhood respiratory outcomes. With regard to childhood cognitive 
outcomes, few studies that do not show strong evidence for a potential intrauterine effect 
have been performed. A study among 1,783 Danish parents and their 5-year old children 
observed similar associations for maternal and paternal BMI with childhood IQ.
50
 A study 
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among 2,379 infants and their parents from 2 Southern-European birth cohorts showed that 
although the association for maternal BMI with offspring cognition was stronger than for 
paternal BMI, the confidence intervals of the maternal and paternal effect estimates were not 
statistically different. These findings suggest that maternal pre-pregnancy BMI may, at least 
partly, influence offspring birth weight and childhood cardio-metabolic health through direct 
intrauterine mechanisms, but this remains to be further explored for other childhood health 
outcomes. A limitation of this statistical method is the assumption that a mother and father 
contribute equally to the shared lifestyle-related characteristics between parents and their 
offspring.
68
 However, the influence of the parents on the offspring's diet and exercise may 
differ between mother and father.
68 
 
Another approach used to obtain further insight into the role of confounding in these 
observed associations is by a sibling comparison study.
11, 12
 A sibling comparison study 
allows control for environmental characteristics as well as maternal genotype that are shared 
among siblings.
12
 Important sibling comparison studies have been performed among children 
from mothers who had high levels of pre-pregnancy weight loss due to biliopancreatic 
diversion bariatric surgery. These studies showed that among children born to mothers before 
surgery, the risk of macrosomia, obesity, reduced insulin sensitivity and suboptimal lipid 
levels was higher than among those children born to mothers after surgery.
71
 These findings 
provide evidence to suggest that some of the effect of extreme maternal obesity on offspring 
outcomes may be through direct intrauterine mechanisms. However, it remains unclear 
whether this effect is also present for less extreme maternal pre-pregnancy BMI levels and a 
variety of childhood health outcomes. Two large sibling comparison studies from the USA 
showed that children born to mothers who gained a large amount of weight during pregnancy 
had a higher birth weight and higher childhood BMI than children born to mothers who 
gained less weight during pregnancy.
72, 73
 The association with childhood BMI was only 
partly mediated by offspring birth weight.  A sibling comparison study among Swedish men 
aged 18 years showed that among siblings from overweight and obese mothers, higher total 
gestational weight gain was associated with higher offspring BMI.
74
 However, in the same 
study population, no evidence was found for an association of maternal BMI with offspring 
BMI among siblings.
75
 Thus far, no sibling comparison studies have focused on childhood 
respiratory outcomes and only few sibling comparison studies focused on childhood cardio-
metabolic outcomes or cognitive outcomes. A study among 4,908 brother-pairs from Sweden 
showed no associations of maternal gestational weight gain and offspring blood pressure or 
risk of hypertension at 18 years among siblings.
76
 A study among 333,057 participants from 
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Sweden showed that maternal BMI at the first antenatal visit was not associated with autism 
spectrum disorder among siblings, whereas excessive gestational weight gain was associated 
with the risk of autism spectrum disorder within a matched sibling analysis.
64
 Another study 
among 673,632 individuals from Sweden showed that at the population level, maternal pre-
pregnancy obesity was associated with an increased risk of offspring ADHD, but not among 
siblings.
77
 Thus, findings from sibling comparison studies among less extreme obese 
populations suggest that especially gestational weight gain may affect offspring health 
outcomes through direct intrauterine mechanisms, whereas the associations for maternal pre-
pregnancy BMI with childhood outcomes may be explained by unmeasured confounding 
factors. An important limitation of sibling comparison studies is that besides the major 
exposures of interest, maternal pre-pregnancy BMI and gestational weight gain, other 
lifestyle-related characteristics may differ between siblings.
12
 
A Mendelian randomization approach uses genetic variants, which are robustly 
associated with the exposure of interest and not affected by confounding, as an instrumental 
variable for a specific exposure.
12
 A study among 30,487 mothers-offspring pairs from 18 
cohort studies showed that a genetically higher maternal BMI was associated with a higher 
birth weight, which suggests that genetically higher maternal BMI may be causally related to 
birth weight.
78
 On the contrary, a study among 4,091 mother-offspring pairs showed no 
association of maternal FTO with childhood fat mass at the age of 9 years, which suggests 
that maternal obesity may not be causally related to childhood adiposity outcomes.
69 
However, this study needs to be interpreted cautionary, as this study may be limited by a 
relatively small sample size. The need for a large sample size to have adequate power for 
these types of analyses is an important limitation of the Mendelian Randomization approach. 
However, the findings from these studies mark the importance for further Mendelian 
randomization studies with a larger sample size and using multiple maternal genetic variants 
as instruments focused on a variety of childhood health outcomes.  
Randomized controlled trials are considered as the golden standard to assess 
causality.
11, 12
 However, with randomized controlled trials, we are only able to test a specific 
exposure which is amenable to intervention. Therefore, previous randomized controlled trials 
have focused on influencing determinants of maternal obesity and excessive weight gain 
during pregnancy, such as dietary factors and physical activity levels, since directly 
randomized studies are difficult to perform with maternal pre-pregnancy obesity and 
excessive gestational weight gain as major exposures of interest.
12 
A randomized controlled 
trial among 574 obese infertile women, which provided a 6-month lifestyle intervention 
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program  prior to fertility treatment showed a small reduction in maternal pre-pregnancy 
weight but no effect on rates of healthy singleton life born children.
79
 A meta-analysis among 
44 randomized controlled trials focused on dietary and physical activity interventions during 
pregnancy suggested that especially dietary interventions during pregnancy, and not physical 
activity interventions, may lead to a small reduction in gestational weight gain and to a 
slightly lower risk of adverse pregnancy outcomes.
80
 A Cochrane review which included 65 
randomized controlled trials suggested that interventions during pregnancy focused on diet or 
exercise, or combined, can reduce the risk of excessive gestational weight gain.
81
 However, 
the effect of these interventions on childhood outcomes remains to be explored. A small 
randomized controlled trial among 254 mothers and their children, which provided both 
dietary advice and exercise to obese mothers during pregnancy, showed no difference in their 
infant BMI or metabolic risk factors.
82
 Long-term follow-up of participants in these trials is 
important as it will provide insight into the causality of observed associations as well as the 
effectiveness of maternal lifestyle interventions during pregnancy for improving common 
health outcomes in offspring.
12
 
Altogether, these epidemiological studies specifically designed to explore the 
causality for the associations of maternal obesity with common childhood health outcomes 
show inconsistent results. Each method has important methodological limitations and 
combined results from these different approaches will be needed to obtain further insight into 
the causality of these observed associations.  
 
Underlying mechanisms 
The mechanisms underlying the associations of maternal pre-pregnancy obesity or excessive 
gestational weight gain with offspring health outcomes remain unclear. Maternal pre-
pregnancy BMI and gestational weight gain are complex traits, which are inversely 
correlated.
20
 In general, women with a higher pre-pregnancy BMI gain less weight during 
pregnancy as compared to women with a lower pre-pregnancy BMI.
8
 Most observational 
studies mutually adjusted their analyses for maternal pre-pregnancy BMI and gestational 
weight gain to explore the independent effects of these maternal exposures on offspring 
outcomes.
11, 12
 However, both maternal pre-pregnancy BMI and gestational weight gain 
reflect multiple components.
12
 Maternal pre-pregnancy obesity not only reflects maternal fat 
accumulation, but also other maternal characteristics, including maternal nutritional status, 
insulin and glucose metabolism and low-grade systemic inflammation.
12
 Similarly, maternal 
weight gain during pregnancy reflects maternal fat accumulation, but also maternal and 
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amniotic fluid expansion and growth of the fetus, placenta and uterus.
12 
Both maternal pre-
pregnancy obesity and excessive gestational weight gain as well as the correlated maternal 
exposures may lead to programming effects in the offspring through several pathways.
12 
 
Not much is known about the potential programming effects by maternal obesity or 
excessive gestational weight gain. The fetal overnutrition hypothesis suggests that increased 
placental transfer of nutrients to the developing fetus in obese mothers and mothers with high 
levels of gestational weight gain, may subsequently affect fetal development, fetal fat 
deposition and the development of the hypothalamic-endocrine system that controls appetite 
and energy metabolism.
12
 Inflammation and immunological mechanisms due to maternal 
obesity during pregnancy may also affect offspring cardio-metabolic, pulmonary and brain 
development.
65, 83, 84
 This may predispose individuals to a greater risk of adverse health 
outcomes in later life. Accumulating evidence suggests that epigenetic mechanisms may play 
a key role in these programming mechanisms.
85
 Thus far, animal studies provide support for 
programming effects of maternal obesity and excessive gestational weight gain through 
epigenetic mechanisms.
86
 Also, several small human studies using a epigenome-wide 
approach showed associations of maternal pre-pregnancy BMI or gestational weight gain 
with DNA methylation in offspring cord blood.
87-91
 However, the mechanisms proposed have 
not been tested yet in large epidemiological studies. Further mechanistic studies are important 
to obtain a better understanding of the underlying mechanisms.  
 
Challenges for future epidemiological research 
Although current evidence suggests that maternal obesity during pregnancy adversely affect 
common childhood health outcomes, there remain major issues to be addressed in future 
studies, as previously described.
11, 12
  
 First, despite extensive adjustment for potential confounding factors in most studies 
and the use of more sophisticated study designs in some observational studies, the causality 
of the observed associations remains unclear. Large observational studies with sophisticated 
designs, such as parent-offspring comparison studies, sibling comparison studies and 
Mendelian randomization studies are needed for insight into the causality of the observed 
associations.
11, 12
 These studies need to move beyond childhood adiposity as an outcome of 
interest and also focus on a variety of offspring health outcomes, including cardio-metabolic, 
respiratory and cognitive outcomes. Long-term follow-up of participants in trials focused on 
reducing maternal weight throughout pregnancy will also provide further insight into the 
causality of the observed associations.
11, 12
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Second, the underlying mechanisms of the observed associations of maternal obesity 
during pregnancy with childhood health outcomes need to be further explored.
11, 12
 Although 
animal studies and small human studies have suggested several pathways that may be 
involved in the observed associations, these pathways remain to be studied in large human 
studies.
11, 12
 Identification of potential underlying pathways is complicated, as maternal pre-
pregnancy obesity and excessive gestational weight gain both reflect several lifestyle-related 
and biological components.
11, 12
 Future studies need to obtain detailed assessments of the 
maternal exposures of interest from the start of pregnancy onwards, such as repeated 
measurements of maternal weight, body composition and metabolic status.
11, 12
 For the 
offspring outcomes, more detailed measurements of growth, body composition, cardio-
metabolic, respiratory and cognitive development, such as cardiac structures, endothelial 
function, lipid spectrums, insulin/glucose metabolism, spirometry parameters, fractional 
exhaled nitric oxide levels, bronchial hyper-responsiveness and cranial structures assessed by 
MRI might also lead to further insight into the underlying mechanisms present in the 
observed associations. Since epigenetic mechanisms are one of the major underlying 
mechanisms of interest, repeated offspring blood samples throughout the life course are 
needed to assess the influence of the specific maternal exposures on offspring epigenetic 
adaptations. Long-term follow-up of participants in observational studies is needed to assess 
the influence on common adverse health outcomes throughout the life-course.
11, 12
 
Third, further research focused on optimizing maternal pre-pregnancy BMI and 
weight gain during pregnancy for the prevention of adverse health outcomes in offspring is 
needed.
11, 12
 Further insight needs to be obtained into the optimal amounts of maternal weight 
gain for short- and long-term maternal and offspring health outcomes to further improve the 
IOM recommendations for gestational weight gain.
11, 12
 By conducting long-term follow-up 
studies of mothers and their children participating in randomized trials focused on reducing 
maternal weight throughout pregnancy by dietary and physical activity interventions, we will 
gain insight into the effectiveness of these maternal lifestyle interventions during pregnancy 
for improving a variety of long-term health outcomes in offspring.
11, 12
 
 
Conclusions 
Maternal pre-pregnancy obesity and excessive weight gain during pregnancy are common 
and important modifiable risk factors for adverse fetal outcomes and childhood adiposity, 
cardio-metabolic, respiratory and cognitive related health outcomes. To explore the causality 
of these associations, parent offspring comparison studies, sibling comparison studies, 
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Mendelian randomization studies and randomized controlled trials are needed. Further 
mechanistic studies, especially in large human populations are needed to obtain insight in the 
underlying mechanisms. Finally, the potential for prevention of common diseases in future 
generations by reducing maternal obesity and excessive weight gain during pregnancy needs 
to be explored. Preventive strategies focused on improving maternal health in the 
preconception period and in pregnancy by optimizing preconception care may improve long-
term health outcomes in the offspring. 
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Table 1. IOM criteria for gestational weight gain
1
 
Pre-pregnancy body mass index 
Recommended amount of  
total gestational weight gain, kg 
Underweight  
(Body mass index< 18.5 kg/m
2
) 
12.5–18 
Normal weight 
(Body mass index ≥ 18.5–24.9 kg/m2) 
11.5–16 
Overweight  
(Body mass index ≥ 25.0–29.9 kg/m2) 
7–11.5 
Obesity  
(Body mass index ≥ 30.0 kg/m2) 
5–9 
1
 Recommended gestational weight gain guidelines according to women’s pre-pregnancy body mass 
index. Adapted from the IOM criteria.
8
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Figure 1. Maternal obesity during pregnancy and adverse childhood outcomes  
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CHAPTER 2.2 
 
Maternal obesity, excessive gestational weight gain 
and subcutaneous fat mass in infancy  
 
Varsha V. Jharap, Susana Santos, Eric A.P. Steegers, Vincent W.V. Jaddoe, Romy 
Gaillard 
 
Adapted from Early Hum Dev 2017;108:23-28. 
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Abstract 
 
Background: Not much is known about the associations of maternal obesity and excessive 
gestational weight gain with body fat in infancy. 
 
Objective: To examine the associations of maternal pre-pregnancy body mass index and 
gestational weight gain with infant subcutaneous fat. 
 
Methods: In a population-based prospective cohort study among 845 mothers and their 
infants, we obtained maternal pre-pregnancy body mass index and measured maternal weight 
during pregnancy. At 1.5, 6 and 24 months, we estimated infant total subcutaneous fat (sum 
of biceps, triceps, suprailiacal and subscapular skinfold thicknesses) and central-to-total 
subcutaneous fat ratio (sum of suprailiacal and subscapular skinfold thicknesses/total 
subcutaneous fat). 
 
Results: Maternal body mass index was positively associated with higher infant body mass 
index from 6 months onwards. Maternal body mass index was not associated with infant 
subcutaneous fat measures at 1.5 or 6 months. A 1-standard deviation scores (SDS) higher 
maternal body mass index was associated with a 0.09 (95% Confidence Interval 0.01, 0.17) 
SDS higher infant total subcutaneous fat at 24 months, but not with central-to-total 
subcutaneous fat ratio. No associations were present for maternal total or period-specific 
gestational weight gain with infant fat.       
 
Conclusion: Maternal body mass index was positively associated with infant body mass 
index and total subcutaneous fat in late infancy. Maternal total and period-specific gestational 
weight gain were not associated with infant body fat mass measures. 
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Introduction 
Maternal pre-pregnancy obesity and excessive weight gain during pregnancy are associated 
with an increased risk of obesity in childhood.
1,2
 Body mass index is a suboptimal measure of 
body fat mass and provides no information about body fat distribution.
3
 Several studies have 
shown that compared to body mass index, central fat distribution is more strongly associated 
with an adverse cardiovascular risk profile.
4
 Previously, we reported that maternal obesity 
and excessive weight gain especially in early-pregnancy seem to be associated with an 
adverse body fat distribution, such as higher android-to-gynoid fat mass ratio, at 6 years.
5,6
 
We have also shown that maternal pre-pregnancy body mass index tended to be more 
strongly associated with childhood total and abdominal fat than paternal body mass index, 
suggesting that intrauterine mechanisms might be involved.
6
 Thus far, previous studies did 
not assess the associations and explore the underlying mechanisms of maternal obesity and 
excessive weight gain during pregnancy with detailed offspring fat mass measures already 
from early infancy onwards, which is a well-known critical period for adiposity development 
in later life.
7
 Skinfold thickness is a valid measurement of total and regional subcutaneous fat 
mass in infancy.
8
 We have previously shown that subcutaneous fat mass measured by 
skinfolds tends to track throughout infancy and is positively associated with cholesterol levels 
at school-age children.
9,10
  
Therefore, we examined in a population-based prospective cohort study among 845 
parents and their infants, the associations of maternal pre-pregnancy body mass index and 
weight gain in different periods of pregnancy with subcutaneous fat mass measures 
throughout infancy. We also compared the strength of the associations of maternal and 
paternal body mass index with infant fat mass measures to obtain further insight in the 
underlying mechanisms.  
 
Methods  
 
Study design 
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards among 9,778 mothers and their children living in 
Rotterdam, the Netherlands.
11
 The local Medical Ethical Committee approved the study. 
Written informed consent was obtained from parents. Additional detailed assessments of 
growth and development were conducted in a subgroup of Dutch mothers and their children 
from late pregnancy onwards. Of all approached women, 80% agreed to participate. From the 
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total of 1,205 mothers and their singleton children participating in the subgroup study, 1,033 
mothers had information about pre-pregnancy body mass index. Missing information about 
pre-pregnancy body mass index was mainly because of later enrolment in the study and 
nonparticipation in the first questionnaire. Body mass index or skinfold thicknesses measured 
at the age of 1.5, 6 or 24 months were available in 845 children (Flow chart is given in 
Supplemental Figure S1). Missing body fat mass measurements during infancy were due to 
loss to follow-up or crying behavior.  
 
Parental anthropometrics 
As previously described, maternal pre-pregnancy weight was obtained by questionnaire at 
enrolment.
11
 Maternal height (cm) and paternal height (cm) and weight (kg) were measured 
without shoes and heavy clothing at enrolment. Body mass index (kg/m
2
) was calculated. 
Maternal and paternal body mass index were categorized into 4 categories (underweight (<20 
kg/m
2
), normal weight (20–24.9 kg/m2), overweight (25–29.9 kg/m2), and obese (≥30 
kg/m
2
)). We measured maternal weight without shoes and heavy clothing at median 12.8 
(95% range 9.9,17.0), 20.4 (95% range 18.6,22.7) and 30.4 (95% range 28.5,32.5) weeks of 
gestation. In a subgroup of 509 mothers, information about maximum weight during 
pregnancy was assessed by questionnaire 2 months after delivery. Based on the timing of 
maternal weight measurements within our study cohort, we defined early-, mid- and late-
pregnancy weight, using self-reported and measured maternal weight data, as: at 13 weeks of 
gestation (median 12.8, 95% range 9.9,18.9); at 26 weeks of gestation (median 29.9, 95% 
range 20.4,31.6); and at 40 weeks of gestation (median 39.0, 95% range 32.6,42.0), 
respectively. Using this method, information about early-, mid- and late-pregnancy weight 
was available for 762, 824 and 493 mothers, respectively. Among the subgroup of mothers 
with maximum weight during pregnancy available, we defined excessive gestational weight 
gain in relation to maternal pre-pregnancy body mass index according to the Institute of 
Medicine (IOM) guidelines.
12
  
 
Body fat measurements during infancy 
We measured weight to the nearest gram in naked infants at the age of 1.5 and 6 months by 
using an electronic infant scale and at 24 months by using a mechanical personal scale 
(SECA, Almere, the Netherlands). Body length at the age of 1.5 and 6 months was measured 
in supine position to the nearest millimeter by using a neonatometer and body height at 24 
months was measured in standing position by using a Harpenden stadiometer (Holtain 
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Limited, Dyfed, UK). Body mass index (kg/m
2
) was calculated. We measured skinfold 
thicknesses at the ages of 1.5, 6 and 24 months on the left side of the body at the biceps, 
triceps, suprailiacal and subscapular area by using a skinfold caliper (Slim Guide, Creative 
Health Products).
9
 We calculated total subcutaneous fat mass from the sum of all four 
skinfold thicknesses, and central subcutaneous fat mass from the sum of suprailiacal and 
subscapular skinfold thicknesses.
13
 Measurements of body fat quantity and distribution 
require appropriate adjustment for body size or total fat mass, respectively, in order to 
undertake informative comparisons between children and within children over time. To create 
total subcutaneous fat mass independent of length or height and central subcutaneous fat 
mass independent of total subcutaneous fat mass, we estimated the optimal adjustment by 
log-log regression analyses.
14
 Based on these analyses, total subcutaneous fat mass was only 
weakly correlated with length at 1.5 and 6 months or height at 24 months, and was not 
adjusted for it. A central-to-total subcutaneous fat mass ratio was calculated as central 
divided by total subcutaneous fat mass.  
 
Covariates 
Information on maternal and paternal age, educational level and parity was obtained at 
enrolment.
11
 Information on maternal smoking was assessed by questionnaires during 
pregnancy. First trimester maternal nutritional information was obtained by food frequency 
questionnaire. Information about pregnancy complications, mode of delivery, child’s sex, 
gestational age and weight at birth was obtained from medical records.
15
 Information about 
breastfeeding duration and timing of introduction of solid foods was obtained by 
questionnaires in infancy.  
 
Statistical analysis 
First, we examined differences in subject characteristics between maternal body mass index 
categories with 1-way ANOVA tests and χ2 tests. Next, we examined the associations of 
maternal and paternal body mass index with infant subcutaneous fat mass measures at each 
time period using linear regression models. We also used repeated measurement regression 
models to assess the associations of parental pre-pregnancy overweight with the repeatedly 
measured infant fat mass measures. These models take the correlation between repeated 
measurements of the same subject into account, and allow for incomplete outcome data. 
Third, we examined the associations of maternal maximum gestational weight gain and 
excessive gestational weight gain according to the IOM criteria with infant subcutaneous fat 
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mass measures using linear regression models. Since maternal weight measurements 
throughout pregnancy are strongly correlated, we performed conditional linear regression 
analyses to assess the independent associations of maternal pre-pregnancy weight and early-, 
mid- and late-pregnancy weight gain with infant subcutaneous fat mass measures. We 
obtained standardized residuals for each weight measurement from the regression of maternal 
weight at a specific time point on prior maternal weight measurements. These weight 
variables are statistically independent from each other, and can be simultaneously included in 
the regression models.
16
  
Models were adjusted for maternal and childhood socio-demographic and lifestyle-
related characteristics. Covariates were included based on associations with the exposures 
and outcomes of interest in previous studies, or a change in effect estimates >10%. We 
constructed SDS ((observed value−mean)/SD) for parental body mass index and gestational 
weight gain and infant fat mass measures to enable comparison of effect estimates. Since no 
significant interactions between parental body mass index or maternal gestational weight gain 
and child’s sex in the associations with infant subcutaneous fat mass measures were present, 
no further stratified analyses were performed. Missing values in covariates were multiple-
imputed, by using Markov chain Monte Carlo approach. Five imputed datasets were created 
and analyzed together. All statistical analyses were performed using the Statistical Package of 
Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA). 
 
Results 
 
Subject characteristics 
Characteristics of included mothers, fathers and their children are given in Table 1. Non-
response analyses showed that as compared to mothers who did not participate in the follow-
up studies, those who did participate were slightly older, had a higher educational level and 
their children were breastfed for a longer period (p<0.05), but no differences were observed 
regarding maternal and paternal body mass index and maternal weight gain during pregnancy 
(Supplemental Table S1). 
 
Parental body mass index and infant body fat 
Table 2 shows the associations of maternal and paternal body mass index with infant 
subcutaneous fat mass measures. We observed no associations of maternal pre-pregnancy 
body mass index with infant body fat mass measures at 1.5 months. A higher maternal pre-
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pregnancy body mass index was associated with higher infant body mass index from 6 
months onwards (difference at 6 and 24 months: 0.09 (95% Confidence Interval (CI) 
0.01,0.17) SDS, 0.17 (95% CI 0.09,0.26) SDS per 1-SDS higher maternal body mass index, 
respectively). A higher maternal pre-pregnancy body mass index was also associated with 
higher infant total subcutaneous fat mass at 24 months (difference: 0.09 (95% CI 0.01, 0.17) 
SDS per 1-SDS higher maternal body mass index), but not with infant central-to-total 
subcutaneous fat mass ratio. A higher paternal body mass index was only associated with 
higher infant body mass index at 1.5 and 24 months (p-values<0.05). Including both maternal 
and paternal body mass index in the same model did not change the effect estimates for infant 
fat mass measures at 1.5, 6 and 24 months. 
Supplemental Figure S2 shows that maternal pre-pregnancy overweight was 
associated with higher infant body mass index growth from 6 months onwards, resulting in 
higher body mass index at 24 months (all p-values<0.05). Maternal pre-pregnancy 
overweight also tended to be associated with higher total subcutaneous fat mass and central-
to-total subcutaneous fat mass ratio at 24 months (difference: 0.09 (95% CI 0.01,0.17) SDS, 
0.08 (95% CI -0.01,0.17) SDS for maternal pre-pregnancy overweight as compared to 
maternal pre-pregnancy normal weight, respectively). No associations of paternal overweight 
with infant body fat mass measures were present.    
 
Maternal gestational weight gain and infant body fat 
Table 3 shows no consistent associations for maternal maximum and excessive gestational 
weight gain with infant body mass index and subcutaneous fat mass measures at 1.5, 6 and 24 
months. Excessive maternal gestational weight gain was only associated with higher infant 
body mass index at 6 months (difference: 0.30 (95% CI 0.11,0.48) SDS for excessive 
maternal weight gain as compared to non-excessive weight gain). No associations were 
observed for maternal weight gain measured until 30 weeks of gestation with infant body fat 
mass measures (Supplemental Table S2). In Supplemental Figure S3, early-pregnancy 
weight gain was associated with higher total subcutaneous fat mass at 6 months, but not at 
older ages. No independent associations were observed for maternal mid- and late-pregnancy 
weight gain with infant fat mass measures. 
 
Discussion 
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This study showed that maternal pre-pregnancy body mass index was positively associated 
with infant body mass index and total subcutaneous fat mass from 6 months onwards. 
Maternal total and period-specific gestational weight gain were not associated with infant 
body fat mass measures. 
 
Methodological considerations 
Strengths of this study were the prospective design with extensive maternal data collection 
from early pregnancy onwards and detailed infant body fat measurements available. Of the 
1,033 mothers and their singleton children with pre-pregnancy body mass index available, 
82% (845) had information on infant body fat measures. The non-response could lead to 
biased effect estimates if the associations of maternal obesity during pregnancy with infant 
body fat were different between participants included and excluded in the analyses. This 
seems unlikely since no differences were observed between participants and non-participants 
regarding parental pre-pregnancy body mass index and maternal gestational weight gain. A 
limitation of our study might be the generalizability of our findings to other ethnic groups, 
due to our homogenous ethnic study population. Maternal pre-pregnancy body mass index 
and maximum gestational weight gain were self-reported, which may have led to 
misclassification and underestimation of the reported associations. However, we observed 
similar results when we used maternal weight measured at enrolment (results not shown) and 
weight gain measured until 30 weeks of gestation. Skinfold thickness is a valid measure to 
estimate infants subcutaneous fat mass but provides no information about intra-abdominal fat 
mass.
8
 However, infants body fat is mainly located subcutaneously in the first two years of 
life.
17
 Also, inter- and intra-observer measurement error might be larger compared to other 
anthropometric measurements.
18,19
  
 
Interpretation of main findings 
A higher maternal pre-pregnancy body mass index is associated with higher body mass index 
from early childhood onwards.
1,2
 Also, maternal pre-pregnancy obesity seems to be 
associated with an adverse offspring body fat pattern, characterized by higher total fat mass 
and abdominal fat mass levels from the age of 2 years onwards.
20-22
 A study among 325 
infants showed that maternal pre-pregnancy obesity was positively associated with total fat 
mass already throughout infancy.
23
 In the current study, we observed that maternal pre-
pregnancy body mass index was already associated with a higher infant body mass index and 
total subcutaneous fat mass from the age of 6 months onwards. No associations were 
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observed for central-to-total subcutaneous fat mass ratio at all ages. Thus, maternal obesity 
seems to influence total body fat mass development already from early infancy onwards.  
By comparing the strength of associations of maternal and paternal body mass index 
with offspring fat mass outcomes, further insight into the underlying mechanisms can be 
obtained. Stronger maternal associations would suggest that intrauterine programming effects 
might be part of the underlying mechanisms, whereas similar or stronger paternal 
associations suggests that genetics and lifestyle-related characteristics might explain the 
observed associations. Previous studies comparing the strength of associations of parental 
body mass index with infant and childhood body mass index have reported inconsistent 
associations.
24-26
 We have shown, among 4,871 parents and their 6-year-old children, that 
maternal pre-pregnancy body mass index was more strongly associated with childhood total 
fat mass and android-to-gynoid fat mass ratio, as compared to paternal body mass index.
6
 In 
this current study, we observed more consistent and stronger associations for maternal pre-
pregnancy body mass index with infant subcutaneous fat mass measures from the age of 6 
months onwards, as compared to the associations of paternal body mass index with infant 
outcomes. At 1.5 months, we observed stronger associations for paternal body mass index 
with infant body mass index as compared to maternal body mass index. Thus, these results 
suggest that intrauterine programming effects may become more apparent at later ages. The 
intrauterine programming effects may involve increased placental transfer of nutrients during 
fetal development. This may subsequently cause permanent adaptations in appetite, energy 
metabolism and neuro-endocrine function in offspring, which predispose individuals to a 
greater risk of obesity in later life.
24
 These findings could also be explained by a stronger 
influence of maternal lifestyle-related characteristics on child’s lifestyles and subsequent 
body fat mass. However, previous studies have suggested that maternal and paternal diet and 
physical activity are both associated with child’s diet and physical activity, without a stronger 
maternal influence.
27,28
 Also, since we adjusted our analyses for multiple potential 
confounders the influence of lifestyle-related characteristics on our findings might be limited. 
Next to maternal pre-pregnancy obesity, higher maternal total gestational weight gain 
is also associated with a higher childhood body mass index, total fat mass levels and waist 
circumference.
29,30
 We did not observe consistent associations of maternal total gestational 
weight gain with early infant fat mass measures. It has been suggested that the associations of 
maternal weight gain with offspring fat mass outcomes may depend upon the timing of 
gestational weight gain. A prospective cohort study among 5,154 UK mothers and their 
children  showed that maternal weight gain during early-pregnancy was positively associated 
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with childhood body mass index and total fat mass.
25
 In line with these findings, we have 
previously shown that a higher maternal weight gain, especially in early-pregnancy, is 
associated with a higher childhood body mass index, total body fat mass and abdominal fat 
mass levels at the age of 6 years.
5
 However, these associations were weaker as compared to 
the associations for maternal pre-pregnancy body mass index with these offspring fat mass 
measures. A study among 977 Greek mothers and their children aged 4 years showed that 
maternal weight gain during early-pregnancy was positively associated with childhood body 
mass index, waist circumference and sum of skinfold thickness.
31
 In the current study, no 
associations were present for maternal early-, mid- and late-pregnancy weight gain during 
pregnancy with early infant fat mass measures. Thus, maternal weight gain during pregnancy 
seems not to influence fat mass development in early infancy, but the effects may become 
more apparent at older offspring ages.  
 
Conclusions 
A higher maternal pre-pregnancy body mass index is associated with higher infant body mass 
index and total subcutaneous fat mass from the age of 6 months onwards. Maternal 
gestational weight gain was not associated with infant body fat. Further studies are needed to 
obtain insight into the causality of the observed associations, and the underlying biological 
mechanisms. 
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Table 1. Characteristics of mothers, fathers and their children
1
  
Characteristics 
Total group 
(N=845) 
Maternal 
underweight 
(N=113) 
Maternal normal 
weight (N=518) 
Maternal 
overweight 
(N=151) 
Maternal 
obesity (N=63) 
P-value 
Maternal characteristics       
Age, mean (SD), years 31.8 (4.1) 31.4 (4.8) 32.0 (4.0) 31.7 (3.8) 31.1 (4.2) 0.206 
Education (higher education), n (%) 548 (65.2) 70 (61.9) 368 (71.5) 86 (57.3) 24 (38.1) <0.001 
Parity (nulliparous), n (%) 522 (61.8) 71 (62.8) 322 (62.6) 89 (58.9) 40 (63.5) 0.878 
Body mass index, mean (SD), kg/m
2 
23.5 (4.1) 19.0 (0.7) 22.2 (1.4) 26.9 (1.4) 34.1 (3.5) <0.001 
Maximum gestational weight gain, mean (SD), kg 15.5 (5.7) 14.7 (4.9) 15.8 (5.2) 16.2 (6.0) 12.7 (8.6) 0.005 
Excessive gestational weight gain (IOM criteria), n (%) 242 (47.9) 13 (20.0) 132 (42.9) 76 (78.4) 23 (59.0) <0.001 
Weight in early-pregnancy, mean (SD), kg 70.8 (12.9) 57.6 (5.9) 67.1 (6.5) 80.8 (7.7) 100.0 (12.9) <0.001 
Weight in mid-pregnancy, mean (SD), kg 78.0 (13.3) 64.6 (6.1) 74.4 (7.7) 88.5 (8.5) 105.4 (12.9) <0.001 
Weight in late-pregnancy, mean (SD), kg 84.5 (13.5) 71.2 (6.8) 80.9 (8.3) 94.8 (9.2) 112.7 (13.7) <0.001 
Total energy intake, mean (SD), kcal 2119 (512) 2246 (504) 2131 (510) 2040 (481) 1969 (568) 0.069 
Smoking during pregnancy (yes), n (%) 186 (23.3) 27 (26.0) 112 (23.0) 38 (25.9) 9 (15.0) 0.351 
Gestational diabetes, n (%) 9 (1.1) 0 (0) 3 (0.6) 4 (2.7) 2 (3.2) 0.034 
Gestational hypertensive disorders, n (%) 62 (7.6) 4 (3.5) 27 (5.4) 15 (10.1) 16 (29.6) <0.001 
Paternal characteristics       
Age, mean (SD), years 33.9 (5.1) 33.5 (5.6) 34.1 (5.0) 33.6 (4.2) 33.9 (6.3) 0.517 
Education (higher education), n (%) 472 (64.2) 68 (68.7) 312 (68.7) 73 (55.7) 19 (37.3) <0.001 
Body mass index, mean (SD), kg/m
2
 25.2 (3.2) 24.5 (2.9) 25.0 (2.9) 26.0 (3.6) 26.6 (4.4) <0.001 
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Birth and infant characteristics       
Boys, n (%) 439 (52.0) 60 (53.1) 277 (53.5) 69 (45.7) 33 (52.4) 0.405 
Gestational age at birth, median (95% range), weeks 40.3 (35.9-42.4) 40.0 (36.0-42.0) 40.4 (35.9-42.6) 40.4 (35.6-42.4) 39.9 (34.3-42.8) 0.013 
Birth weight, mean (SD), g 3515 (537) 3342 (527) 3530 (526) 3582 (545) 3542 (576) 0.002 
Caesarean delivery, n (%) 119 (14.9) 13 (11.9) 71 (14.8) 21 (14.4) 14 (22.2) 0.326 
Breastfeeding duration, mean (SD), months 4.4 (3.9) 4.7 (4.2) 4.6 (3.8) 4.4 (3.9) 2.7 (3.6) 0.008 
Introduction of solids foods (before 6 months), n (%) 600 (80.2) 71 (73.9) 371 (79.6) 116 (86.6) 42 (80.8) 0.004 
Infant fat mass measures       
1.5 months       
Age, mean (SD), months 1.6 (0.5) 1.6 (0.4) 1.7 (0.5) 1.5 (0.4) 1.6 (0.5) 0.029 
Body mass index, mean (SD), kg/m
2 
15.2 (1.4) 14.9 (1.3) 15.2 (1.4) 15.3 (1.5) 15.1 (1.4) 0.273 
Total subcutaneous fat mass, mean (SD), mm 24.4 (7.5) 23.6 (7.8) 24.7 (7.8) 23.9 (6.7) 24.4 (7.0) 0.538 
Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.50 (0.05) 0.50 (0.05) 0.50 (0.04) 0.50 (0.04) 0.949 
6 months       
Age, mean (SD), months 6.5 (0.7) 6.6 (0.7) 6.5 (0.7) 6.6 (0.8) 6.4 (0.6) 0.252 
Body mass index, mean (SD), kg/m
2 
16.8 (1.3) 16.6 (1.3) 16.7 (1.3) 16.9 (1.4) 17.1 (1.4) 0.068 
Total subcutaneous fat mass, mean (SD), mm 27.1 (6.5) 26.3 (6.1) 27.0 (6.3) 27.7 (7.4) 27.5 (5.7) 0.420 
Central-to-total subcutaneous fat mass ratio, mean (SD) 0.47 (0.06) 0.47 (0.06) 0.46 (0.06) 0.47 (0.05) 0.48 (0.06) 0.163 
24 months       
Age, mean (SD), months 25.3 (1.2) 25.3 (1.1) 25.3 (1.2) 25.2 (1.2) 25.4 (1.0) 0.804 
Body mass index, mean (SD), kg/m
2 
15.9 (1.3) 15.6 (1.4) 15.8 (1.2) 16.1 (1.3) 16.6 (1.4) <0.001 
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Total subcutaneous fat mass, mean (SD), mm 27.6 (7.3) 26.9 (6.2) 27.4 (7.3) 27.6 (7.3) 30.0 (9.2) 0.078 
Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.07) 0.44 (0.07) 0.42 (0.06) 0.43 (0.06) 0.45 (0.08) 0.013 
 
1
Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %).
 
Total subcutaneous fat mass = 
biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. SD, standard deviation. IOM criteria, Institute of Medicine criteria. 
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Table 2. Associations of parental body mass index with infant subcutaneous fat mass measures
1
 
 
Fat mass measures in standard deviation scores 
Difference (95% Confidence Interval) 
 1.5 months 6 months 24 months 
Model 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Maternal model 
   
   
   
  n = 845 n = 729 n = 694 n = 694 n = 739 n = 733 n = 733 n = 659 n = 631 n = 631 
  Unadjusted model  
0.05  
(-0.03,0.12) 
0 
(-0.08,0.08) 
0.04  
(-0.04,0.11) 
0.09 
(0.02,0.17)* 
0.04 
(-0.04,0.11) 
0.01 
(-0.07,0.08) 
0.19 
(0.11,0.25)** 
0.08 
(0.01,0.16)* 
0.08 
(0.01,0.16)* 
  Adjusted model§ 
0.03 
(-0.04,0.10) 
-0.02 
(-0.10,0.06) 
0.04 
(-0.04,0.12) 
0.09 
(0.01,0.17)* 
0.02 
(-0.06,0.10) 
0.02 
(-0.06,0.10) 
0.17 
(0.09,0.26)** 
0.09 
(0.01,0.17)* 
0.08 
(-0.01,0.17) 
Paternal model          
  n = 797 n = 687 n = 656 n = 656 n = 700 n = 693 n = 693 n = 621 n = 597 n = 597 
  Unadjusted model 
0.12  
(0.05,0.20)* 
-0.02 
(-0.10,0.06) 
0.06  
(-0.01,0.14) 
0.05 
(-0.02,0.13) 
-0.01 
(-0.09,0.06) 
0.02 
(-0.06,0.09) 
0.10  
(0.02,0.18)* 
0.03  
(-0.05,0.11) 
0.08  
(-0.01,0.16) 
  Adjusted model¶ 
0.10 
(0.03,0.17)* 
-0.02 
(-0.10,0.05) 
0.06 
(-0.02,0.13) 
0.04 
(-0.04,0.12) 
-0.03 
(-0.11,0.05) 
0.03 
(-0.05,0.11) 
0.08 
(0.01,0.16)* 
0.02 
(-0.06,0.10) 
0.07 
(-0.01,0.15) 
Combined maternal and 
paternal model 
         
  n = 797 n = 687 n = 656 n = 656 n = 700 n = 693 n = 693 n = 621 n = 597 n = 597 
  Unadjusted model          
      Maternal  body mass index 
0.02  
(-0.06,0.09) 
0 
(-0.08,0.08) 
0.03  
(-0.05,0.11) 
0.09 
(0.01,0.16)* 
0.04 
(-0.04,0.11) 
0.01 
(-0.07,0.08) 
0.18 
(0.10,0.26)** 
0.08 
(0.01,0.16)* 
0.07  
(-0.01,0.15) 
      Paternal  body mass index 
0.12  
(0.04,0.19)* 
-0.02 
(-0.10,0.06) 
0.06  
(-0.02,0.14) 
0.03 
(-0.05,0.11) 
-0.02 
(-0.10,0.06) 
0.01 
(-0.07,0.09) 
0.06  
(-0.02,0.13) 
0.01  
(-0.07,0.09) 
0.06  
(-0.02,0.14) 
  Adjusted model‡ 
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1
Values are regression coefficients (95% confidence interval) from linear regression models that reflect differences in subcutaneous fat mass 
measures in standard-deviation scores at 1.5, 6 and 24 months per standard-deviation scores change in maternal and paternal pre-pregnancy body 
mass index. Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat 
mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. 
§Maternal model includes maternal age and educational level, parity, maternal total energy intake, smoking habits and weight gain until 30 
weeks of gestation, gestational diabetes, gestational hypertensive disorders, child’s sex and gestational age-adjusted birth weight standard-
deviation scores, cesarean delivery, breastfeeding duration and timing of introduction of solid foods (for 6 and 24 months outcomes).                                                                                                                                                       
¶Paternal model includes the same potential confounders as maternal model but paternal age and educational level instead of maternal age and 
educational level.                                                                                                                                                               
‡Combined maternal and paternal model includes all potential confounders. 
*P-value<0.05; **P-value<0.01. 
      Maternal  body mass index 
0.01  
(-0.06,0.08) 
-0.02 
(-0.11,0.06) 
0.05  
(-0.04,0.13) 
0.09 
(0.01,0.17)* 
0.03 
(-0.06,0.11) 
0.02 
(-0.06,0.11) 
0.17 
(0.09,0.26)** 
0.09 
(0.01,0.18)* 
0.07  
(-0.02,0.16) 
      Paternal  body mass index 
0.10  
(0.03,0.16)* 
-0.02 
(-0.10,0.06) 
0.05  
(-0.03,0.13) 
0.02 
(-0.05,0.10) 
-0.04 
(-0.12,0.05) 
0.02 
(-0.06,0.10) 
0.05  
(-0.03,0.13) 
0  
(-0.08,0.09) 
0.06  
(-0.02,0.14) 
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Table 3. Associations of maternal maximum gestational weight gain with infant subcutaneous fat mass measures
1
 
 
1
Values are regression coefficients (95% confidence interval) from linear regression models that reflect differences in subcutaneous fat mass 
measures in standard-deviation scores at 1.5, 6 and 24 months per standard-deviation scores change in maternal maximum gestational weight 
gain or for excessive weight gain as compared to the reference group (insufficient and sufficient weight gain). Total subcutaneous fat mass = 
biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass.                                                
¶Adjusted for maternal age and educational level, parity, pre-pregnancy body mass index (for models with maximum gestational weight gain as 
a continuous variable), maternal total energy intake, smoking habits during pregnancy, gestational diabetes, gestational hypertensive disorders, 
 
Fat mass measures in standard deviation scores 
Difference (95% Confidence Interval) 
 1.5 months 6 months 24 months 
 
Body mass 
index  
Total 
subcutaneou
s fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneou
s fat mass 
ratio 
Body mass 
index  
Total 
subcutaneou
s fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Maximum gestational weight gain model 
   
   
   
  n = 501 n = 447 n = 430 n = 430 
n = 466 n = 460 n = 460 
n = 433 n = 414 n = 414 
  Unadjusted  
0.10 
(0.01,0.19)* 
-0.03 
(-0.12,0.07) 
-0.02  
 (-0.11,0.08) 
0.11 
(0.02,0.20)* 
0.06 
 (-0.04,0.15) 
0.04 
(-0.05,0.14) 
0 
(-0.10,0.09) 
-0.05 
(-0.14,0.05) 
-0.10 
(-0.20,-0.01)* 
  Adjusted  
0.05 
(-0.04,0.14) 
-0.04 
(-0.14,0.06) 
0.01 
(-0.09,0.12) 
0.09 
(-0.01,0.19) 
0.09 
(-0.01,0.19) 
0.07 
(-0.03,0.17) 
0.01 
(-0.09,0.10) 
-0.04 
 (-0.14,0.06) 
-0.11 
(-0.21,-0.01)* 
Excessive gestational weight gain  
model¶ 
   
   
   
  n = 242 n = 219 n = 212 n = 212 
n = 225 n = 222 n = 222 
n = 213 n = 202 n = 202 
  Unadjusted  
0.19 
(0.01,0.37)* 
0 
(-0.19,0.19) 
0.04 
(-0.15,0.23) 
0.32 
(0.14,0.50)** 
0.11 
(-0.07,0.30) 
0.11 
(-0.08,0.29) 
0.12 
(-0.07,0.30) 
-0.01 
(-0.20,0.19) 
-0.11 
(-0.31,0.08) 
  Adjusted  
0.12 
(-0.06,0.29) 
-0.03 
(-0.23,0.18) 
0.09 
(-0.11,0.30) 
0.30 
(0.11,0.48)** 
0.13 
(-0.06,0.32) 
0.16 
(-0.03,0.35) 
0.16 
(-0.04,0.35) 
0.03 
 (-0.17,0.23) 
-0.14 
(-0.34,0.07) 
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child’s sex and gestational age-adjusted birth weight standard-deviation scores, cesarean delivery, breastfeeding duration and timing of 
introduction of solid foods (for 6 and 24 months outcomes). 
*P-value<0.05; **P-value<0.01 
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Supplementary materials 
Figure S1. Flow chart of participants in study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
N = 1,205 
Eligible mothers and their singleton 
children  
N = 172 
Excluded: mothers without information about pre-
pregnancy body mass index available 
N = 1,033 
Mothers and their singleton children 
with pre-pregnancy body mass index 
available 
N = 188 
Excluded: children without postnatal visit at the ages 
of 1.5, 6 and 24 months or without data on body 
mass index and skinfold thicknesses at the ages of 
1.5, 6 and 24 months available 
For maternal pre-pregnancy body mass index analyses: N = 845 
1.5 months  n =741 
6 months  n =748 
24 months  n =711 
 
For paternal body mass index analyses: N = 797 
1.5 months  n =698 
6 months  n =708  
24 months  n =672 
 
For maternal maximum gestational weight gain analyses: N = 509 
1.5 months  n =454 
6 months  n =470 
24 months  n =464 
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Table S1. Comparison of subject characteristics between children included and not included 
in the analyses
1
 
 
Characteristics 
Participants 
(N=845) 
Non-participants 
(N=188) 
P-value 
Maternal characteristics    
Age, mean (SD), years 31.8 (4.1) 30.5 (4.5) <0.001 
Education (higher education), n (%) 548 (65.2) 103 (55.7) 0.042 
Parity (nulliparous), n (%) 522 (61.8) 113 (60.1) 0.671 
Body mass index, mean (SD), kg/m
2 
23.5 (4.1) 23.5 (4.3) 0.855 
Maximum gestational weight gain, mean (SD), 
kg 
15.5 (5.7) 14.9 (5.6) 0.424 
Excessive gestational weight gain (IOM criteria), 
n (%) 
242 (47.9) 23 (41.1) 0.449 
Weight in early-pregnancy, mean (SD), kg 70.8 (12.9) 71.2 (13.2) 0.752 
Weight in mid-pregnancy, mean (SD), kg 78.0 (13.3) 78.3 (13.2) 0.832 
Weight in late-pregnancy, mean (SD), kg 84.5 (13.5) 83.1 (13.4) 0.462 
Total energy intake, mean (SD), kcal 2119 (512) 2142 (518) 0.722 
Smoking during pregnancy (yes), n (%) 186 (23.3) 47 (26.3) 0.408 
Gestational diabetes, n (%) 9 (1.1) 1 (0.6) 0.528 
Gestational hypertensive disorders, n (%) 62 (7.6) 8 (4.5) 0.141 
Paternal characteristics    
Age, mean (SD), years 33.9 (5.1) 32.9 (5.3) 0.014 
Education (higher education), n (%) 472 (64.2) 80 (51.3) 0.010 
Body mass index, mean (SD), kg/m
2
 25.2 (3.2) 25.6 (3.5) 0.142 
Birth and infant characteristics    
Boys, n (%) 439 (52.0) 99 (52.7) 0.861 
Gestational age at birth, median (95% range), 
weeks 
40.3 (35.9-42.4) 40.1 (33.7-42.1) 0.278 
Birth weight, mean (SD), g 3515 (537) 3478 (601) 0.403 
Caesarean delivery, n (%) 119 (14.9) 23 (13.8) 0.705 
Breastfeeding duration, mean (SD), months 4.4 (3.9) 3.6 (3.8) 0.030 
Introduction of solids foods (before 6 months), n 
(%) 
600 (80.2) 112 (89.6) 0.041 
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1
Values are observed data and represent means (SD), medians (95% range) or numbers of 
subjects (valid %). Differences were tested using Student’s t-tests and Mann-Whitney tests for 
normally and non-normally distributed variables, respectively and χ2-test for dichotomous 
variables. SD, standard deviation. IOM criteria, Institute of Medicine criteria. 
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Figure S2. Associations of parental pre-pregnancy overweight with infant subcutaneous fat mass 
measures
1-2
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Body mass index 
B. Total subcutaneous fat mass 
C. Central-to-total subcutaneous fat mass ratio 
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1
Values are regression coefficients (95% confidence interval) from repeated measurement linear 
regression models that reflect differences in subcutaneous fat mass measures in standard-
deviation scores at 1.5, 6 and 24 months for maternal and paternal overweight/obesity as 
compared to the reference group (maternal and paternal underweight/normal weight). Total 
subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. 
Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular skinfold 
thicknesses)/total subcutaneous fat mass.                                               
2
Maternal model includes maternal age and educational level, parity, maternal total energy 
intake, smoking habits and weight gain until 30 weeks of gestation, gestational diabetes, 
gestational hypertensive disorders, child’s sex and gestational age-adjusted birth weight 
standard-deviation scores, cesarean delivery, breastfeeding duration and timing of introduction of 
solid foods. Paternal model includes the same potential confounders as maternal model but 
paternal age and educational level instead of maternal age and educational level.                                                                                                                                                                                                                                                           
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Table S2. Associations of maternal weight gain until 30 weeks of gestation with infant subcutaneous fat mass measures
1
 
 
 
1
Values are regression coefficients (95% confidence interval) from linear regression models that reflect differences in subcutaneous fat mass 
measures in standard-deviation scores at 1.5, 6 and 24 months per standard-deviation scores change in maternal weight gain until 30 weeks of 
gestation or for maternal excessive weight gain as compared to the reference group (insufficient and sufficient weight gain). Body mass index 
= weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total 
subcutaneous fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass.                                                
¶Adjusted for maternal age and educational level, parity, pre-pregnancy body mass index (for models with weight gain until 30 weeks of 
gestation as a continuous variable), maternal total energy intake, smoking habits during pregnancy, gestational diabetes, gestational 
hypertensive disorders, child’s sex and gestational age-adjusted birth weight standard-deviation scores, cesarean delivery, breastfeeding 
duration and timing of introduction of solid foods (for 6 and 24 months outcomes). 
*P-value<0.05.
 
Fat mass measures in standard deviation scores 
Difference (95% Confidence Interval) 
 1.5 months 6 months 24 months 
 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Body mass 
index  
Total 
subcutaneous 
fat mass  
Central-to-
total 
subcutaneous 
fat mass ratio 
Weight gain until 30 weeks of 
gestation model 
   
   
   
  n = 833 n =721 n =687 n =687 n = 729 n = 723 n = 723 n =647 n =621 n =621 
  Unadjusted  
0.08 
(0.01,0.16)* 
0.01 
(-0.07,0.08) 
0 
 (-0.07,0.08) 
0.08 
(0.01,0.16)* 
0.06 
(-0.01,0.14) 
0.02 
(-0.06,0.09) 
-0.01 
(-0.09,0.06) 
-0.05 
(-0.13,0.02) 
-0.07 
(-0.14,0.01) 
  Adjusted  
0.02 
(-0.05,0.09) 
-0.02 
(-0.10,0.06) 
0.01 
(-0.07,0.09) 
0.04 
(-0.04,0.12) 
0.07 
(-0.01,0.14) 
0.05 
(-0.03,0.12) 
-0.03 
(-0.11,0.04) 
-0.06 
(-0.15,0.02) 
-0.07 
(-0.15,0.01) 
Excessive gestational weight 
gain model¶ 
   
   
   
  n = 116 n =104 n =95 n =95 n = 100 n = 98 n = 98 n =94 n =91 n =91 
  Unadjusted  
0.05 
(-0.16,0.25) 
-0.15 
(-0.37,0.07) 
0 
(-0.22,0.21) 
0.19 
(-0.02,0.40) 
0.17 
(-0.04,0.38) 
0.13 
(-0.08,0.34) 
0.06 
(-0.16,0.28) 
-0.02 
(-0.24,0.20) 
-0.17 
(-0.39,0.06) 
  Adjusted  
-0.03 
(-0.22,0.16) 
-0.17 
(-0.39,0.05) 
0.04 
 (-0.19,0.26) 
0.10 
(-0.12,0.31) 
0.13 
(-0.09,0.35) 
0.19 
(-0.03,0.40) 
0.02 
(-0.20,0.25) 
-0.07 
(-0.30,0.17) 
-0.20 
(-0.43,0.04) 
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Figure S3. Associations of maternal pre-pregnancy weight and early-, mid- and late-
pregnancy weight with infant subcutaneous fat mass measures from conditional analyses
1-2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Body mass index 
B. Total subcutaneous fat mass 
C. Central-to-total subcutaneous fat mass ratio 
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1
Values are regression coefficients (95% confidence interval) from linear regression models 
that reflect differences in subcutaneous fat mass measures in standard-deviation scores at 1.5, 
6 and 24 months per standard-deviation scores change in maternal pre-pregnancy weight and 
per standard-deviation scores change in standardized residual change in maternal early-, mid- 
and late-pregnancy weight from conditional regression analyses.
 
Total subcutaneous fat mass 
= biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total 
subcutaneous fat mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total 
subcutaneous fat mass. 
2
Models were adjusted for maternal age and educational level, parity, height at intake, 
maternal total energy intake, smoking habits during pregnancy, gestational diabetes, 
gestational hypertensive disorders, child’s sex and gestational age-adjusted birth weight 
standard-deviation scores, cesarean delivery, breastfeeding duration and timing of 
introduction of solid foods (for 6 and 24 months outcomes).  
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CHAPTER 2.3 
 
Maternal prenatal exposures and fat mass in 
children: intrauterine programming or birth weight 
effects? 
Susana Santos, Milton Severo, Romy Gaillard, Ana C. Santos, Henrique Barros, 
Andreia Oliveira 
 
Adapted from Nutr Metab Cardiovasc Dis 2016;26(11):1004:1010.
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Abstract 
 
Background and aims: It remains unknown whether the effects of prenatal exposures on 
child´s adiposity reflect entirely intrauterine programming. We aimed to assess the effects of 
maternal gestational weight gain, diabetes and smoking on child´s body fat patterns, 
disentangling the direct (through intrauterine programming) and indirect (through birth 
weight) effects.  
 
Methods and results: We included 4747 singleton 7-year-old children from the Generation 
XXI birth cohort (Porto, Portugal). At birth, maternal and newborn´s characteristics were 
obtained. Anthropometrics were measured at 7 years old and body fat patterns were identified 
by principal component analysis. Path analysis was used to quantify direct, indirect and total 
effects of gestational weight gain, diabetes and smoking on body fat patterns. Pattern 1 was 
characterized by strong factor loadings with body mass index, fat mass index and waist-to-
height ratio (fat quantity) and pattern 2 with waist-to-hip ratio, waist-to-thigh ratio, and waist-
to-weight ratio (fat distribution). The positive total effect of maternal gestational weight gain 
and diabetes on child’s fat quantity was mainly through a direct pathway, responsible for 
91.7% and 83.7% of total effects, respectively (β=0.022; 95% Confidence Interval (CI): 
0.017, 0.027; β=0.041; 95% CI: -0.011, 0.093). No effects on fat distribution were found. 
Maternal prenatal smoking had a positive direct effect on patterns 1 and 2, explaining 94.9% 
and 76.1% of total effects, respectively. 
 
Conclusion: The effects of maternal gestational weight gain, diabetes and smoking on child´s 
fat quantity seem to be mainly through intrauterine programming. Maternal smoking also 
showed a positive direct effect on child’s fat distribution. 
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Introduction 
Intrauterine programming has been pointed out, along with genetic predisposition, as a major 
cause of childhood obesity.
1
 A large body of evidence has focused on adiposity programming 
by maternal under- or over-nutrition, weight gain, diabetes and smoking during pregnancy.
2
 
These exposures are likely to affect the development of adipocytes and their capacity to 
expand or contract, the appetite control system and the energy metabolism in later life.
3
 
However, it remains unknown whether the observed effects in these previous studies reflect 
entirely intrauterine programming. Confounding by lifestyles or genetics and the possibility 
of pathways mediated by other exposures might still be an issue. 
Previous studies have addressed the effect of prenatal exposures on the risk of 
childhood obesity with and without adjustment for birth weight.
4-7
 Since birth weight may be 
a mediator in these associations, the adjustment for birth weight might be inappropriate. First, 
the effect estimate obtained from a model adjusted for birth weight does no longer correspond 
to the total effect. Secondly, the approach of simply adjusting for mediators in the regression 
models is prone to bias and may produce flawed conclusions.
8
 To our knowledge, no study 
has discussed separately the intrauterine programming effects from those mediated by birth 
weight. Assessing these effects separately will help to get further insight into the paths and 
mechanisms involved and their specific contributions to the associations between prenatal 
exposures and adiposity in later life.  
Most studies looking at the relation between prenatal exposures and later adiposity 
have used proxies and have relied on single measures for defining adiposity, which might 
have limited their ability to detect associations.
9
 The combination of anthropometric indices 
according to their inter-correlations into robust and uncorrelated patterns of body fat could be 
a more accurate and yet simple approach of evaluating childhood adiposity. 
The present study aimed to assess the effects of prenatal exposures (gestational weight 
gain, diabetes and smoking) on body fat patterns of 7-year-old children. A path analysis 
helped to understand whether these effects are mainly explained by a direct (through 
intrauterine programming) or indirect pathway (through birth weight). 
 
Methods 
 
Study population 
This study included participants from Generation XXI – a population-based birth cohort 
assembled during 2005-2006 at all public maternity units of Porto, Portugal. Of the invited 
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mothers, 91.4% accepted to participate, corresponding to 8647 newborns. A detailed 
description of the cohort methodology was previously reported.
10
 At the age of 7 years (2012-
2014), 6889 children were re-evaluated (79.7% of the entire cohort), of which 5849 provided 
data by face-to-face interviews.  
For the definition of body fat patterns, of 5849 children who attended the face-to-face 
interviews at 7 years old, we excluded 130 children with missing information on 
anthropometrics and/or tetra-polar bioelectric impedance, yielding a total of 5719 children 
(48.5% females). Further, we excluded 212 twins and 760 children who lacked data on 
selected variables of interest. The final study sample included 4747 children (48.6% females). 
The comparison between participants (n=4747) and non-participants (excluding twins, 
n=3604) showed that mothers in this study were slightly older [mean (standard deviation, 
SD)=29.6 (5.30) vs. 28.1 (5.94) years old] and higher educated [mean (SD)=11.1 (4.27) vs. 
9.5 (4.04) years] than mothers who were not included in this study. However, the magnitude 
of the differences was not high (Cohen’s effect size values11 of 0.27 and 0.38 for maternal 
age and education, respectively), suggesting that the differences were mostly due to the large 
sample size rather than due to large differences between participants’ characteristics. 
 
Data collection 
Baseline evaluation 
Data on maternal characteristics were collected in face-to-face interviews, within 72 hours 
after delivery, during the hospital stay. Maternal age and educational level at birth were 
recorded as completed years of aging and schooling. Information on prenatal smoking habits 
was collected and mothers were grouped into never or ever smokers during pregnancy. Pre-
pregnancy weight was obtained through recall. Maternal height was measured by 
interviewers, and, when not possible, was abstracted from the national identity card. Pre-
pregnancy body mass index (kg/m
2
, BMI) was calculated. Maternal gestational weight gain 
was calculated as the difference between the final pre-delivery weight, reported by mothers, 
and the pre-pregnancy weight. Personal history of diabetes mellitus was considered present 
when participants reported a medical diagnosis of this condition before the current 
pregnancy. Gestational diabetes was considered present when recorded on obstetrical records 
as a diagnosis during the current pregnancy. Mothers were grouped into never or ever had a 
diagnosis of type 1 or type 2 diabetes mellitus or gestational diabetes. Clinical records were 
reviewed at birth to retrieve data on gestational age and birth weight. Gestational age was 
estimated by ultrasound and, when it was missing, it was estimated based on the last 
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menstrual period. The z-scores of birth weight for gestational age were calculated according 
to a sex-specific, population-based Canadian reference.
12
 
 
Re-evaluation at 7 years old 
Anthropometrics were obtained by trained personnel with children in underwear and 
barefoot, according to standard procedures. Body weight and height were measured using a 
digital scale (TANITA
®
) and a wall stadiometer (SECA
®
), respectively. Waist circumference 
was measured at the umbilicus level, with abdomen relaxed and hip circumference was 
measured at the level of the greatest posterior protuberance of the buttocks. Thigh 
circumference was measured at the position around the mid-thigh and perpendicular to the 
long axis of the thigh, with the leg slightly flexed. All anthropometrics were measured to the 
nearest 0.1 kg or cm. Body mass index was calculated (kg/m
2
). The waist-to-height, waist-to-
hip and waist-to-thigh ratios were calculated as waist circumference divided by height, hip 
circumference and thigh circumference, respectively. The relationship between waist 
circumference and weight was assessed using a log-log regression analysis. Log-waist 
circumference was regressed on log-weight. The gradient of the regression line was 
approximately 0.5, corresponding to the value by which weight should be raised in order to 
calculate a measure uncorrelated with it. Waist-to-weight ratio was calculated as waist 
circumference divided by the square root of weight. 
Bioelectric impedance analysis was performed using a tetra-polar device (BIA 101 
Anniversary, Akern, Florence, Italy). Four surface electrodes were placed on the right wrist, 
ankle, hand and foot with the child lying horizontally. Measurements were performed at least 
30 minutes after the last meal. Fat free mass was determined using Schaefer et al. equation
13
 
and fat mass was derived accordingly. Fat mass was divided by the squared height to obtain 
the fat mass index,
14
 in which fat mass was effectively uncorrelated with height, as confirmed 
by a log-log regression analysis.  
 
Ethics 
All phases of the study complied with the Ethical Principles for Medical Research Involving 
Human Subjects expressed in the Declaration of Helsinki. The study was approved by the 
University of Porto Medical School/ S. João Hospital Centre ethics committee and a signed 
informed consent according Helsinki was required for all participants. 
 
Statistical analysis 
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Principal component analysis was applied to BMI, waist-to-height ratio, waist-to-hip ratio, 
waist-to-thigh ratio, waist-to-weight ratio, and fat mass index to identify uncorrelated patterns 
of body fat. The number of factors was decided using the Kaiser’s criterion, by which factors 
with an eigenvalue ≥1.0 are retained. Varimax rotation was performed to simplify the 
interpretation of the factor loadings structure. The interpretation of the factors was based on 
those measures with factor loadings higher than 0.30, considering 0.30-0.70 as moderate and 
≥0.70 as strong factor loadings. The scores that were entered in all subsequent analyses were 
calculated using the regression method with standardized scores. Analyses were conducted 
using the R® software version 3.0.1. 
Path analysis determines whether data fit well within a prespecified causal model and 
allows the study of direct and indirect effects with multiple independent and dependent 
variables.
15
 Path analysis was used to quantify direct, indirect (by multiplication of path 
regression coefficients involved) and total effects (by summing direct and indirect effects) of 
prenatal exposures on body fat patterns, taking into consideration the relationships depicted 
in the causal diagram presented as Figure 1. The path analysis used linear regression models 
for continuous outcomes and probit regression models for categorical outcomes and results 
were presented as regression coefficients (β) and corresponding 95% confidence intervals 
(95% CI). The adjustment sets for each regression model are presented in the footnotes of 
Figure 1. Covariates were included in the analyses when they changed the effect estimates 
substantially (>10%): maternal pre-pregnancy body mass index, age and educational level at 
birth. Other covariates such as parity, mode of delivery, child’s sex, breastfeeding duration, 
physical exercise and fruit/vegetables intake were tested but did not fulfill the criterion for 
being considered confounders and therefore were not included in the regression models. 
Models were fitted, simultaneously for all body fat patterns identified, with Mplus software 
version 5.2 (Muthén & Muthén, Los Angeles, CA, USA). A Comparative Fit Index (CFI) and 
a Tucker-Lewis Index (TLI)≥0.90 and a Root Mean Square Error of Approximation 
(RMSEA) close to zero were used as criteria to support the goodness of fit.
16
 No significant 
interactions between prenatal exposures and child’s sex in the associations with body fat 
patterns were found. 
 
Results 
Characteristics of participants are shown in Table 1. Two body fat patterns, similar for both 
sexes, were identified: a pattern 1 characterized by strong factor loadings with BMI, fat mass 
index and waist-to-height ratio (fat quantity) and a pattern 2 characterized by strong factor 
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loadings with waist-to-hip ratio, waist-to-thigh ratio and waist-to-weight ratio (fat 
distribution) (Table 2). Both patterns explained 88.3% of the total variance (45.3% was 
explained by pattern 1 and 43.0% by pattern 2). 
Figure 1 shows the theoretical causal diagram for the effects of prenatal exposures on 
body fat patterns, in which the direct effects correspond to the programming effects and the 
indirect effects correspond to the effects mediated by other exposures. Figure 1 also shows 
the effect estimates for each path. Table 3 presents the estimates of direct, indirect and total 
effects of prenatal exposures on the body fat patterns. The overall fit of the model was good: 
CFI=0.993, TLI=0.954 and RMSEA=0.023. Maternal gestational weight gain had a positive 
total effect on pattern 1 (β=0.024; 95% CI: 0.019, 0.028), mainly due to a direct pathway that 
was responsible for 91.7% of the total effect (β=0.022; 95% CI: 0.017, 0.027). We observed a 
positive total effect of borderline statistical significance of maternal diabetes on pattern 1 
(β=0.049; 95% CI: -0.003, 0.101), mainly due to a direct pathway that was responsible for 
83.7% of the total effect (β=0.041; 95% CI: -0.011, 0.093). The indirect effects through birth 
weight of these prenatal exposures on both patterns were statistically significant but close to 
0. After excluding the mothers with type 1 and type 2 diabetes mellitus from the analyses, 
similar results were observed for the associations of maternal gestational diabetes with both 
body fat patterns at 7 years old (results not shown). Maternal smoking during pregnancy had 
a positive total effect on both body fat patterns (pattern 1: β=0.178; 95% CI: 0.113, 0.243; 
pattern 2: β=0.109; 95% CI: 0.038, 0.180), mostly due to a direct effect that explained 94.9% 
and 76.1% of the total effect on patterns 1 and 2, respectively. A negative indirect effect 
through birth weight on pattern 1 (β=-0.024; 95% CI: -0.034, -0.014) and a positive indirect 
effect through birth weight on pattern 2 (β=0.032; 95% CI: 0.020, 0.043) were also found, 
i.e., prenatal smoking was negatively associated with birth weight (β=-0.275; 95% CI: -0.333, 
-0.216) which was positively related to pattern 1 (β=0.087; 95% CI: 0.055, 0.120) and 
negatively related to pattern 2 (β=-0.115; 95% CI: -0.150, -0.080) (Table 3 and Figure 1). We 
observed similar results in the principal component analysis and path analysis when we used 
the age- and sex-adjusted BMI standard deviation scores based on the World Health 
Organization Child Growth Standards (results not shown). 
 
Discussion 
The effects of maternal weight gain, diabetes and smoking during pregnancy on body fat 
quantity of 7-year-old children seem to be mainly through their intrauterine programing 
effects. These effects on child´s adiposity prevailed over the indirect effects through birth 
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weight. Maternal smoking during pregnancy also showed a positive direct effect on body fat 
distribution of children.  
A previous meta-analysis showed that offspring of women with excessive gestational 
weight gain were at an increased risk of obesity, compared with offspring of women with 
adequate gestational weight gain.
6
 Our study showed that this effect of maternal gestational 
weight gain on child’s body fat quantity is mainly through intrauterine programming effects 
instead of indirect effects through birth weight. Higher maternal weight gain in pregnancy 
might program higher adiposity in the offspring through fetal over-nutrition that has been 
associated with a permanent increase in the capacity of adipocytes to store lipids,
17
 and with 
excessive appetite postnatally.
18
 Previous studies found that higher maternal gestational 
weight gain was associated with a central fat distribution in the offspring, mainly assessed by 
waist circumference.
19-21
 As waist circumference and BMI are strongly correlated,
22
 these 
associations could be reflecting the well-established positive effect of maternal gestational 
weight gain on fat quantity. In this study, no effects of maternal gestational weight gain on 
body fat distribution were found.  
The effect of exposure to a diabetic intrauterine environment on child´s adiposity has 
raised some controversy. A systematic review has yielded inconclusive results, but overall the 
associations were not statistically significant in 8 studies from a total of 12 included studies.
5
 
Additionally, a meta-analysis has reported an association between maternal diabetes and 
increased offspring BMI that was no longer significant after adjustment for maternal pre-
pregnancy BMI.
7
 In the present study, maternal diabetes tended to be positively associated 
with child’s body fat quantity after taking maternal pre-pregnancy BMI into consideration. 
The intrauterine programming effects prevailed over the indirect effects through birth weight. 
Hyperglycemia is thought to induce excessive appetite postnatally,
23
 which might explain 
these results. Few studies have addressed the effect of maternal diabetes on child´s body fat 
distribution, reporting, on one hand, a positive association with trunk fat from dual energy x-
ray absorptiometry (DXA)
24
 but, on the other hand, no association with visceral or 
subcutaneous abdominal fat obtained by magnetic resonance imaging.
25
 In this study, no 
effects of maternal diabetes on body fat distribution were found. 
A previous meta-analysis has suggested that maternal prenatal smoking leads to 
offspring obesity.
4
 Thus far, some studies have reported positive associations whereas other 
studies have reported no associations between maternal prenatal smoking and child’s central 
fat.
26, 27
 Our study showed that maternal smoking during pregnancy was associated with 
higher body fat quantity and a central fat distribution in childhood. These effects were mainly 
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through intrauterine programming. The mechanisms by which maternal prenatal smoking 
may program child´s adiposity involve an effect of cigarette smoke constituents, such as 
nicotine, which readily cross the placenta towards the fetus leading to permanent changes in 
the regulation of food intake and energy expenditure, such as increased appetite and 
decreased mobilization of fat from adipose tissue later in life.
28, 29
 Maternal smoking during 
pregnancy may also mimic fetal under-nutrition by reducing blood supply to the fetus via the 
vasoconstrictive effects of nicotine
2
 or by reducing the mother´s food intake.
30
 Fetal under-
nutrition has been associated with a reduced storage capacity of adipocytes, which may favor 
visceral fat deposition in the presence of a positive energy balance postnatally.
31
 This could 
be one of the mechanisms involved in the higher accumulation of central fat in offspring of 
smoking mothers in our study. Moreover, fetal under-nutrition has been associated with 
reduced levels or a reduced effect of leptin during the postnatal period, thereby inducing 
excessive appetite.
32
 A process favoring a better metabolic efficiency might also occur to 
enable fetal survival in a limited energy environment, which might lead to an excessive fat 
storage when enough food is available.
1
 Even though weak, indirect effects through birth 
weight of maternal prenatal smoking on child´s fat quantity and distribution were also 
observed in our study. Maternal smoking during pregnancy seems to lead to a child with low 
birth weight that subsequently maintains this low weight and tends to have a central fat 
distribution at 7 years old. Smoking delays fetus growth due to the high levels of 
carboxyhemoglobin and other toxic substances in blood, the vasoconstrictive effects of 
nicotine and fetal under-nutrition.
2, 3 
The maintenance of a low weight during childhood by 
low birth weight newborns could be explained, at least in part, by parental child-feeding 
practices, although this was not addressed in our study. However, we have previously shown 
in 4- and 7-year-old children of the Generation XXI birth cohort that a lower BMI leads to a 
greater parental use of pressure to eat that subsequently leads to a lower BMI.
33
 Yet unknown 
mechanisms could be involved in the association of birth weight with body fat distribution.  
Some limitations and strengths should be considered. Pre-pregnancy weight and final 
pre-delivery weight were both self-reported. Overall, weight tends to be underreported by 
women,
34 
which might have led to an underestimation of pre-pregnancy BMI. The attendance 
of prenatal visits could have made pregnant women more aware of their weight status, 
minimizing the error of self-reported final pre-delivery weight. Similarly, data on diabetes 
mellitus relied on self-reporting. If misclassification of women occurred, the association 
between maternal diabetes and offspring adiposity could be attenuated. Moreover, treatment 
of diabetes (based on diet or insulin), by contributing to a better glycemic control, may 
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reduce the risk of long-term adverse outcomes for the offspring, thus complicating the 
detection of associations in observational studies like ours. Information on maternal smoking 
habits during pregnancy also relied on self-reporting, without biochemical validation, which 
may result in misclassification due to a reluctance to disclose a known adverse pregnancy 
behavior. However, any under-reporting would likely bias results towards the null, 
underestimating the associations. We measured fat mass at 7 years old using BIA which is a 
valid method to assess whole body composition.
35
 We relied on anthropometrics to assess 
body fat distribution which might have greater measurement error, and be less accurate but 
on the other hand be easier and cheaper to obtain in large epidemiological studies as 
compared to imaging techniques of body composition.
36 
In this study, we considered that the 
direct effects reflected the intrauterine programming effects. We tried to perform a 
comprehensive analysis, by including the most important paths described to date, and by 
testing several covariates as confounders. However, we cannot exclude the possibility of 
existing other paths not considered in this study and also residual confounding by lifestyles or 
genetics that might have biased our estimates for the intrauterine programming effects. This 
seems unlikely and the bias might be only limited. The major strength of this study is the 
comprehensive assessment of the effects of prenatal exposures, by quantifying their direct 
and indirect effects, on uncorrelated and more robust measures of fat quantity and distribution 
in a large population-based sample of 7-year-old children. 
 
Conclusion 
This study showed that the effects of maternal weight gain, diabetes and smoking during 
pregnancy on body fat quantity of 7-year-old children seem to be mainly through intrauterine 
programming. Maternal smoking during pregnancy also showed a positive direct effect on 
body fat distribution of children. Considering the lasting and lifelong effects of intrauterine 
programming, primary prevention strategies for obesity, as early as during prenatal care, are 
of utmost importance. Although the indirect effects through birth weight seem to be weak, 
this study reinforces the need for careful interpretation of findings adjusted and not adjusted 
for birth weight in studies addressing the associations between prenatal exposures and 
adiposity in later life.  
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Figure 1. Causal diagram for the effects of prenatal exposures on body fat patterns identified by principal component analysis at 7-year-old 
children
1-2
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1
Direct effects correspond to the intrauterine programming effects (solid arrows) and the indirect effects correspond to the effects mediated by 
other exposures (dashed arrows). 
2
Adjustment sets for each regression model: 
a
adjusted for the other two prenatal exposures, birth weight for gestational age, maternal pre-pregnancy body mass index, age and educational 
level at birth.  
b
adjusted for the prenatal exposures, maternal pre-pregnancy body mass index, age and educational level at birth. 
c
adjusted for the other two prenatal exposures, and maternal pre-pregnancy body mass index. 
d
adjusted for maternal pre-pregnancy body mass index and age at birth. 
e
adjusted for maternal pre-pregnancy body mass index, age and educational level at birth. 
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Table 1. Characteristics of study participants (n=4747)
1
 
 
Child´s characteristics Mean (SD) 
    Birth weight for gestational age, z-scores  -0.3 (0.85) 
    Body mass index at 7 y, kg/m
2 
 17.1 (2.51) 
    Fat mass index at 7 y, kg/m
2 
 3.2 (2.33) 
    Waist-to-height ratio at 7 y  0.5 (0.05) 
    Waist-to-hip ratio at 7 y  0.9 (0.05) 
    Waist-to-thigh ratio at 7 y  1.6 (0.10) 
    Waist-to-weight ratio at 7 y, cm/√kg  10.2 (0.48) 
Maternal characteristics   
    Age at birth, years  29.6 (5.30) 
    Educational level at birth, years  11.1 (4.27) 
Pre-pregnancy body mass index,  kg/m
2
 23.8 (4.16) 
Gestational weight gain, kg 13.7 (5.77) 
 n (%) 
Diabetes (type 1 or type 2 diabetes mellitus or gestational diabetes) 327 (6.9) 
Smokers during pregnancy  992 (20.9) 
 
1
SD, standard deviation
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Table 2. Factor loadings, obtained from principal component analysis, for anthropometric 
and bioelectric impedance measures (n=5719) 
 
 
 
 
 
 
 
 
 
 
 
 
a
Representing fat quantity; 
b
Representing fat distribution.  
 
 
 
 
 
 
 
 
 
 
 Factor loadings 
 Pattern 1
a
 Pattern 2
b
 
Body mass index, kg/m
2
 0.980 0.051 
Fat mass index, kg/m
2
 0.937 0.059 
Waist-to-height ratio 0.873 0.454 
Waist-to-hip ratio  0.277 0.877 
Waist-to-thigh ratio -0.044 0.893 
Waist-to-weight ratio, cm/√kg 0.202 0.895 
   
Variance explained 45.3% 43.0% 
Cumulative variance explained 45.3% 88.3% 
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Table 3. Estimates of direct, indirect and total effects of prenatal exposures on body fat 
patterns of 7-year-old children, calculated by path analysis (n=4747)
1 
 
 
 
 Pattern 1 Pattern 2 
 β [95% CI] % of total effect β [95% CI] % of total effect 
     
Maternal gestational weight gain     
Direct effect 
0.022 
 [0.017,0.027] 
91.7% -0.001 
 [-0.006,0.004] 
25% 
Indirect effects 
0.002  
[0.001,0.003] 
8.3% -0.003  
[-0.004,-0.002] 
75% 
     Indirect effect through 
birth weight 
0.002  
[0.001,0.003] 
100%a -0.003  
 [-0.004,-0.002] 
100%a 
Total effect 
0.024  
[0.019,0.028] 
 -0.004  
[-0.009,0.001] 
 
     
Maternal diabetes     
Direct effect 
0.041  
[-0.011,0.093] 
83.7% -0.005  
[-0.066,0.055] 
33.3% 
Indirect effects 
0.008  
[0.004,0.012] 
16.3% -0.010  
[-0.015,-0.005] 
66.7% 
     Indirect effect through 
birth weight 
0.008  
[0.004,0.012] 
100%a -0.010  
[-0.015,-0.005] 
100%a 
Total effect 
0.049  
[-0.003,0.101] 
 -0.015  
[-0.076,0.045] 
 
     
Maternal smoking during 
pregnancy 
 
 
 
 
Direct effect 
0.169  
[0.104,0.234] 
94.9% 0.083 
[0.011,0.155] 
76.1% 
Indirect effects 
0.009  
[-0.006,0.024] 
5.1% 0.026 
[0.012,0.040] 
23.9% 
     Indirect effect through 
birth weight 
-0.024  
[-0.034,-0.014] 
—b 0.032  
[0.020,0.043] 
—b 
Total effect 
0.178   
[0.113,0.243] 
 0.109 
[0.038,0.180] 
 
 
1β, regression coefficient; CI, confidence interval. Statistically significant results are shown in bold. 
a
Results expressed in % of indirect effects;  
b
Results not expressed in % of indirect effects since effects of opposite direction contribute to the total 
of indirect effects. 
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Abstract 
 
Background: Maternal obesity and excessive gestational weight gain are associated with an 
increased risk of obesity in the offspring.  
 
Objective: To examine the associations of maternal pre-pregnancy body mass index (BMI) 
and gestational weight gain with general, abdominal, pericardial and liver fat measures in 
children aged 10 years. 
 
Design: In a population-based prospective cohort study from early pregnancy onwards 
among 2,354 mothers and their children, we obtained information about maternal pre-
pregnancy BMI and gestational weight gain. We measured offspring BMI, fat mass index 
(total fat mass/height
4
) by dual-energy X-ray absorptiometry and subcutaneous fat index 
(subcutaneous fat mass/height
4
), visceral fat index (visceral fat mass/height
3
), pericardial fat 
index (pericardial fat mass/height
3
) and liver fat fraction by Magnetic Resonance Imaging 
(MRI) at 10 years.  
 
Results: A 1-standard deviation score (SDS) higher maternal BMI was associated with 
higher childhood BMI (difference 0.32 (95% Confidence Interval (CI) 0.28, 0.36) SDS), fat 
mass index (difference 0.28 (95% CI 0.24, 0.31) SDS), subcutaneous fat index (difference 
0.26 (95% CI 0.22, 0.30) SDS), visceral fat index (difference 0.24 (95% CI 0.20, 0.28) SDS), 
pericardial fat index (difference 0.12 (95% CI 0.08, 0.16) SDS) and liver fat fraction 
(difference 0.15 (95% CI 0.11, 0.19) SDS). After conditioning each MRI measure of 
adiposity on BMI at 10 years, higher maternal BMI remained associated with higher 
childhood subcutaneous and visceral fat indices. Maximum gestational weight gain was not 
consistently associated with organ specific fat measures.  
 
Conclusions: Higher maternal BMI, but not gestational weight gain, was associated with 
higher abdominal, pericardial and liver fat measures. The associations with abdominal 
subcutaneous and visceral fat were independent of BMI. Our results suggest that promoting a 
healthy BMI in women of reproductive age may be of greater importance for childhood organ 
fat than influencing gestational weight gain. 
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Introduction 
Maternal obesity is associated with several short- and long-term adverse health effects, 
including an increased risk of obesity in the offspring.
1-5
 It has been hypothesized that 
maternal obesity is related to an increased placental transfer of nutrients to the fetus, which 
might affect the development of adipocytes, the appetite control system, and the energy 
metabolism.
6
 However, these associations might also be explained by shared family-based 
lifestyle or genetic factors. Although many studies reported the associations between 
maternal and offspring obesity, it remains unclear whether maternal obesity also affects body 
fat distribution in the offspring. Information about body fat distribution is important since, as 
compared to body mass index (BMI), body fat distribution, and more specifically excess 
visceral, heart and liver fat, may be better indicators of cardiometabolic health.
7-9
 Previous 
studies have reported that higher maternal BMI is associated with higher abdominal and liver 
fat in newborns.
10, 11
 Maternal pre-pregnancy obesity was also associated with higher visceral 
fat mass in Greek schoolchildren.
12
 Next to maternal obesity, paternal obesity and excessive 
gestational weight gain may also affect childhood adiposity.
13-18
 To date, results from studies 
focused on the associations of paternal BMI and gestational weight gain with body fat 
distribution remain scarce and not consistent.
16-18
 
We examined, in a population-based prospective cohort study among 2,354 mothers, 
fathers and their children, the associations of parental pre-pregnancy BMI and gestational 
weight gain with offspring BMI, fat mass index measured by dual-energy X-ray 
absorptiometry (DXA) and subcutaneous fat index, visceral fat index, pericardial fat index 
and liver fat fraction measured by Magnetic Resonance Imaging (MRI) at 10 years. We 
explored whether any association with organ specific fat measures reflects specific 
accumulation, or just reflects general adiposity. 
 
Subjects and methods 
 
Study design 
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards in Rotterdam, the Netherlands.
19
 The study was 
approved by the Medical Ethical Committee of the Erasmus MC, Rotterdam (MEC 
198.782/2001/31). Written informed consent was obtained from parents.
19
 Pregnant women 
were enrolled between 2001 and 2005. Of all the eligible children in the study area, 61% 
participated at birth in the study. In total, 5,706 mothers and their singleton children attended 
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the study visit at 10 years, of whom information about pre-pregnancy BMI was available in 
4,298 subjects. Further, we excluded children without any organ specific fat measures 
assessed by MRI (n=1,944). Thus, the population for analysis was 2,354 mothers and their 
children (Supplemental Figure 1). 
 
Parental anthropometrics 
Maternal and paternal height and weight were measured at enrolment. Information about 
maternal weight just before pregnancy was obtained by questionnaire. We calculated 
maternal and paternal BMI (kg/m
2
). In our population for analysis, 56.4% of all women were 
enrolled before a gestational age of 14 weeks. Correlation of pre-pregnancy weight, obtained 
by questionnaire, and weight measured at enrolment was 0.96 (p-value<0.01). In this study, 
maternal pre-pregnancy BMI was used and categorized into underweight (<18.5 kg/m
2
), 
normal weight (18.5-24.9 kg/m
2
), overweight (25.0-29.9 kg/m
2), and obesity (≥30.0 kg/m2). 
For the parental BMI comparison analyses, pre-pregnancy maternal and paternal BMI were 
categorized into normal weight (18.5-24.9 kg/m
2) and overweight/obesity (≥ 25.0 kg/m2). As 
previously described, we measured maternal weight at early, mid and late pregnancy (median 
13.2 weeks of gestation (95% range 9.8, 18.9), median 30.1 weeks of gestation (95% range 
20.5, 31.4) and median 39.0 weeks of gestation (95% range 32.8, 42.0), respectively).
17
 
Information about maximum weight during pregnancy was assessed by questionnaire 2 
months after delivery. Maximum weight from questionnaire and weight measured at late 
pregnancy were strongly correlated (r=0.99, p-value<0.01). We calculated maximum weight 
gain during pregnancy as the difference between maximum weight and pre-pregnancy 
weight. Further, we divided maximum weight gain by gestational age at birth to obtain the 
maximum weight gain per week. Maximum gestational weight gain was also classified as 
insufficient, sufficient and excessive weight gain in relation to maternal pre-pregnancy BMI 
according to the Institute of Medicine guidelines.
20
  
 
Measures of adiposity at 10 years 
We measured child’s height and weight without shoes and heavy clothing and calculated 
BMI (kg/m
2
). We calculated sex- and age- adjusted standard deviation scores (SDS) of 
childhood BMI based on Dutch reference growth charts (Growth Analyzer 4.0, Dutch Growth 
Research Foundation).
21
 We measured total body fat mass using a DXA scanner (iDXA, GE-
Lunar, 2008, Madison, WI, USA, enCORE software v.12.6), according to standard 
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procedures.
22
 Previous studies have validated DXA against computed tomography for body 
fat assessment.
23-25
  
Measures of organ fat at 10 years were obtained from MRI scans.
19
 MRI has been 
described as an accurate and reproducible technique and considered the gold standard for the 
measurement of intra-abdominal and organ fat deposition.
24, 26-28
 All children were scanned 
using a 3.0 Tesla MRI (MR 750w, GE Healthcare, Milwaukee, WI, USA) for body fat 
imaging using standard imaging and positioning protocols. They wore light clothing without 
metal objects while undergoing the body scan.
29
 Abdominal fat scans were acquired in three 
separate acquisitions using a 3-point Dixon technique for fat and water separation (IDEAL 
sequence). The three acquisitions were centralized on the liver, on the umbilicus (abdominal 
fat scan), and on the top of the femur bone (hip scan), respectively. Obtained fat scans were 
subsequently analyzed by the Precision Image Analysis company (PIA, Kirkland, 
Washington, United States). Subcutaneous, visceral, pericardial and liver fat were quantified 
using the sliceOmatic (TomoVision, Magog, Canada) software package. All extraneous 
structures and any image artifacts were removed manually.
26
 Total subcutaneous and visceral 
volumes were generated by summing the volumes of three scans. Subcutaneous and visceral 
fat masses were obtained by multiplying the total volumes by the specific gravity of adipose 
tissue, 0.9 g/ml. Pericardial fat included both epicardial- and paracardial fat directly attached 
to the pericardium. Pericardial fat volume was quantified using the summation of discs 
method and was subsequently multiplied by the specific gravity of adipose tissue, 0.9 g/ml. 
Liver fat fraction was determined using the IDEAL IQ sequence.
30
 Four samples of at least 4 
cm
2
 were taken from the central portion of the hepatic volume. Subsequently, the mean signal 
intensities were averaged to generate an overall mean liver fat fraction estimation.  
To create measures of general and organ fat independent of height at 10 years, we 
estimated the optimal adjustment by log-log regression analyses and subsequently we divided 
total and subcutaneous fat mass by height
4
 (fat mass index and subcutaneous fat index) and 
visceral and pericardial fat mass by height
3 
(visceral and pericardial fat indices) (More details 
given in Supplemental Methods).
31, 32
  
 
Covariates 
Information on maternal and paternal age, educational level, and ethnicity, and maternal 
parity and smoking habits was obtained by questionnaires during pregnancy. Information on 
child’s sex was obtained from medical records. Information on breastfeeding duration and 
timing of introduction of solid foods was obtained by questionnaires in infancy, and 
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information on the average television watching time was obtained by questionnaires at the 
age of 10 years. 
 
Statistical analysis 
First, we used linear regression models to examine the associations of maternal and paternal 
pre-pregnancy BMI and maximum gestational weight gain, continuously and using clinical 
categories, with measures of adiposity (BMI, fat mass index, subcutaneous, visceral and 
pericardial fat indices and liver fat fraction) at 10 years. Second, we examined the 
independent associations of maternal pre-, early, mid, and late pregnancy weight with the 
childhood outcomes using conditional linear regression analyses to account for the 
correlations between the weight measurements.
33
 For these models, we obtained standardized 
residuals for each weight from the regression of a maternal weight at a specific time point on 
prior maternal weights. These variables correspond to the difference between the actual 
weight and the expected weight based on prior weights and thus are statistically independent 
from each other and can be included simultaneously in the regression models.
33
 Third, we 
used conditional regression analyses to assess whether the associations of maternal and 
paternal pre-pregnancy BMI and gestational weight gain with measures of organ fat at 10 
years were independent of BMI at 10 years. We used as outcomes the standardized residuals 
for each measure of organ fat at 10 years obtained from the regression of those outcomes on 
BMI.
33
 For all analyses, we used a basic model including child´s sex and age at outcome 
measurements, and a confounder model, which additionally included covariates. We included 
covariates in the models if they were strongly associated with parental anthropometrics and 
childhood adiposity in our study, or if they changed the effect estimates substantially (>10%). 
We log-transformed the non-normally distributed childhood DXA and MRI adiposity 
measures. We constructed SDS [(observed value - mean)/SD] of the sample distribution for 
all continuous exposures and DXA and MRI outcomes to enable comparisons of effect sizes. 
We tested for statistical interactions between maternal BMI and gestational weight gain, 
maternal BMI and paternal BMI and between both maternal BMI and gestational weight gain 
with child´s sex, but none of these were consistently significant. Since the maximum 
gestational weight gain was self-reported, sensitivity analyses using weight gain measured 
until late pregnancy were performed. Missing values in covariates (ranging from 0 to 28%) 
were multiple-imputed by using Markov chain Monte Carlo approach. Five imputed datasets 
were created and analyzed together. All statistical analyses were performed using the 
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Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, 
USA). 
 
Results 
 
Subject characteristics 
Table 1 shows the subject characteristics. Non-response analyses showed that parents of 
children with MRI follow-up data available were slightly older and had a higher educational 
level, and mothers were more likely to be non-smokers (p-values<0.05). No differences were 
observed for maternal BMI and gestational weight gain and paternal BMI (Supplemental 
Table 1). Supplemental Table 2 shows that the correlation coefficients of BMI and fat mass 
index with subcutaneous and visceral fat indices are moderate to strong and higher than the 
correlation coefficients with pericardial fat index and liver fat fraction.  
 
Maternal and paternal BMI and childhood organ fat measures 
Table 2 shows that a 1-SDS higher maternal BMI was associated with higher childhood BMI 
(difference 0.32 (95% Confidence Interval (CI) 0.28, 0.36) SDS), fat mass index (difference 
0.28 (95% CI 0.24, 0.31) SDS), subcutaneous fat index (difference 0.26 (95% CI 0.22, 0.30) 
SDS), visceral fat index (difference 0.24 (95% CI 0.20, 0.28) SDS), pericardial fat index 
(difference 0.12 (95% CI 0.08, 0.16) SDS) and liver fat fraction (difference 0.15 (95% CI 
0.11, 0.19) SDS). As compared to maternal normal weight, maternal underweight was 
associated with lower fat measures whereas maternal overweight and obesity were associated 
with higher fat measures in childhood (p-values<0.05). After conditioning each MRI measure 
of adiposity on BMI at 10 years, higher maternal BMI remained associated with higher 
childhood subcutaneous and visceral fat indices (p-values<0.05).  
 Figure 1A shows that, as compared to normal weight parents, those in which only 
mothers or only fathers were overweight/obese had children with higher levels of all 
adiposity measures at the age of 10 years (p-values<0.05). The associations tended to be 
stronger when only mothers rather than only fathers were overweight/obese. The strongest 
associations were observed for children in which both parents were overweight/obese. After 
conditioning each MRI measure of child’s adiposity on BMI at 10 years (Figure 1B), no 
significant associations were observed for couples in which only mothers or only fathers were 
overweight/obese. Those couples in which both parents were overweight/obese had children 
with higher subcutaneous, visceral and pericardial fat indices (p-values<0.05).  
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Maternal gestational weight gain and childhood organ fat measures 
Table 3 shows that a 1-SDS higher maximum weight gain per week was only associated with 
higher childhood BMI (difference 0.08 (95% CI 0.03, 0.13) SDS). Excessive weight gain, as 
compared to sufficient weight gain, was associated with higher childhood BMI, fat mass 
index and subcutaneous and visceral fat indices (p-values<0.05). After conditioning each 
MRI measure of adiposity on BMI at 10 years, no consistent associations were observed. 
Similar results were observed when using maternal weight gain measured until late 
pregnancy (Supplemental Table 5). Figure 2A shows that independent from weights in 
other periods, higher pre-pregnancy weight was associated with higher levels of all adiposity 
measures (p-values<0.05). Higher early pregnancy weight was associated with higher BMI 
and fat mass index, but not with organ fat measures at 10 years. No associations were 
observed for mid and late pregnancy weight. After conditioning each MRI measure of 
adiposity on BMI at 10 years (Figure 2B), higher pre-pregnancy weight remained associated 
with higher subcutaneous and visceral fat indices. No associations were observed for early, 
mid and late pregnancy weight. 
 
Discussion 
We observed, in this population-based prospective cohort study, that higher maternal pre-
pregnancy BMI was associated with higher BMI, fat mass index, subcutaneous, visceral and 
pericardial fat indices and liver fat fraction at 10 years. The associations of maternal BMI 
with offspring subcutaneous and visceral fat indices seemed to be independent of offspring 
BMI. Total and period-specific gestational weight gain were not consistently associated with 
organ fat measures. 
 
Interpretation of main findings 
Maternal obesity is a major public health concern.
34
 A meta-analysis of published studies 
showed an increased risk of overweight in offspring of mothers with overweight and obesity, 
as compared to offspring of mothers with normal weight.
5
 In the same cohort as the current 
study, we have previously reported that maternal overweight and obesity were strongly 
associated with increased risks of overweight and obesity in the offspring aged 4 and 6 
years.
18, 35
 In the present study, maternal overweight and obesity were associated with higher 
BMI and fat mass index at 10 years.  
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Large cohort studies such as the Framingham Heart Study and the Jackson Heart 
Study have reported that excess visceral and ectopic fat deposition is related to various 
cardiometabolic abnormalities in adults.
36-42
 In 105 healthy mother-newborn pairs, higher 
maternal BMI was associated with higher infant abdominal fat, independently of weight, and 
higher intrahepatocellular lipid content.
10
 In another study among 25 newborns, infants born 
to obese mothers with gestational diabetes had higher intrahepatocellular fat compared with 
infants born to normal weight mothers.
11
 Maternal pre-pregnancy obesity was also associated 
with higher visceral fat mass levels in 1,228 Greek children aged 9-13 years.
12
 In the present 
study, higher maternal BMI was associated with higher subcutaneous, visceral and pericardial 
fat indices and liver fat fraction at 10 years. The associations of maternal BMI with offspring 
subcutaneous and visceral fat indices seemed to be independent of offspring BMI. This 
means that higher maternal BMI is associated with a specific accumulation of fat in 
abdominal depots that is not a result of general adiposity. We did not observe differences in 
the results when we conditioned on fat mass index instead of BMI. These results are not in 
line with those of our previous study in 6-year-old children suggesting that higher maternal 
pre-pregnancy BMI was not associated with subcutaneous and preperitoneal abdominal fat 
measured by ultrasound, independently of child´s BMI.
18
 The differences in results may be 
due to different ages or different imaging methods. 
Previously, we reported that higher paternal BMI was associated with higher BMI but 
was not associated with subcutaneous and preperitoneal abdominal fat at the age of 6 years, 
independently of child’s BMI.18 In the present study, paternal overweight was associated with 
higher BMI, fat mass index and organ fat measures in children aged 10 years. The 
associations observed with MRI adiposity measures were not independent of BMI at 10 
years. Our results suggest that both maternal and paternal BMI before pregnancy may be risk 
factors for offspring cardiometabolic health by influencing general and organ fat 
accumulation in later life. Previous studies comparing the associations of maternal and 
paternal BMI with childhood BMI and total fat mass have shown conflicting results.
18, 43-46
 A 
recent study using genetic variants in a Mendelian randomization approach found little 
evidence to support strong causal intrauterine effects of maternal BMI on offspring 
adiposity.
47
 Although we observed a tendency for stronger associations of maternal BMI, as 
compared to paternal BMI, with general and abdominal fat measures, the differences between 
the maternal and paternal effect estimates were not statistically significant. These findings 
may suggest that the associations of maternal BMI with offspring adiposity might be 
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explained by shared family-based lifestyle and genetic characteristics rather than by 
intrauterine programming.
48
 
Next to maternal obesity, excessive gestational weight gain also seems to be 
associated with an increased risk of childhood overweight.
13-15
 In our study, excessive weight 
gain was associated with higher BMI and fat mass index. A previous study among 313 
mother-child pairs reported that higher maternal BMI was associated with higher childhood 
subcutaneous and visceral fat, particularly among mothers with excessive gestational weight 
gain.
16
 However, in the same cohort as the current study, maternal weight gain in early, mid 
and late pregnancy was not associated with childhood subcutaneous and preperitoneal 
abdominal fat mass levels at 6 years, independently of BMI.
17
 In our study, total and period-
specific weight gain was not consistently associated with any MRI adiposity measures. Thus, 
gestational weight gain, contrary to BMI before pregnancy, seems to have a limited influence 
on offspring organ fat in later life. 
The mechanisms by which maternal adiposity during pregnancy affects offspring 
organ fat accumulation are not fully known yet. Maternal over-nutrition may affect the 
development of adipocytes and their capacity to expand or contract, the appetite control 
system and the energy metabolism in later life,
6
 which might lead to increased body fat in the 
offspring. Maternal over-nutrition might also lead to accumulation of fat in the liver and other 
developing organs of the fetus, especially during early and mid pregnancy due to the absence 
of adipose tissue.
49
 The postnatal persistence of increased fat in these depots might be related 
to reduced fatty acid oxidation, changes in lipogenesis and lipoprotein export.
49
  
Our study shows that higher maternal pre-pregnancy BMI, as opposed to gestational 
weight gain, is related to higher organ fat measures, which have important adverse 
cardiometabolic health consequences. Future preventive strategies focused on promoting a 
healthy weight in women of reproductive age before pregnancy are needed to improve 
cardiometabolic health of the offspring.  
 
Methodological considerations 
Strengths of this study were the large sample size, prospective design and data available on 
multiple maternal weight measurements throughout pregnancy and detailed childhood 
adiposity measures. Of the 4,298 mothers and their singleton children with information on 
pre-pregnancy BMI available, 2,354 had information on MRI adiposity measures at 10 years. 
The non-response could lead to biased effect estimates if the associations of maternal BMI 
and gestational weigh gain with childhood adiposity measures differ between mothers and 
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children included and not included in the present analyses. However, this seems unlikely 
since participants and non-participants did not differ regarding maternal BMI and weight gain 
during pregnancy. We relied on self-reported pre-pregnancy weight and maximum weight 
during pregnancy. Women tend to underestimate their weight on self-report,
50
 which might 
have led to an underestimation of observed effects for maternal BMI. Since pre-pregnancy 
weight and maximum gestational weight are both self-reported and probably underestimated, 
the influence on maximum weight gain is likely to be minimal, which is confirmed by the 
fact that similar results were observed for weight gain measured until late pregnancy. Finally, 
although we adjusted for a large number of potential confounders, residual confounding due 
to lifestyle-related characteristics such as parental and child nutritional intake and physical 
activity might still be present in the observed associations. 
 
Conclusions 
Our study suggests that higher maternal BMI, but not gestational weight gain, is associated 
with organ fat accumulation, especially abdominal fat, in the offspring. Our findings 
emphasize the importance of promoting a healthy BMI in women who are planning to 
become pregnant rather that influencing weigh gain during pregnancy.  
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Table 1. Characteristics of mothers, fathers and their children (n=2,354)
1
 
Characteristics Value 
Maternal characteristics  
Age, mean (SD), years 31.0 (4.8) 
Education, n (%)  
     Low 160 (6.9) 
     Medium 935 (40.5) 
     High 1,211 (52.5) 
Ethnicity, n (%)  
     European 1,532 (65.3) 
     Non-European 815 (34.7) 
Parity, n (%)  
     Nulliparous 1,419 (60.3) 
     Multiparous  934 (39.7) 
Pre-pregnancy body mass index, median (95% range), kg/m
2 
22.5 (18.0, 34.9) 
Pre-pregnancy body mass index clinical categories, n (%)  
     Underweight 97 (4.1) 
     Normal weight 1,639 (69.6) 
     Overweight 451 (19.2) 
     Obesity 167 (7.1) 
Maximum gestational weight gain, mean (SD), kg 14.8 (5.8) 
Gestational weight gain clinical categories (IOM criteria), n (%)  
     Insufficient gestational weight gain 299 (20.5) 
     Sufficient gestational weight gain 505 (34.5) 
     Excessive gestational weight gain 658 (45.0) 
Weight in early pregnancy, mean (SD), kg 69.0 (12.9) 
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Weight in mid pregnancy, mean (SD), kg 76.0 (12.6) 
Weight in late pregnancy, mean (SD), kg 81.6 (12.5) 
Smoking during pregnancy, n (%)  
     Yes 504 (22.3) 
     No 1,757 (77.7) 
Paternal characteristics  
Age, mean (SD), years 33.6 (5.3) 
Education, n (%)  
     Low 83 (4.9) 
     Medium 652 (38.6) 
     High 953 (56.5) 
Ethnicity, n (%)  
     European 1,383 (74.4) 
     Non-European 477 (25.6) 
Body mass index, mean (SD), kg/m
2
 25.3 (3.3) 
Body mass index clinical categories, n (%)  
     Underweight 9 (0.5) 
     Normal weight 945 (50.3) 
     Overweight 771 (41.1) 
     Obesity 152 (8.1) 
Birth and infant characteristics  
Child’s sex, n (%)  
     Boys 1,151 (48.9) 
     Girls 1,203 (51.1) 
Breastfeeding duration, median (95% range), months 3.5 (0.0, 12.0) 
Introduction of solid foods, n (%)  
     < 3 months 123 (7.0) 
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     3-6 months 1,435 (81.7) 
     > 6 months 199 (11.3) 
Childhood characteristics  
Age, mean (SD), years 9.8 (0.3) 
Television watching time, n (%)  
     < 2 hours/day 1,342 (70.0) 
     ≥ 2 hours/day 575 (30.0) 
Body mass index, mean (SD), kg/m
2 
17.5 (2.6) 
Total fat mass, median (95% range), g 8,451 (4,549, 21,235) 
Subcutaneous fat mass, median (95% range), g 1,297 (603, 5,226) 
Visceral fat mass, median (95% range), g 365 (163, 1,004) 
Pericardial fat mass, median (95% range), g  10.6 (4.6, 22.6) 
Liver fat fraction, median (95% range), % 2.0 (1.2, 5.2) 
1
Values are observed data and represent means (SD), medians (95% range) or numbers of subjects 
(valid %). IOM, Institute of Medicine; SD, standard deviation.
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 Table 2. Maternal body mass index and childhood general and organ fat measures
1
 
 
1
Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except for sex- and age-adjusted body mass index SDS), 
maternal age, educational level, ethnicity, parity, and smoking habits during pregnancy, and child’s breastfeeding duration, timing of introduction of solid foods and 
television watching time. Results from the basic model are given in Supplemental Table 3. **P-value<0.05, *P-value<0.01. 
2
Values are regression coefficients (95% 
Confidence Intervals) from linear regression models that reflect differences in childhood outcomes in SDS per SDS change in maternal pre-pregnancy body mass index or for 
body mass index clinical groups as compared to the reference group (normal weight). 
3
Values are regression coefficients (95% Confidence Intervals) from linear regression 
models that reflect differences in the standardized residuals of the childhood outcomes (obtained by conditional regression analyses on body mass index at 10 years) per SDS 
 
Measures of adiposity at 10 years in SDS
2
 
Body mass index 
(n=2,354) 
Fat mass index 
(n=2,339) 
Subcutaneous fat index 
(n=2,049) 
Visceral fat index 
(n=2,052) 
Pericardial fat index 
(n=2,123) 
Liver fat fraction 
(n=2,319) 
BMI (kg/m
2
 in SDS) 0.32 (0.28, 0.36)* 0.28 (0.24, 0.31)* 0.26 (0.22, 0.30)* 0.24 (0.20, 0.28)* 0.12 (0.08, 0.16)** 0.15 (0.11, 0.19)* 
Underweight 
(<18.5 kg/m
2
) 
-0.49 (-0.69, -0.29)* -0.32 (-0.50, -0.14)* -0.31 (-0.50, -0.12)* -0.37 (-0.58, -0.17)* -0.26 (-0.47, -0.05)** -0.17 (-0.37, 0.04) 
Normal weight 
(18.5 – 24.9 kg/m2) 
Reference Reference Reference Reference Reference Reference 
Overweight 
(25.0 – 29.9 kg/m2) 
0.46 (0.36, 0.56)* 0.39 (0.30, 0.48)* 0.40 (0.30, 0.50)* 0.35 (0.24, 0.45)* 0.15 (0.04, 0.26)* 0.19 (0.09, 0.30)* 
Obesity 
(≥30.0 kg/m2) 
0.88 (0.73, 1.04)* 0.81 (0.66, 0.95)* 0.76 (0.61, 0.92)* 0.69 (0.52, 0.86)* 0.42 (0.24, 0.59)* 0.45 (0.28, 0.61)* 
  
 
MRI measures of adiposity at 10 years in SDS conditional on body mass index
3
 
  
 Subcutaneous fat index 
(n=2,049) 
Visceral fat index 
(n=2,052) 
Pericardial fat index 
(n=2,123) 
Liver fat fraction 
(n=2,319) 
BMI (kg/m
2
 in SDS)   0.05 (0.01, 0.09)** 0.07 (0.03, 0.11)* 0.02 (-0.02, 0.07) 0.03 (-0.01, 0.07) 
Underweight 
(<18.5 kg/m
2
) 
 
 
0.09 (-0.09, 0.28) -0.12 (-0.33, 0.10) -0.10 (-0.31, 0.11) 0.02 (-0.19, 0.23) 
Normal weight 
(18.5 – 24.9 kg/m2) 
 
 
Reference Reference Reference Reference 
Overweight 
(25.0 – 29.9 kg/m2) 
 
 
0.12 (0.03, 0.22)** 0.13 (0.02, 0.24)** 0.02 (-0.09, 0.13) 0.02 (-0.09, 0.13) 
Obesity 
(≥30.0 kg/m2) 
 
 
0.26 (0.10, 0.41)* 0.24 (0.07, 0.42)* 0.16 (-0.01, 0.34) 0.12 (-0.04, 0.29) 
MATERNAL ADIPOSITY DURING PREGNANCY 
 
114 
 
change in maternal pre-pregnancy body mass index or for body mass index clinical groups as compared to the reference group (normal weight). SDS, standard deviation 
scores. 
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Figure 1. Parental body mass index and childhood general and organ fat measures (n=1,795)
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Estimates are based on multiple imputed data. Model includes child´s sex and age at 
outcome measurements (except for sex- and age-adjusted body mass index SDS), parental 
age, educational level, and ethnicity, parity, maternal smoking habits during pregnancy, 
breastfeeding duration, and timing of introduction of solid foods. Results from the basic 
model are given in Supplemental Figure 2. Values in A are regression coefficients (95% 
Confidence Intervals) from linear regression models that reflect differences in childhood 
outcomes in SDS for parental body mass index clinical groups as compared to the reference 
group (maternal and paternal normal weight). Values in B are regression coefficients (95% 
Confidence Intervals) from linear regression models that reflect differences in the 
standardized residuals of the childhood outcomes (obtained by conditional regression 
analyses on body mass index at 10 years) for parental body mass index clinical groups as 
compared to the reference group (maternal and paternal normal weight). SDS, standard 
deviation scores. 
B. 
A. 
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Table 3. Maternal gestational weight gain and childhood general and organ fat measures
1
 
  
1
Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except for sex- and age- adjusted body mass index SDS), 
maternal age, educational level, ethnicity, parity, smoking habits during pregnancy, and child’s breastfeeding duration, timing of introduction of solid foods and television 
watching time. Models for maximum weight gain per week were additionally adjusted for pre-pregnancy body mass index. Results from the basic model are given in 
Supplemental Table 4. **P-value<0.05, *P-value<0.01. 
2
Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences 
in childhood outcomes in SDS per SDS change in maternal maximum weight gain per week or for IOM weight gain clinical groups as compared to the reference group 
(sufficient weight gain). 
3
Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences in the standardized residuals of 
the childhood outcomes (obtained by conditional regression analyses on body mass index at 10 years) per SDS change in maternal maximum weight gain per week or for 
IOM weight gain clinical groups as compared to the reference group (sufficient weight gain). SDS, standard deviation scores.
 
Measures of adiposity at 10 years in SDS
2
 
Body mass index 
(n=1,462) 
Fat mass index 
(n=1,451) 
Subcutaneous fat index 
(n=1,287) 
Visceral fat index 
(n=1,288) 
Pericardial fat index 
(n=1,336) 
Liver fat fraction 
(n=1,444) 
Maximum weight gain per 
week (kg in SDS) 
0.08 (0.03, 0.13)* 0.02 (-0.03, 0.06) 0.01 (-0.04, 0.05) 0.03 (-0.02, 0.08) 0.02 (-0.03, 0.08) 0.00 (-0.05, 0.05) 
Insufficient weight gain -0.09 (-0.23, 0.05) 0.01 (-0.12, 0.14) -0.01 (-0.14, 0.13) -0.03 (-0.17, 0.12) 0.04 (-0.11, 0.20) 0.05 (-0.09, 0.19) 
Sufficient weight gain Reference Reference Reference Reference Reference Reference 
Excessive weight gain 0.19 (0.07, 0.30)* 0.14 (0.04, 0.25)* 0.12 (0.01, 0.23)** 0.16 (0.04, 0.28)** 0.09 (-0.03, 0.22) 0.06 (-0.05, 0.18) 
  
 
MRI measures of adiposity at 10 years in SDS conditional on body mass index
3
 
  
 Subcutaneous fat index 
(n=1,287) 
Visceral fat index 
(n=1,288) 
Pericardial fat index 
(n=1,336) 
Liver fat fraction 
(n=1,444) 
Maximum weight gain per 
week (kg in SDS) 
 
 
-0.09 (-0.13, -0.04)* -0.02 (-0.07, 0.04) 0.00 (-0.06, 0.05) -0.04 (-0.09, 0.02) 
Insufficient weight gain   0.11 (-0.02, 0.23) 0.04 (-0.10, 0.19) 0.08 (-0.07, 0.23) 0.10 (-0.04, 0.24) 
Sufficient weight gain   Reference Reference Reference Reference 
Excessive weight gain   -0.03 (-0.13, 0.08) 0.07 (-0.05, 0.19) 0.04 (-0.09, 0.16) -0.01 (-0.12, 0.11) 
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Figure 2. Maternal pre-, early, mid, and late pregnancy weight with childhood general 
and organ fat measures (n=1,121)
1 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Estimates are based on multiple imputed data. Model includes child´s sex and age at 
outcome measurements (except for sex- and age-adjusted body mass index SDS), 
maternal age, educational level, and ethnicity, parity, height at intake, smoking habits 
during pregnancy, breastfeeding duration, and timing of introduction of solid foods. 
Results from the basic model are given in Supplemental Figure 3. Values in A are 
regression coefficients (95% Confidence Intervals) from linear regression models that 
reflect differences in childhood outcomes in SDS per SDS change in maternal pre-
pregnancy weight and per change in standardized residuals of maternal early, mid, and 
late pregnancy weight obtained from conditional regression analyses. Values in B are 
regression coefficients (95% Confidence Intervals) from linear regression models that 
A. 
B. 
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reflect differences in the standardized residuals of the childhood outcomes (obtained by 
conditional regression analyses on body mass index at 10 years) per SDS change in 
maternal pre-pregnancy weight and per change in standardized residuals of maternal 
early, mid, and late pregnancy weight obtained from conditional regression analyses. 
SDS, standard deviation scores. 
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Supplementary materials 
 
Supplemental Figure 1. Selection of study participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mothers and singleton children available 
for analysis 
n = 2,354 
 
 
Mothers and singleton children that 
attended the study visit at 10 years 
n = 5,706 
n = 1,944 Excluded: no data on any 
measures of adiposity obtained by 
Magnetic Resonance Imaging at 10 years 
  
 
n = 1,408 Excluded: no data on maternal 
pre-pregnancy body mass index  
Mothers and singleton children with 
information on pre-pregnancy body 
mass index available 
n = 4,298 
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Supplemental Methods: Log-log regression analyses 
 
To create measures of adiposity independent of height at 10 years, we estimated the 
optimal adjustment by log-log regression analyses.
1
 Total fat mass, subcutaneous fat 
mass, visceral fat mass and pericardial fat mass and height were log-transformed, using 
natural logs. Log-adiposity measures were regressed on log-height. The regression slope 
corresponds to the power by which height should be raised in order to calculate an index 
uncorrelated with height. Thus, we divided total fat mass by height
4
, subcutaneous fat 
mass by height
4
, visceral fat mass by height
3
, and pericardial fat mass by height
3
. 
 
References 
1. Wells JC, Cole TJ, ALSPAC study team. Adjustment of fat-free mass and fat mass 
for height in children aged 8 y. Int J Obes Relat Metab Disord. 2002;26:947-952. 
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Supplemental Table 1. Comparison of subject characteristics between participants and non-participants.
1
 
Characteristics 
Participants 
(n=2,354) 
Non-participants 
(n=1,944) 
P-value 
Maternal characteristics    
Age, mean (SD), years 31.0 (4.8) 30.6 (5.1) 0.01 
Education (higher education), n (%) 1211 (52.5) 887 (46.9) <0.01 
Ethnicity (European), n (%) 1532 (65.3) 1256 (64.7) 0.72 
Parity (nulliparous), n (%) 1419 (60.3) 1123 (57.9) 0.10 
Pre-pregnancy body mass index, median (95% range), kg/m
2 
22.5 (18.0, 34.9) 22.6 (18.2, 34.2) 0.90 
Obesity, n (%) 167 (7.1) 164 (8.4) 0.22 
Maximum gestational weight gain, mean (SD), kg 14.8 (5.8) 14.9 (5.5) 0.62 
Excessive gestational weight gain (IOM criteria), n (%) 658 (45.0) 416 (42.9) 0.16 
Weight in early pregnancy, mean (SD), kg 69.0 (12.9) 68.7 (12.0) 0.47 
Weight in mid pregnancy, mean (SD), kg 76.0 (12.6) 75.5 (12.5) 0.17 
Weight in late pregnancy, mean (SD), kg 81.6 (12.5) 80.1 (11.8) 0.01 
Smoking during pregnancy (yes), n (%) 504 (22.3) 473 (25.5) 0.02 
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1
Values are observed data and represent means (SD), medians (95% range) or numbers of subjects (valid %). Differences were tested using Student’s t-tests 
and Mann-Whitney tests for normally and non-normally distributed variables, respectively and χ2-test for dichotomous variables. IOM, Institute of Medicine; 
SD, standard deviation. 
Paternal characteristics    
Age, mean (SD), years 33.6 (5.3) 33.1 (5.7) 0.02 
Education (higher education), n (%) 953 (56.5) 713 (52.5) 0.02 
Ethnicity (European), n (%) 1383 (74.4) 1089 (72.9) 0.36 
Body mass index, mean (SD), kg/m
2
 25.3 (3.3) 25.2 (3.4) 0.33 
Birth and infant characteristics    
Boys, n (%) 1151 (48.9) 986 (50.7) 0.23 
Breastfeeding duration, median (95% range), months 3.5 (0.0, 12.0) 3.5 (0.0, 12.0) 0.58 
Introduction of solid foods (> 6 months), n (%) 199 (11.3) 99 (9.8) 0.44 
Childhood characteristics    
Age, mean (SD), years 9.8 (0.3) 9.8 (0.4) 0.02 
Television watching time (≥ 2 hours/day), n (%) 575 (30.0) 477 (32.8) 0.09 
Body mass index, mean (SD), kg/m
2
 17.5 (2.6) 17.7 (2.9) 0.04 
Total fat mass, median (95% range), g 8,451 (4,549, 21,235) 8,557 (4,505, 23,454) 0.26 
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Supplemental Table 2. Correlation coefficients between all measures of adiposity at 10 years (n=2,354)
1
 
 
1
Values are Spearman correlation coefficients. *P-value<0.01 
 
 
Measures of adiposity Body mass index Fat mass index Subcutaneous fat index Visceral fat index Pericardial fat index Liver fat fraction 
Body mass index 
1 0.81* 0.77* 0.58* 0.31* 0.38* 
Fat mass index 0.81* 1 0.95* 0.69* 0.33* 0.42* 
Subcutaneous fat index 0.77* 0.95* 1 0.74* 0.35* 0.45* 
Visceral fat index 
0.58* 0.69* 0.74* 1 0.47* 0.39* 
Pericardial fat index 
0.31* 0.33* 0.35* 0.47* 1 0.18* 
Liver fat fraction 
0.38* 0.42* 0.45* 0.39* 0.18* 1 
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Supplemental Table 3. Maternal body mass index and childhood general and organ fat measures
1 
 
 
1
Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences in childhood outcomes in SDS per SDS change in 
maternal pre-pregnancy body mass index or for body mass index clinical groups as compared to the reference group (normal weight). Model includes child´s sex and age at 
outcome measurements (except for sex- and age-adjusted body mass index SDS). **P-value<0.05, *P-value<0.01. SDS, standard deviation scores. 
 
 
 
 
Measures of adiposity at 10 years in SDS 
Body mass index 
(n=2,354) 
Fat mass index 
(n=2,339) 
Subcutaneous fat index 
(n=2,049) 
Visceral fat index 
(n=2,052) 
Pericardial fat index 
(n=2,123) 
Liver fat fraction 
(n=2,319) 
BMI (kg/m
2
 in SDS) 0.35 (0.31, 0.39)* 0.32 (0.28, 0.36)* 0.30  (0.26, 0.34)* 0.25 (0.21, 0.29)* 0.12 (0.08, 0.16)* 0.18 (0.14, 0.22)* 
Underweight 
(<18.5 kg/m
2
) 
-0.44 (-0.64, -0.24)* -0.27 (-0.45, -0.08)* -0.25 (-0.44, -0.05)** -0.35 (-0.56, -0.15)* -0.27 (-0.48, -0.06)** -0.15 (-0.36, 0.05) 
Normal weight 
(18.5 – 24.9 kg/m2) 
Reference Reference Reference Reference Reference Reference 
Overweight 
(25.0 – 29.9 kg/m2) 
0.53 (0.43, 0.63)* 0.48 (0.38, 0.57)* 0.47 (0.37, 0.57)* 0.36 (0.26, 0.47)* 0.15 (0.04, 0.26)* 0.25 (0.15, 0.35)* 
Obesity 
(≥30.0 kg/m2) 
0.99 (0.83, 1.14)* 0.95 (0.81, 1.10)* 0.89 (0.73, 1.05)* 0.72 (0.55, 0.88)* 0.42 (0.25, 0.60)* 0.53 (0.37, 0.69)* 
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Supplemental Figure 2. Parental body mass index and childhood general and organ fat 
measures (n=1,795)
1 
 
1
Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect 
differences in childhood outcomes in SDS for parental body mass index clinical groups as compared to 
the reference group (maternal and paternal normal weight). Model includes child´s sex and age at 
outcome measurements (except for sex- and age-adjusted body mass index SDS). SDS, standard deviation 
scores. 
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Supplemental Table 4. Maternal gestational weight gain and childhood general and organ fat measures
1
 
 
 
1
Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences in childhood outcomes in SDS per SDS change in 
maternal maximum weight gain per week or for IOM weight gain clinical groups as compared to the reference group (sufficient weight gain). Model includes child´s sex and 
age at outcome measurements (except for sex- and age-adjusted body mass index SDS). **P-value<0.05, *P-value<0.01. SDS, standard deviation scores. 
 
 
 
 
 
 
 
 
Measures of adiposity at 10 years in SDS 
Body mass index 
(n=1,462) 
Fat mass index 
(n=1,451) 
Subcutaneous fat index 
(n=1,287) 
Visceral fat index 
(n=1,288) 
Pericardial fat index 
(n=1,336) 
Liver fat fraction 
(n=1,444) 
Maximum weight gain per 
week (kg in SDS) 
0.02 (-0.03, 0.07) -0.03 (-0.08, 0.01) -0.04 (-0.09, 0.01) 0.00 (-0.05, 0.06) 0.01 (-0.04, 0.07) -0.02 (-0.07, 0.03) 
Insufficient weight gain -0.06 (-0.21, 0.08) 0.06 (-0.07, 0.19) 0.04 (-0.10, 0.17) 0.00 (-0.15, 0.15) 0.04 (-0.11, 0.19) 0.08 (-0.06, 0.22) 
Sufficient weight gain Reference Reference Reference Reference Reference Reference 
Excessive weight gain 0.21 (0.10, 0.33)* 0.18 (0.07, 0.29)* 0.15 (0.04, 0.26)** 0.20 (0.08, 0.32)* 0.11 (-0.01, 0.23) 0.10 (-0.02, 0.21) 
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Supplemental Table 5. Maternal weight gain until late pregnancy and childhood general and organ fat measures
1
 
 
1
Estimates are based on multiple imputed data. Model includes child´s sex and age at outcome measurements (except for sex- and age-adjusted body mass index SDS), 
maternal age, educational level, ethnicity, parity, smoking habits during pregnancy, and child’s breastfeeding duration, timing of introduction of solid foods and television 
watching time. Models for weight gain until late pregnancy per week were additionally adjusted for pre-pregnancy body mass index. **P-value<0.05, *P-value<0.01. 
2
Values 
are regression coefficients (95% Confidence Intervals) from linear regression models that reflect differences in childhood outcomes in SDS per SDS change in maternal 
weight gain until late pregnancy per week or for IOM weight gain clinical groups as compared to the reference group (sufficient weight gain). 
3
Values are regression 
 
Measures of adiposity at 10 years in SDS
2
 
Body mass index 
(n=1,316) 
Fat mass index 
(n=1,306) 
Subcutaneous fat index 
(n=1,157) 
Visceral fat index 
(n=1,158) 
Pericardial fat index 
(n=1,207) 
Liver fat fraction 
(n=1,301) 
Weight gain until late 
pregnancy per week (kg in 
SDS) 
0.08 (0.03, 0.13)* 0.02 (-0.03, 0.07) 0.01 (-0.04, 0.06) 0.04 (-0.02, 0.09) 0.02 (-0.04, 0.08) 0.00 (-0.05, 0.06) 
Insufficient weight gain -0.13 (-0.28, 0.02) -0.05 (-0.19, 0.08) -0.02 (-0.16, 0.12) -0.04 (-0.19, 0.12) 0.06 (-0.11, 0.22) 0.04 (-0.11, 0.18) 
Sufficient weight gain Reference Reference Reference Reference Reference Reference 
Excessive weight gain 0.18 (0.06, 0.30)* 0.14 (0.03, 0.25)** 0.14 (0.02, 0.25)** 0.19 (0.06, 0.31)* 0.12 (-0.01, 0.25) 0.07 (-0.05, 0.19) 
  
 
MRI measures of adiposity at 10 years in SDS conditional on body mass index
3
 
  
 Subcutaneous fat index 
(n=1,157) 
Visceral fat index 
(n=1,158) 
Pericardial fat index 
(n=1,207) 
Liver fat fraction 
(n=1,301) 
Weight gain until late 
pregnancy per week (kg in 
SDS) 
 
 
-0.09 (-0.14, -0.04)* -0.01 (-0.07, 0.05) 0.00 (-0.06, 0.06) -0.03 (-0.08, 0.02) 
Insufficient weight gain   0.13 (0.00, 0.27) 0.06 (-0.10, 0.21) 0.11 (-0.06, 0.27) 0.10 (-0.05, 0.25) 
Sufficient weight gain   Reference Reference Reference Reference 
Excessive weight gain   0.01 (-0.10, 0.12) 0.11 (-0.01, 0.24) 0.07 (-0.06, 0.20) 0.01 (-0.11, 0.13) 
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coefficients (95% Confidence Intervals) from linear regression models that reflect differences in the standardized residuals of the childhood outcomes (obtained by conditional 
regression analyses on body mass index at 10 years) per SDS change in maternal weight gain until late pregnancy per week or for IOM weight gain clinical groups as 
compared to the reference group (sufficient weight gain). SDS, standard deviation scores. 
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Supplemental Figure 3. Maternal pre-, early, mid, and late pregnancy weight with childhood general 
and organ fat measures (n=1,121)
1 
 
 
 
 
 
 
 
 
 
 
1
 Values are regression coefficients (95% Confidence Intervals) from linear regression models that reflect 
differences in childhood outcomes in SDS per SDS change in maternal pre-pregnancy weight and per change in 
standardized residuals of maternal early, mid, and late pregnancy weight obtained from conditional regression 
analyses. Model includes child´s sex and age at outcome measurements (except for sex- and age-adjusted body 
mass index SDS). SDS, standard deviation scores. 
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CHAPTER 3.1 
 
Anthropometric indices based on waist circumference 
as measures of total and abdominal adiposity in 
children  
Susana Santos, Milton Severo, Carla Lopes, Andreia Oliveira 
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Abstract 
 
Background: We compared the accuracy of body fat patterns and single measures in 
assessing body fat and clarified the use of indices based on waist circumference as measures 
of adiposity in children.  
 
Methods: This study included 2531 7-year-old children from the Generation XXI birth 
cohort (Porto, Portugal). Anthropometrics were obtained by trained personnel and body fat 
patterns were identified by principal component analysis. Whole-body dual energy X-ray 
absorptiometry (DXA) scans were performed. Pearson´s correlation coefficients of the scores 
obtained by principal component analysis and the single measures with DXA-fat mass index 
and -central fat were obtained. 
 
Results: Principal component analysis identified two body fat patterns, similar by sex and 
explaining 88.3% of total variance. Pattern 1 (body mass index, fat mass index from tetra-
polar bioelectric impedance and waist-to-height ratio) showed stronger correlations with 
DXA-fat mass index (r=0.85, p<0.001) and pattern 2 (waist-to-hip, waist-to-thigh and waist-
to-weight ratios) showed stronger correlations with DXA-central fat (r=0.35, p<0.001). As 
compared to single measures, body fat patterns showed similar correlations with DXA-
derived measures. 
 
Conclusions: As compared to single anthropometric indices, body fat patterns seem to add 
little value for estimating body fat in children. Waist-to-height ratio seems to be a proxy for 
total fat, while waist-to-hip, waist-to-thigh and waist-to-weight ratios seem to be proxies for 
central fat. Further studies should address the predictive ability of waist-to-weight ratio to 
identify children at risk of developing cardiometabolic disease, as this was the first time 
describing its potential usefulness. 
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Introduction 
Epidemiologic studies on childhood obesity often use proxies and single measures for its 
definition, which might have limited their ability to detect associations.
1
 The combination of 
anthropometric indices into robust body fat patterns could be a more accurate and yet simple 
approach of evaluating childhood obesity. However, no study has addressed whether body fat 
patterns are more accurate than single measures for assessing body fat in children. Another 
drawback of most previous studies is related to the use of waist circumference as proxy for 
central fat. Waist circumference has been more strongly correlated with body mass index 
(BMI) and total body fat than with abdominal visceral fat and thus should be considered a 
marker of total fat, rather than of central fat.
2, 3
 This evidence raises doubts about the use of 
indices based on waist circumference, such as waist-to-height ratio, as proxies for central fat, 
but no study has addressed this to date.  
We aimed to compare the accuracy of body fat patterns and single measures for 
assessing body fat and to clarify the use of indices based on waist circumference as measures 
of adiposity in children. 
 
Methods 
This study included participants from the population-based birth cohort Generation XXI that 
was assembled during 2005-2006 at all public maternity units of Porto, Portugal.
4
 Of 5849 
children who attended the face-to-face interviews at 7 years old, 5719 children had 
anthropometrics and tetra-polar bioelectric impedance available. A sub-sample of 2531 
children had whole-body dual energy X-ray absorptiometry (DXA) measurements (47.6% 
females). As compared to children without DXA measurements (n=3188), those children 
with DXA measurements (n=2531) were slightly younger [mean (standard deviation, 
SD)=6.7 (0.49) vs. 6.9 (0.36) years old] and had a lower BMI [mean (SD)=16.9 (2.45) vs. 
17.1 (2.55) kg/m
2
]. Although these differences were statistically significant, the magnitude of 
the differences was small. No differences were observed for child’s sex and for the other 
anthropometric indices. All phases of the study complied with the Ethical Principles for 
Medical Research Involving Human Subjects expressed in the Declaration of Helsinki. The 
study was approved by the University of Porto Medical School/ S. João Hospital Centre 
Ethics Committee and a signed informed consent according Helsinki was required for all 
participants. 
Anthropometrics were obtained by trained personnel with children in underwear and 
barefoot, according to standard procedures.
5
 Body weight was measured to the nearest 0.1 kg 
INFANT ADIPOSITY 
 
136 
 
using a digital scale (TANITA®) and height was measured to the nearest 0.1 cm using a wall 
stadiometer (SECA®). Waist circumference was measured at the umbilicus level, with 
abdomen relaxed and hip circumference at the level of the greatest posterior protuberance of 
the buttocks; both were measured to the nearest 0.1 cm, with the child in a standing position, 
arms at the sides and feet positioned together. Thigh circumference was measured to the 
nearest 0.1cm around the mid-thigh and perpendicular to the long axis of the thigh, with the 
leg slightly flexed. The inter-observer variability in anthropometric measurements was 
assessed comparing a subset of measurements made by each interviewer. The inter-observer 
variability adjusted for child’s age was close to zero for all anthropometrics, showing no 
differences between interviewers.  
Body mass index was calculated as the value of weight (kg) over the squared height 
(m). Waist-to-height ratio, waist-to-hip ratio and waist-to-thigh ratio were calculated as waist 
circumference divided by height, hip and thigh circumferences, respectively. The relationship 
between waist circumference and weight was assessed using a log-log regression analysis, 
which gave a slope of 0.5, corresponding to the value by which weight should be raised in 
order to calculate a measure uncorrelated with it. Waist-to-weight ratio was calculated, for 
the first time in the literature, as waist circumference/weight
0.5
. 
Tetra-polar bioelectric impedance analysis was performed (BIA 101 Anniversary, 
Akern, Florence, Italy). Fat free mass was determined using Schaefer et al. equation and fat 
mass was derived accordingly.
6
 Fat mass/height
2
 was calculated to obtain the fat mass index 
(BIA-FMI), in which fat mass was effectively uncorrelated with height. 
Whole-body DXA scans were performed (QDR 4500A; Hologic, Bedford, MA, 
USA). Fat mass/height
4
 was calculated and was effectively uncorrelated with height. Central 
fat was assessed as trunk fat. Fat mass obtained from bioelectric impedance and DXA was 
compared. Pearson´s correlation coefficient was strong (r=0.89, p<0.001) and an intraclass 
correlation coefficient using an absolute agreement definition of 58.7% was obtained through 
a two-way mixed effects model, showing reasonable accuracy of bioelectric impedance 
analysis.  
Principal component analysis was applied to BMI, waist-to-height ratio, waist-to-hip 
ratio, waist-to-thigh ratio, waist-to-weight ratio, and BIA-FMI. Factors with eigenvalues ≥1.0 
were retained and varimax rotation was performed. Factor loadings>0.30 were used in the 
interpretation of factors. The scores were calculated using the regression method with 
standardized scores. Pearson´s correlation coefficients of the scores obtained by principal 
component analysis and the single measures with DXA-FMI and -central fat were obtained. 
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Analyses were conducted using R® version 3.0.1 and SPSS 21.0 (SPSS Inc. 2004, Chicago, 
IL, USA). 
 
Results 
Characteristics of participants are shown in Table 1. Two independent body fat patterns, 
which explained 88.3% of total variance, were identified: a pattern 1 characterized by BMI, 
BIA-FMI and waist-to-height ratio and a pattern 2 characterized by waist-to-hip, waist-to-
thigh and waist-to-weight ratios (Table 2). No sex differences in the body fat patterns were 
observed (data not shown). Pattern 1 (Fat quantity) presented a stronger correlation with 
DXA-FMI (r=0.85, p<0.001) while pattern 2 (Fat distribution) presented a stronger 
correlation with DXA-central fat (r=0.35, p<0.001) (Table 3). The magnitude of the 
correlations with DXA-derived measures was similar for body fat patterns and single 
measures. Waist-to-height ratio presented a stronger correlation with DXA-FMI (r=0.82, 
p<0.001) while waist-to-thigh ratio presented a stronger correlation with DXA-central fat 
(r=0.30, p<0.001). Waist-to-hip and waist-to-weight ratios were similarly correlated with 
both DXA-derived measures. No sex differences in the associations of body fat patterns and 
single measures with DXA-derived measures were observed (data not shown).  
 
Discussion 
Pattern 1 combines well-known measures of total adiposity (BMI and BIA-FMI) and pattern 
2 combines measures of regional adiposity (waist-to-hip ratio and waist-to-thigh ratio) and 
seem to represent fat quantity and distribution, respectively. This is corroborated by the 
stronger correlations between pattern 1 and DXA-FMI and between pattern 2 and DXA-
central fat. Nonetheless, both body fat patterns showed similar correlations with DXA-
derived measures as compared to single measures. Body fat patterns seem to add little value 
for estimating body fat in children. Fat distribution, either using patterns or single measures, 
seems to be poorer measured as compared to fat quantity. 
Anthropometric indices based on waist circumference may represent both fat quantity 
and distribution, which may raise controversial findings in population-based settings. In our 
study, waist-to-height ratio was stronger correlated with DXA-FMI while waist-to-thigh ratio 
was stronger correlated with DXA-central fat and thus seem to be proxies for total and central 
fat, respectively. Although waist-to-hip ratio and waist-to-weight ratio were similarly 
correlated with both DXA-derived measures, their correlations with DXA-FMI were much 
weaker as compared to BMI, BIA-FMI and waist-to-height ratio while their correlations with 
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DXA-central fat were similar as compared to waist-to-thigh ratio and thus might be 
reasonable proxies for central fat. Waist-to-thigh ratio seems to be the measure of central fat 
less correlated with total fat. Waist circumference showed similar findings as compared to 
waist-to-height ratio (data not shown). 
Measurements of waist circumference require adjustment for body height or weight if 
comparisons between individuals, or within individuals over time, are to be meaningful. 
Previous studies showed that shorter subjects had a higher cardiometabolic risk than taller 
subjects with similar waist circumference, which contributed to the definition of waist-to-
height ratio as another proxy for central adiposity.
7
 The correction of waist circumference for 
height allows that a single cut-off level may be used in different ethnic, age and sex groups
8
 
while waist circumference requires sex- and population-specific cut-off levels to account for 
the effect of height on metabolic risk within different populations.
9
 However, adjustment of 
waist circumference for height seems not enough to distinguish children according to their fat 
distribution. Two hypothetical children of identical height might have different waist 
circumference due to different body weights. Thus, waist-to-height ratio remains influenced 
by body weight and, like waist circumference, is a better index of total adiposity rather than 
of central adiposity, as corroborated by our findings. Previous studies have discussed whether 
waist circumference adjusted for BMI is a better predictor of visceral fat in adults as 
compared to waist circumference and have reported contradictory results.
10, 11
 In our sample 
of 7-year-old children, height explains 3.9% while weight explains 83.4% of the variance of 
waist circumference, and thus adjustment for weight seems to be appropriate in order to 
obtain an accurate measure of central adiposity. Waist circumference can be adjusted for 
weight as waist circumference/weight
p
, where p is the appropriate power by which to raise 
weight in order to obtain an index uncorrelated with it. As compared to waist-to-hip ratio and 
waist-to-thigh ratio, the other measures of fat distribution in our study, waist-to-weight ratio 
might be easier to obtain and less likely to measurement error in most age groups. This was 
the first time suggesting waist-to-weight ratio as a proxy for central fat, and thus further 
studies are needed to address its predictive ability to identify children at risk of developing 
cardiometabolic disease.  
Some strengths and limitations should be considered. Major strengths of this study are 
the population-based design with detailed childhood body fat measurements available. We 
relied on anthropometric measurements, which might have greater measurement error and be 
less accurate, but on the other hand be easier and cheaper to obtain in large epidemiological 
studies as compared to imaging techniques of body composition.
12
 In this study, we have also 
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used DXA, which is an imaging technique that quantifies total and regional body fat content 
with high precision.
12
 Of the 5719 children with anthropometrics and tetra-polar bioelectric 
impedance available, 2531 children had DXA measurements. However, the non-response is 
unlikely to lead to biased effect estimates since children with and without DXA 
measurements did not differ regarding sex, age and the anthropometric indices. 
In conclusion, this study suggests that body fat patterns, as compared to single 
anthropometric indices, add little value for estimating body fat quantity and distribution in 
children. Waist-to-height ratio seems to be a proxy for total fat (and not for central fat, as 
suggested in previous studies), while waist-to-hip, waist-to-thigh and waist-to-weight ratios 
seem to be proxies for central fat. Waist-to-weight ratio is a promising proxy for abdominal 
fat distribution, with population-based advantages over other measures, that warrants further 
research. 
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Table 1 Characteristics of study participants (n=2531)
1
 
 
Child´s characteristics Mean (SD) 
    Age, years 6.7 (0.49) 
    Body mass index, kg/m
2 
 16.9 (2.45) 
    BIA-fat mass index, kg/m
2 
 3.1 (2.27) 
    Waist-to-height ratio   0.5 (0.05) 
    Waist-to-hip ratio 0.9 (0.04) 
    Waist-to-thigh ratio  1.6 (0.10) 
    Waist-to-weight ratio, cm/√kg  10.2 (0.47) 
    DXA-fat mass index, kg/m
4
 3.7 (1.32) 
    DXA-central fat, kg 3.3 (1.71) 
 
1
BIA, bioelectric impedance analysis; DXA, dual energy X-ray absorptiometry; SD, 
standard deviation.
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Table 2 Factor loadings, obtained from principal component analysis, for anthropometric and 
bioelectric impedance measures (n=5719)
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
BIA, bioelectric impedance analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
  Factor loadings 
  Pattern 1
 
 Pattern 2
 
 
Body mass index, kg/m
2
  0.98 0.05 
BIA-fat mass index, kg/m
2
  0.94 0.06 
Waist-to-height ratio  0.87 0.45 
Waist-to-hip ratio   0.28 0.88 
Waist-to-thigh ratio  -0.04 0.89 
Waist-to-weight ratio, cm/√kg  0.20 0.90 
   
Variance explained  45.3% 43.0% 
Cumulative variance explained  45.3% 88.3% 
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Table 3 Pearson´s correlation coefficients of body fat patterns and single measures with 
DXA-derived measures in children (n=2531)
1
 
 
 DXA-fat mass index, kg/m
4
 DXA-central fat, kg
a
 
Pattern 1 - Fat quantity 0.85 (p<0.001) 0 (p=0.879) 
Pattern 2 - Fat distribution 0.10 (p<0.001) 0.35 (p<0.001) 
   
Body mass index, kg/m
2
 0.83 (p<0.001) 0.08 (p<0.001) 
BIA-fat mass index, kg/m
2
 0.80 (p<0.001) -0.02 (p=0.305) 
Waist-to-height ratio 0.82 (p<0.001) 0.28 (p<0.001) 
Waist-to-hip ratio  0.27 (p<0.001) 0.31 (p<0.001) 
Waist-to-thigh ratio 0.02 (p=0.462) 0.30 (p<0.001) 
Waist-to-weight ratio, cm/√kg 0.35 (p<0.001) 0.33 (p<0.001) 
 
1
BIA, bioelectric impedance analysis; DXA, dual energy X-ray absorptiometry. 
a
adjusted for total fat mass. 
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CHAPTER 3.2 
 
Subcutaneous fat mass in infancy and total and 
abdominal fat mass at school-age  
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Abstract 
 
Background: Skinfold thickness enables the measurement of overall and regional 
subcutaneous fatness in infancy and may be associated with total and abdominal body fat in 
later childhood. We examined the associations of subcutaneous fat in infancy with total and 
abdominal fat at school-age. 
 
Methods: In a population-based prospective cohort study among 821 children, we calculated 
total subcutaneous fat (sum of biceps, triceps, suprailiacal and subscapular skinfold 
thicknesses) and central-to-total subcutaneous fat ratio (sum of suprailiacal and subscapular 
skinfold thicknesses/total subcutaneous fat) at 1.5 and 24 months. At 6 years, we measured 
fat mass index (total fat/height
3
), central-to-total fat ratio (trunk fat/total fat) and android-to-
gynoid fat ratio (android fat/gynoid fat) by dual-energy X-ray absorptiometry and 
preperitoneal fat mass area by abdominal ultrasound.  
 
Results: Central-to-total subcutaneous fat ratio at 1.5 months was positively associated with 
fat mass index and central-to-total fat ratio at 6 years, whereas both total and central-to-total 
subcutaneous fat ratio at 24 months were positively associated with all childhood adiposity 
measures. A 1-standard-deviation scores higher total subcutaneous fat at 24 months was 
associated with an increased risk of childhood overweight (Odds Ratio 1.70 [95% Confidence 
Interval 1.36, 2.12]). These associations were weaker than those for body mass index and 
stronger among girls than boys.     
 
Conclusions: Subcutaneous fat in infancy is positively associated with total and abdominal 
fat at school-age. Our results also suggest that skinfold thicknesses add little value to estimate 
later body fat, as compared to body mass index.   
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Introduction 
Infancy seems to be a critical period for the development of obesity.
1
 An accumulating body 
of evidence has suggested that nutrition and growth in infancy are related to the risk of 
obesity in later life.
2, 3
 Also, infant growth patterns seem to be related not only to body mass 
index, but also to an adverse body fat distribution.
4, 5
 Several studies have shown that 
compared to body mass index, body fat distribution plays a greater role in the development of 
obesity-related complications, such as cardiovascular disease and type 2 diabetes.
6 
Although 
previous studies have suggested that central fat mass tracks moderately from mid-childhood 
into adulthood,
7-10
 it is not known whether body fat distribution measures in infancy are 
associated with similar measures in later childhood. 
Skinfold thickness is a valid measurement of subcutaneous fat mass that enables 
assessment of overall and regional fatness in infancy.
11
 Previously, we reported the tracking 
of subcutaneous fat mass measured by skinfold thickness during the first 2 years of life.
12 
Assessing the associations of these specific fat mass measures during infancy with fat mass 
measures during childhood helps to further understand the stability of body fat across 
childhood. Also, skinfold thickness measurements in infancy may be associated with an 
adverse body fat pattern in later childhood.  
Therefore, we examined, in a population-based prospective cohort study among 821 
children, the associations of infant subcutaneous fat mass measures with total and abdominal 
fat mass measures and with the risk of overweight at school-age.  
 
Methods 
 
Study design 
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards among 9778 mothers and their children living in 
Rotterdam, the Netherlands.
13
 The study was approved by the local Medical Ethical 
Committee. Written informed consent was obtained from all mothers. Additional detailed 
assessments of fetal and postnatal growth and development were conducted in a subgroup of 
Dutch mothers and their children from late pregnancy onwards. Of all approached women, 
80% agreed to participate. Of the total of 1205 singleton children participating in the 
subgroup study, 965 children had body mass index or skinfold thicknesses measured at the 
age of 1.5 or 24 months. Of the group of 965 children, 821 children had follow-up 
measurements at the age of 6 years (Flow chart is given in Supplemental Figure S1).  
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Body fat measurements during infancy 
We measured weight to the nearest gram in naked infants at the age of 1.5 months by using 
an electronic infant scale and at 24 months by using a mechanical personal scale (SECA, 
Almere, the Netherlands). Body length at the age of 1.5 months was measured in supine 
position to the nearest millimeter by using a neonatometer and body height at 24 months was 
measured in standing position by using a Harpenden stadiometer (Holtain Limited, Dyfed, 
UK). Body mass index (kg/m
2
) was calculated. 
We measured skinfold thicknesses at the ages of 1.5 and 24 months on the left side of 
the body at the biceps, triceps, suprailiacal and subscapular area by using a skinfold caliper 
(Slim Guide, Creative Health Products) according to standard procedures.
12
 We calculated 
total subcutaneous fat mass from the sum of all four skinfold thicknesses, and central 
subcutaneous fat mass from the sum of suprailiacal and subscapular skinfold thicknesses.
14, 15
 
To create total subcutaneous fat mass independent of length or height and central 
subcutaneous fat mass independent of total subcutaneous fat mass, we estimated the optimal 
adjustment by log-log regression analyses.
16
 Details of these regressions are given in the 
Supplemental Methods. Total subcutaneous fat mass was only weakly correlated with 
length or height, and was not adjusted for it whereas a central-to-total subcutaneous fat mass 
ratio was calculated as central divided by total subcutaneous fat mass.   
 
Body fat measurements at school-age 
Measurements were performed in a dedicated research center by a well-trained staff.
4
 We 
measured height to the nearest millimeter by using a Harpenden stadiometer (Holtain 
Limited, Dyfed, UK) and weight to the nearest gram by using a mechanical personal scale 
(SECA, Almere, the Netherlands) in standing position without shoes and heavy clothing. We 
calculated body mass index (kg/m
2
), and defined overweight and obesity as described by 
Cole et al.
17 
 
We measured total and regional body fat mass using a DXA scanner (iDXA, GE-
Lunar, 2008, Madison, WI, USA, enCORE software v.12.6), according to standard 
procedures.
4
 Previous studies have validated DXA against computed tomography for body fat 
assessment.
18-20
 We divided total fat mass by height
3
 in order to obtain a fat mass index 
uncorrelated with height, as confirmed by a log-log regression analysis.
16, 21
 We assessed 
central fat mass as fat mass of the trunk, and divided by total fat mass in order to obtain a 
central-to-total fat mass ratio effectively uncorrelated with total fat mass. We calculated the 
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ratio of android and gynoid fat mass, which reflects the relation between fat mass in the 
abdomen (android) and hip (gynoid) regions.  
Abdominal preperitoneal fat mass, as a proxy for visceral fat mass, was measured by 
abdominal ultrasound (GE LOGIQ E9, Milwaukee, WI, USA), as described previously.
22
 
Briefly, a linear (L12-5 MHz) transducer was placed perpendicular to the skin surface on the 
median upper abdomen.
23
 We scanned longitudinally from the xiphoid process to the navel 
along the midline (linea alba). Preperitoneal fat mass area was measured as the area of 2 cm 
length along the midline starting from the reference point in direction of the navel.  
 
Covariates 
Information on maternal age, educational level, parity, pre-pregnancy weight and smoking 
habits during pregnancy was assessed using self-reported questionnaires during pregnancy. 
We measured maternal height at enrolment, and calculated pre-pregnancy body mass index 
(kg/m
2
). Information about child’s sex, gestational age and weight at birth was obtained from 
medical records. Information about breastfeeding duration, timing of introduction of solid 
foods and average television watching time at 6 years old was obtained by questionnaires.  
 
Statistical analysis  
We examined differences between boys and girls for maternal and child’s characteristics with 
Student’s t-tests and Mann-Whitney tests for normally and non-normally distributed 
variables, respectively and with χ2-test for dichotomous variables. We used Pearson’s or 
Spearman’s rank correlation coefficients to estimate correlations of subcutaneous fat mass 
measures at 1.5 or 24 months with total and abdominal fat mass measures at 6 years. We 
assessed the associations of infant subcutaneous fat mass measures with childhood total and 
abdominal fat mass measures using linear regression models and with the risk of childhood 
overweight using logistic regression models. These regression models were adjusted for 
maternal age, educational level, parity, pre-pregnancy body mass index and smoking habits 
during pregnancy, and child’s gestational age-adjusted birth weight SDS, breastfeeding 
duration, timing of introduction of solid foods, and TV watching time. We included 
covariates in the models when they changed the effect estimates substantially (>10%), or 
when they were strongly associated with body fat mass in our or previous studies. Since we 
observed statistically significant interactions between infant subcutaneous fat mass measures 
and child’s sex in the association with childhood total and abdominal fat mass measures, we 
performed all analyses for the total group and for boys and girls separately. No significant 
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interactions were observed with body mass index categories at 1.5 or 24 months. We 
constructed SDS [(observed value - mean)/SD] for all continuous body fat measures at each 
age to take into account the expected changes in body composition and fat distribution across 
ages and also to enable comparisons in effect size for different exposure and outcome 
measures. Missing values in covariates (ranging from 0 to 15%) were multiple-imputed, by 
using Markov chain Monte Carlo approach. Five imputed datasets were created and analyzed 
together. We performed statistical analyses using the Statistical Package of Social Sciences 
version 21.0 for Windows (SPSS Inc, Chicago, IL, USA). 
 
Results 
 
Subject characteristics 
Tables 1 and 2 show the subject characteristics. Boys had higher body mass index, whereas 
girls had higher central-to-total subcutaneous fat mass ratio at 1.5 months and a higher total 
subcutaneous fat mass and central-to-total subcutaneous fat mass ratio at 24 months (p<0.05). 
At 6 years, girls had higher fat mass index, central-to-total fat mass ratio, and abdominal 
preperitoneal fat mass area than boys (p<0.05). Supplemental Table S2 gives all 
subcutaneous fat mass measures at 1.5 and 24 months. Non-response analyses showed that as 
compared to children who did not participate in the follow-up studies, those who did 
participate were born with a higher weight and gestational age at birth and were breastfed for 
a longer period (p<0.05). (Supplemental Table S3). 
 
Body fat from infancy to childhood 
The crude correlations of infant subcutaneous fat mass measures at 1.5 or 24 months with 
total and abdominal fat mass measures at 6 years old for the total group and by sex are shown 
in Supplemental Tables S4 and S5, respectively.   
A 1-standard-deviation scores (SDS) higher body mass index at 1.5 months was only 
associated with a 0.16 [95% Confidence Interval (CI) 0.09, 0.24] SDS increase in body mass 
index at 6 years (Table 3). A 1-SDS higher central-to-total subcutaneous fat mass ratio at 1.5 
months was associated with a 0.12 [95% CI 0.05, 0.19] SDS increase in fat mass index and a 
0.11 [95% CI 0.04, 0.18] SDS increase in central-to-total fat mass ratio at 6 years. No other 
associations of fat mass at 1.5 months with fat outcomes at 6 years were observed. Also, no 
sex differences were observed.  
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A 1-SDS higher body mass index at 24 months was associated with an increase of 
0.48 [95% CI 0.42, 0.54] SDS in body mass index, 0.33 [95% CI 0.26, 0.40] SDS in fat mass 
index, 0.18 [95% CI 0.11, 0.26] SDS in central-to-total fat mass ratio, and 0.16 [95% CI 0.08, 
0.23] SDS in android-to-gynoid fat mass ratio (Table 4). A 1-SDS higher total subcutaneous 
fat mass at 24 months was associated with an increase of 0.30 [95% CI 0.23, 0.37] SDS in 
body mass index, 0.36 [95% CI 0.29, 0.43] SDS in fat mass index, 0.28 [95% CI 0.20, 0.35] 
SDS in central-to-total fat mass ratio, 0.23 [95% CI 0.16, 0.31] SDS in android-to-gynoid fat 
mass ratio and 0.19 [95% CI 0.12, 0.26] SDS in preperitoneal fat mass area. The associations 
of central-to-total subcutaneous fat mass ratio at 24 months with fat mass measures at 6 years 
were also significant but weaker. The associations tended to be stronger among girls than 
among boys.  
 
Infant body fat and risk of childhood overweight  
A 1-SDS higher body mass index at 1.5 months was associated with an increased risk of 
overweight at 6 years (Odds Ratio (OR) 1.40 [95% CI 1.08, 1.81]) (Figure 1), whereas a 1-
SDS higher central-to-total subcutaneous fat mass ratio at 1.5 months was associated with an 
increased risk of overweight at 6 years among girls only (OR 1.61 [95% CI 1.09, 2.38]). A 1-
SDS higher body mass index and total subcutaneous fat mass at 24 months were associated 
with increased risks of childhood overweight (OR 2.76 [95% CI 2.07, 3.69] and OR 1.70 
[95% CI 1.36, 2.12]), respectively). We did not observe associations for central-to-total 
subcutaneous fat mass ratio at 24 months with the risk of childhood overweight. Stronger 
associations were present among girls than among boys. 
 
Comment 
We observed that infant subcutaneous fat mass measures, calculated from skinfold thickness, 
are associated with total and abdominal fat mass at school-age. The effect estimates were 
stronger for body mass index and total subcutaneous fat mass than for central-to-total 
subcutaneous fat mass ratio, and for girls compared to boys. Also, the effect estimates were 
stronger for 24 months than for 1.5 months fat mass measures. 
 
Interpretation of main findings  
Body mass index tends to track from infancy onwards. A previous review among 21 studies 
has shown that large body size (weight or body mass index) in 0- to 4-year-old children was 
related to large body size at primary school age.
24
 A meta-regression analysis among 48 
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cohort studies has shown a high degree of tracking for body mass index among children until 
10 years of age. The tracking estimates gradually decreased over follow-up time and were not 
influenced by body mass index at first measurement or sex.
25
 In our study, we observed a 
moderate tracking of body mass index from infancy to childhood. Stronger associations were 
observed from 24 months onwards than from 1.5 months onwards, in line with the stronger 
tracking reported in the meta-regression for shorter follow-up periods. We did not observe 
differences in results when we used ponderal index (weight/height
3
) at 1.5 months (data not 
shown). We observed slightly stronger effect estimates among girls compared to boys.  
Body mass index provides limited information about body fat distribution. Android-
to-gynoid fat mass ratio as well as preperitoneal fat mass have previously been associated 
with an adverse cardiovascular risk profile in childhood and adulthood, independently of 
body mass index.
26, 27
 Previous studies have suggested that total and central fat mass track 
moderately from childhood into adulthood,
7-10, 28-30
 although with a lower tracking as 
compared to body mass index. Since we used different body fat mass measures in infancy and 
at school-age, we could not directly estimate tracking coefficients. However, we observed 
that total subcutaneous fat mass at 24 months was positively associated with fat mass index at 
school-age, suggesting tracking of total fat mass from infancy into school-age. Higher total 
and central-to-total subcutaneous fat mass ratio in infancy were associated with higher 
central-to-total and android-to-gynoid fat mass ratios measured by DXA and preperitoneal fat 
mass area measured by abdominal ultrasound at 6 years old. Our results suggest that besides 
higher body mass index, higher total subcutaneous fat mass and central-to-total subcutaneous 
fat mass ratio in infancy relate to an adverse body fat profile at school-age. 
We observed stronger effect estimates for infant total subcutaneous fat mass than for 
central-to-total subcutaneous fat mass ratio, in the associations with similar measures at 
school-age, though both showed weaker effect estimates compared to the tracking of body 
mass index from infancy to childhood. The latter may be explained by the differences in 
methodology to assess the fat mass components in infancy and childhood. In infancy, 
skinfold thickness measurements reflect the subcutaneous depots only, whereas in childhood 
DXA comprise both subcutaneous and intra-abdominal depots.
11
 However, during the first 4 
months of life approximately 90% of body fat is located subcutaneously,
31
 and preperitoneal 
fat mass seems to increase only from the second year of life onwards.
32
 Finally, skinfold 
thickness measurements may be more liable to measurement error than body mass index,
33, 34
 
which may also lead to an underestimation of the effect estimates for subcutaneous fat 
measures from infancy onwards. We also observed stronger effect estimates among girls than 
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boys. Sex-specific adiposity differences have been attributed to sex hormones. During 
infancy, testosterone concentrations increase during the first week of life before decreasing 
around 6 months of life among boys, whereas oestrogen increases shortly after birth and 
remains raised until 2-3 years among girls.
35
 The stronger associations that we observed 
among girls may be partly a result of a more stable body fat development during infancy 
driven by less hormonal fluctuations. Further studies are needed to explore the mechanisms 
underlying the observed sex differences in body fat development. The stronger associations 
observed for 24 months than for 1.5 months could be due to the shorter interval between 24 
months and 6 years old, as previously reported for body mass index.
25
 Also, 1.5 months 
might be more reflective of fetal growth patterns which seemed to be less associated, as 
compared to postnatal growth, with later abdominal adiposity in our previous study.
5
 
Whether skinfold thickness measurements during infancy are useful in clinical 
practice is not known. Our results suggest that compared to body mass index, subcutaneous 
fat mass measures in infancy add little value to estimate total or abdominal fat mass at 
school-age. Given the challenges of obtaining precise and reliable skinfold thickness 
measurements, the additional clinical value of skinfold thicknesses compared to body mass 
index may be only limited. 
 
Methodological considerations 
Major strengths of this study are the population-based prospective design with detailed infant 
and childhood body fat measurements available. Of the 965 singleton children with 
information on body fat mass measures at the age of 1.5 or 24 months, 85% (821) 
participated in the adiposity follow-up study at 6 years old. The non-response could lead to 
biased effect estimates if the associations of interest would differ between children included 
and not included in the analyses. Children included in the analyses were born with a higher 
weight and gestational age and were breastfed for a longer period compared to those not 
included. It is difficult to speculate if these differences might have influenced our effect 
estimates. However, this seems unlikely since children that did not participate in the follow-
up studies did not differ from those who did participate regarding infant body mass index and 
subcutaneous fat mass measures. Our sample was ethnically homogeneous, which may limit 
the generalizability of our results to other ethnic groups.
25
 We used skinfold thickness which 
is a valid measurement of subcutaneous fat in children but in extremely overweight children 
the measurement error is larger.
15
 The inter- and intra-observer measurement error is also 
larger as compared to other anthropometric measurements.
33, 34
 We did not have available 
  INFANT ADIPOSITY 
 
154 
 
skinfold thickness measurements from the lower limbs such as thigh or calf, which could 
have improved our estimates of subcutaneous fat mass. We obtained detailed measures of 
adiposity at school-age by using DXA that quantifies body fat content with high precision 
and abdominal ultrasound which is a valid method to assess abdominal preperitoneal fat mass 
area.
23
 Finally, although we adjusted for a large number of potential confounders, residual 
confounding in the observed associations might still occur, as in any observational study. 
 
Conclusion 
Subcutaneous fat mass measures in infancy are positively associated with total and abdominal 
fat mass at school-age. The effect estimates were stronger for body mass index and total 
subcutaneous fat mass than for central-to-total subcutaneous fat mass ratio, and for girls 
compared to boys. Our results suggest that skinfold thickness measurements in infancy add 
little value to estimate body fat in later childhood, as compared to body mass index.   
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Table 1. Characteristics of study participants
1 
1
Values are expressed as means (SD), medians (95% range) or numbers of subjects (%). The 
values represent the pooled results after multiple imputation. Observed data are given in 
Supplemental Table S1. SD, standard deviation. 
 
 
 
 
 
 
 
 
 
Total group  
(n = 821) 
Boys (n = 412) Girls (n = 409) P-value 
Maternal characteristics     
  Age (years), mean (SD) 32.0 (3.9) 31.8 (3.9) 32.1 (3.8) 0.346 
  Highest completed education, n (%)     
     Primary school 10 (1.2) 3 (0.7) 7 (1.7) 0.428 
     Secondary school 265 (32.3) 135 (32.8) 130 (31.8)  
     Higher education 546 (66.5) 274 (66.5) 272 (66.5)  
  Parity, n (%) primiparae 522 (63.6) 262 (63.6) 260 (63.6) 0.995 
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.5 (4.0) 23.4 (4.0) 23.7 (4.0) 0.208 
  Smoking habits during pregnancy, n (%) yes 175 (21.3) 87 (21.1) 88 (21.5) 0.776 
Child’s characteristics     
  Sex, %  412 (50.2) 409 (49.8)  
  Birth weight (g), mean (SD) 3533 (522) 3588 (503) 3477 (536) 0.002 
  Gestational age at birth (weeks), median (95% range) 
40.3 (36.3-
42.4) 
40.3 (36.5-
42.4) 
40.3 (36.0-42.4) 0.710 
  Breastfeeding duration (months), mean (SD) 4.8 (3.8) 4.7 (3.7) 4.9 (3.9) 0.442 
   Introduction of solid foods, n (%)    
     <3 months 47 (5.7) 23 (5.6) 24 (5.9) 0.885 
 3 to 6 months 631 (76.9) 316 (76.7) 315 (77.0)  
     >6 months 143 (17.4) 73 (17.7) 70 (17.1)  
  TV watching time, n (%)  ≥ 2 hours/day 76 (9.3) 45 (10.9) 31 (7.6) 0.131 
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Table 2. Body fat at 1.5 and 24 months by skinfold thicknesses and at 6 years old by dual-energy 
X-ray absorptiometry and abdominal ultrasound
1
 
1
Values are expressed as means (SD), medians (95% range) or numbers of subjects (valid %). Body 
mass index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + 
subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + 
subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat mass/height
3
. 
Central-to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = 
android fat mass/gynoid fat mass. IOTF, International Obesity Task Force. SD, standard deviation.  
 
 
 
 
 
 
 
 
 
 
Total group Boys  Girls  P-value 
1.5 months  n = 742 n = 372 n = 370  
    Age (months), mean (SD) 1.6 (0.4) 1.6 (0.4) 1.6 (0.5) 0.340 
    Body mass index (kg/m2), mean (SD) 15.1 (1.4) 15.3 (1.5) 15.0 (1.3) 0.001 
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.1) 23.8 (7.0) 24.0 (7.1) 0.705 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.49 (0.05) 0.51 (0.05) <0.001 
24 months  n = 746 n = 381 n = 365  
    Age (months), mean (SD) 25.2 (1.1) 25.3 (1.1) 25.2 (1.1) 0.408 
    Body mass index (kg/m2), mean (SD) 15.9 (1.3) 16.0 (1.3) 15.9 (1.3) 0.145 
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 26.7 (7.2) 28.1 (7.7) 0.012 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 0.42 (0.06) 0.44 (0.06) 0.001 
6 years  
    Age (years), mean (SD) 
n = 821 n = 412 n = 409  
6.0 (0.3) 6.0 (0.3) 6.0 (0.2) 0.450 
    Body mass index (kg/m2), mean (SD) 15.9 (1.4) 15.9 (1.3) 15.9 (1.5) 0.955 
    Overweight and obese (IOTF), n (%)  88 (10.7) 34 (8.3) 54 (13.2) 0.023 
    Fat mass index (kg/m3), mean (SD) 3.2 (0.8) 2.9 (0.7) 3.4 (0.9) <0.001 
    Central-to-total fat mass ratio, mean (SD) 0.33 (0.04) 0.32 (0.03) 0.34 (0.04) <0.001 
    Android-to-gynoid fat mass ratio, mean (SD) 0.24 (0.05) 0.24 (0.05) 0.25 (0.06) 0.089 
    Preperitoneal fat mass area (cm²),  median (95% range) 0.4 (0.2-0.9) 0.3 (0.2-0.7) 0.4 (0.2-1.0) <0.001 
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Table 3. Associations of subcutaneous fat mass measures at 1.5 months with total and 
abdominal fat mass at 6 years old
1-3
 
 
1
Values are standardized regression coefficients [95% confidence interval] and represent the 
difference in standard-deviation scores for fat mass measures at 6 years per 1-standard-deviation 
scores increase in body mass index and subcutaneous fat mass measures at 1.5 months. Body mass 
index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + 
subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + 
subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat 
mass/height
3
. Central-to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat 
mass ratio = android fat mass/gynoid fat mass.   
2
Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, 
smoking habits during pregnancy, and child’s gestational age-adjusted birth weight standard-
deviation scores, breastfeeding duration, timing of introduction of solid foods, and TV watching 
time.  
3
P-value
 
for interaction of child´s sex with fat mass measures at 1.5 months >0.05.  
*P-value<0.05; **P-value<0.01.
 
 
 
 
 
 
Fat mass measures 
at 1.5 months 
Fat mass measures at 6 years in standard-deviation scores 
 Difference [95% Confidence Interval] 
Body mass 
index 
Fat mass index 
Central-to-total 
fat mass ratio 
Android-to- 
gynoid fat mass 
ratio 
Preperitoneal 
fat mass area 
Total group      
Body mass index  
0.16 
[0.09,0.24]** 
0.05 
[-0.03,0.12] 
-0.03 
[-0.11,0.05] 
0.04 
[-0.04,0.12] 
0.05 
[-0.03,0.13] 
Total subcutaneous 
fat mass  
0.06 
[-0.02,0.13] 
0.05 
[-0.02,0.13] 
0.01 
[-0.07,0.09] 
0.01 
[-0.07,0.09] 
0.05 
[-0.02,0.12] 
Central-to-total  
subcutaneous  fat 
mass ratio  
0.04 
[-0.02,0.12] 
0.12 
[0.05,0.19]** 
0.11 
[0.04,0.18]** 
0.07 
[0.00,0.14] 
0.07 
[-0.01,0.14] 
Boys      
Body mass index  
0.25 
[0.14,0.36]** 
0.21 
[0.09,0.33]** 
0.10 
[-0.02,0.22] 
0.13 
[0.02,0.25]* 
0.20 
[0.07,0.33]** 
Total  subcutaneous 
fat mass  
0.12 
[0.01,0.23]* 
0.07 
[-0.04,0.19] 
0.09 
[-0.03,0.20] 
0.03 
[-0.08,0.14] 
0.14 
[0.02,0.26]* 
Central-to-total  
subcutaneous  fat 
mass ratio  
0.03 
[-0.08,0.13] 
0.07 
[-0.03,0.18] 
0.06 
[-0.05,0.16] 
0.07 
[-0.04,0.17] 
0.01 
[-0.11,0.13] 
Girls      
Body mass index  
0.08 
[-0.02,0.18] 
0.02 
[-0.08,0.12] 
-0.06 
[-0.16,0.05] 
-0.03 
[-0.14,0.08] 
0.02 
[-0.09,0.12] 
Total  subcutaneous  
fat mass  
-0.01 
[-0.11,0.09] 
0.01 
[-0.10,0.11] 
-0.08 
[-0.19,0.03] 
-0.02 
[-0.13,0.09] 
-0.03 
[-0.13,0.06] 
Central-to-total  
subcutaneous  fat 
mass ratio  
0.08 
[-0.01,0.18] 
0.10 
[0.01,0.20]* 
0.09 
[-0.01,0.19] 
0.06 
[-0.04,0.17] 
0.06 
[-0.03,0.16] 
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Table 4. Associations of subcutaneous fat mass measures at 24 months with total and abdominal 
fat mass at 6 years old
1-2 
 
1
Values are standardized regression coefficients [95% confidence interval] and represent the 
difference in standard-deviation scores for fat mass measures at 6 years per 1-standard-deviation 
scores increase in body mass index and subcutaneous fat mass measures at 24 months. Body mass 
index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular 
skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. Fat mass index = total fat mass/height
3
. Central-
to-total fat mass ratio = trunk fat mass/total fat mass. Android-to-gynoid fat mass ratio = android fat 
mass/gynoid fat mass.   
2
Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, 
smoking habits during pregnancy, and child’s gestational age-adjusted birth weight standard-
deviation scores, breastfeeding duration, timing of introduction of solid foods, and TV watching 
time.  
†
P-value
 for interaction of child´s sex with fat mass measures at 24 months ≤0.05.  
*P-value<0.05;  **P-value<0.01. 
 
 
 
 
 
Fat mass measures 
at 24 months 
Fat mass measures at 6 years in standard-deviation scores 
Difference [95% Confidence Interval] 
Body mass 
index 
Fat mass index 
Central-to-total 
fat mass ratio 
Android-to- 
gynoid fat mass 
ratio 
Preperitoneal fat 
mass area 
Total group      
Body mass index  
0.48 
[0.42,0.54]**† 
0.33 
[0.26,0.40]**† 
0.18 
[0.11,0.26]**† 
0.16 
[0.08,0.23]**† 
0.07 
[0.00,0.14]† 
Total  subcutaneous 
fat mass  
0.30 
[0.23,0.37]** 
0.36 
[0.29,0.43]**† 
0.28 
[0.20,0.35]** 
0.23 
[0.16,0.31]**† 
0.19 
[0.12,0.26]** 
Central-to-total  
subcutaneous fat 
mass ratio  
0.09 
[0.01,0.16]*† 
0.14 
[0.06,0.22]**† 
0.12 
[0.04,0.20]**† 
0.10 
[0.03,0.18]**† 
0.10 
[0.02,0.17]* 
Boys      
Body mass index  
0.46 
[0.36,0.55]** 
0.35 
[0.25,0.45]** 
0.20 
[0.09,0.30]** 
0.10 
[-0.01,0.21] 
0.01 
[-0.12,0.13] 
Total  subcutaneous 
fat mass  
0.26 
[0.15,0.36]** 
0.33 
[0.22,0.43]** 
0.22 
[0.11,0.32]** 
0.12 
[0.01,0.23]* 
0.14 
[0.01,0.27]* 
Central-to-total  
subcutaneous fat 
mass ratio  
-0.01 
[-0.12,0.10] 
-0.02 
[-0.13,0.10] 
0.00 
[-0.11,0.11] 
0.01 
[-0.10,0.12] 
0.11 
[-0.02,0.24] 
Girls      
Body mass index  
0.50 
[0.41,0.59]** 
0.43 
[0.33,0.52]** 
0.25 
[0.14,0.36]** 
0.22 
[0.11,0.32]** 
0.15 
[0.05,0.25]** 
Total  subcutaneous 
fat mass  
0.34 
[0.24,0.44]** 
0.38 
[0.28,0.47]** 
0.30 
[0.20,0.41]** 
0.31 
[0.20,0.41]** 
0.21 
[0.12,0.29]** 
Central-to-total  
subcutaneous fat 
mass ratio  
0.15 
[0.05,0.26]** 
0.18 
[0.07,0.28]** 
0.14 
[0.04,0.25]** 
0.14 
[0.03,0.25]* 
0.05 
[-0.05,0.15] 
  INFANT ADIPOSITY 
 
162 
 
 
 
Figure 1. Associations of subcutaneous fat mass measures at 1.5 or 24 months with risk of 
overweight at 6 years old
1-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Values are odds ratios (95% Confidence Interval) on a logarithmic scale and represent the 
risk of overweight at 6 years per 1-standard-deviation scores increase in body mass index and 
subcutaneous fat mass measures at 1.5 or 24 months. Body mass index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold 
thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + subscapular 
skinfold thicknesses)/total subcutaneous fat mass. SDS, standard-deviation scores. 
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2
Models are adjusted for maternal age, educational level, parity, pre-pregnancy body mass 
index, smoking habits during pregnancy, and child’s gestational age-adjusted birth weight 
standard-deviation scores, breastfeeding duration, timing of introduction of solid foods, and 
TV watching time. 
3
P-value
 
for interaction of child´s sex with total subcutaneous fat mass and central-to-total 
subcutaneous fat mass ratio at 1.5 months ≤0.05. P-value for interaction of child´s sex with 
body mass index at 24 months <0.05.  
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Supplementary materials 
Figure S1. Flow chart of participants in study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = 1205 
Eligible children  
 
N = 240 
Excluded: no postnatal visit at the ages of 1.5 
and 24 months or missing data on body mass 
index and skinfold thicknesses at the ages of 
1.5 and 24 months  
 
N = 965 
Children with body mass index or 
skinfold thicknesses measured at 
the age of 1.5 or 24 months 
 
N = 144 
Excluded: no visit at 6 years of age or missing 
data on body mass index, dual-energy X-ray 
absorptiometry and abdominal ultrasound at 6 
years of age 
 
N = 821 
Children with required data available 
1.5 months                    n = 742 
24 months                     n = 746 
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Supplemental Methods:  Log-log regression analyses 
 
Measurements of body fat quantity and distribution require appropriate adjustment for body 
size or total fat mass, respectively, in order to undertake informative comparisons between 
children and within children over time. The relationships between total subcutaneous fat mass 
and length or height, and between central subcutaneous fat mass and total subcutaneous fat 
mass were assessed using log-log regression analyses. Total and central subcutaneous fat 
mass measures as well as length or height were all log-transformed. Log-total subcutaneous 
fat mass was regressed on log-length or height. The regression slope corresponds to the 
power P by which length or height should be raised in order to calculate an index 
uncorrelated with length or height (total subcutaneous fat mass/length or height
P
). A similar 
calculation was undertaken for log-central and -total subcutaneous fat mass.
1
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Table S1. Characteristics of study participants
1 
1
Values are observed data and represent means (SD), medians (95% range) or numbers of 
subjects (valid %). Of the total group, data were missing on maternal highest completed 
education (n = 4), pre-pregnancy body mass index (n = 121), smoking habits during 
pregnancy (n = 78), and child’s breastfeeding duration (n = 117), timing of introduction of 
solid foods (n = 67) and TV watching time (n = 77). SD, standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
Total group  
(n = 821) 
Boys (n = 412) Girls (n = 409) P-value 
Maternal characteristics     
  Age (years), mean (SD) 32.0 (3.9) 31.8 (3.9) 32.1 (3.8) 0.346 
  Highest completed education, n (%)     
     Primary school 10 (1.2) 3 (0.7) 7 (1.7) 0.429 
     Secondary school 265 (32.4) 135 (32.9) 130 (31.9)  
     Higher education 542 (66.3) 272 (66.3) 270 (66.3)  
  Parity, n (%) primiparae 522 (63.6) 262 (63.6) 260 (63.6) 0.995 
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 23.4 (4.2) 23.8 (4.2) 0.159 
  Smoking habits during pregnancy, n (%) yes 157 (21.1) 76 (20.7) 81 (21.5) 0.781 
Child’s characteristics     
  Sex, %  50.2 49.8  
  Birth weight (g), mean (SD) 3533 (522) 3588 (503) 3477 (536) 0.002 
  Gestational age at birth (weeks), median (95% range) 
40.3 (36.3-
42.4) 
40.3 (36.5-
42.4) 
40.3 (36.0-42.4) 0.710 
  Breastfeeding duration (months), mean (SD) 4.6 (3.9) 4.5 (3.8) 4.8 (4.0) 0.394 
   Introduction of solid foods, n (%)    
     <3 months 41 (5.4) 20 (5.2) 21 (5.6) 0.857 
 3 to 6 months 578 (76.7) 290 (76.1) 288 (77.2)  
     >6 months 135 (17.9) 71 (18.6) 64 (17.2)  
  TV watching time, n (%) ≥ 2 hours/day 65 (8.7) 38 (10.2) 27 (7.3) 0.153 
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Table S2. Subcutaneous fat mass (mm)
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Values are means (standard deviation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total 
group  
Boys  Girls  P-value 
1.5 months n = 742 n = 372 n = 370  
    Triceps  6.6 (2.2) 6.6 (2.1) 6.6 (2.3) 0.746 
    Biceps  5.4 (2.0) 5.5 (2.0) 5.4 (2.1) 0.318 
  Suprailiacal  5.7 (2.0) 5.6 (2.0) 5.8 (2.1) 0.111 
  Subscapular  6.2 (1.8) 6.1 (1.8) 6.2 (1.8) 0.222 
24 months n = 746 n = 381 n = 365  
    Triceps  8.9 (2.9) 8.9 (3.0) 8.9 (2.8) 0.722 
    Biceps  6.8 (2.4) 6.6 (2.3) 7.0 (2.4) 0.059 
  Suprailiacal  5.6 (2.2) 5.3 (2.0) 6.0 (2.3) <0.001 
  Subscapular  6.1 (1.9) 5.8 (1.7) 6.3 (2.0) <0.001 
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Table S3. Comparison of maternal and child’s characteristics between children included and 
not included in the analyses
1
 
 
 
 
1
Values are observed data and represent means (SD), medians (95% range) or numbers of 
subjects (valid %). Differences were tested using Student’s t-tests and Mann-Whitney tests 
for normally and non-normally distributed variables, respectively and χ2-test for dichotomous 
variables. SD, standard deviation. 
 
 
 
 
 
 
 
 
Participants 
 (n = 821) 
Non-participants 
(n = 144) 
P-value 
Maternal characteristics    
  Age (years), mean (SD) 32.0 (3.9) 30.8 (4.9) 0.008 
  Highest completed education, n (%)    
     Primary school 10 (1.2) 8 (5.6) <0.001 
     Secondary school 265 (32.4) 58 (40.8)  
     Higher education 542 (66.3) 76 (53.5)  
  Parity, n (%) primiparae 522 (63.6) 74 (51.4) 0.005 
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 22.9 (3.4) 0.082 
  Smoking habits during pregnancy, n (%) yes 157 (21.1) 47 (34.6) 0.001 
Child’s characteristics    
  Sex, % male 50.2 58.3 0.071 
  Birth weight (g), mean (SD) 3533 (522) 3402 (611) 0.017 
  Gestational age at birth (weeks), median (95% range) 40.3 (36.3-42.4) 39.9 (34.9-42.5) 0.001 
  Breastfeeding duration (months), mean (SD) 4.6 (3.9) 3.3 (3.6) 0.001 
  Introduction of solid foods, n (%)    
     <3 months 41 (5.4) 7 (6.8) 0.322 
 3 to 6 months 578 (76.7) 72 (69.9)  
     >6 months 135 (17.9) 24 (23.3)  
  TV watching time, n (%) ≥ 2 hours/day 65 (8.7) 4 (7.0) 0.656 
1.5 months     
   Body mass index (kg/m2), mean (SD) 15.1 (1.4) 15.2 (1.3) 0.553 
   Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.1) 24.9 (9.2) 0.267 
   Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.50 (0.04) 0.304 
24 months     
   Body mass index (kg/m2), mean (SD) 15.9 (1.3) 15.9 (1.2) 0.660 
   Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 27.0 (5.8) 0.712 
   Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 0.44 (0.07) 0.161 
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Table S4. Correlation coefficients between body fat mass measures at 1.5 months and 6 years 
old
1
 
 
1
Values are correlation coefficients between body fat mass measures standard-deviation 
scores using Pearson r tests for normally distributed variables and Spearman’s rho tests for 
skewed variables. Body mass index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + 
triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat 
mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat 
mass index = total fat mass/height
3
. Central-to-total fat mass ratio = trunk fat mass/total fat 
mass. Android-to-gynoid fat mass ratio = android fat mass/gynoid fat mass.   
*P-value<0.05;  **P-value<0.01. 
 
 
 
Fat mass 
measures at 1.5 
months 
Fat mass measures at 6 years 
Pearson correlation coefficients 
Spearman 
correlation 
coefficients 
Body mass 
index 
Fat mass 
index 
Central-to-
total fat 
mass ratio 
Android-
to- gynoid 
fat mass 
ratio 
 
Preperitoneal 
fat mass area 
Total group       
Body mass index 0.22** 0.08* -0.01 0.05  0.08* 
Total 
subcutaneous fat 
mass 
0.08* 0.05 0.01 0.03  0.05 
Central-to-total  
subcutaneous fat 
mass ratio 
0.06 0.12** 0.11** 0.07  0.07 
Boys       
Body mass index 0.29** 0.17** 0.06 0.12*  0.18** 
Total  
subcutaneous fat 
mass 
0.14** 0.07 0.06 0.06  0.08 
Central-to-total 
subcutaneous fat 
mass ratio 
0.05 0.09 0.07 0.08  0.01 
Girls       
Body mass index 0.16** 0.09 -0.01 0.01  0.08 
Total  
subcutaneous fat 
mass 
0.02 0.03 -0.05 0.01  0.01 
Central-to-total 
subcutaneous fat 
mass ratio 
0.07 0.07 0.07 0.05  0.04 
  INFANT ADIPOSITY 
 
170 
 
Table S5. Correlation coefficients between body fat mass measures at 24 months and 6 years 
old
1 
 
1
Values are correlation coefficients between body fat mass measures standard-deviation 
scores using Pearson r tests for normally distributed variables and Spearman’s rho tests for 
skewed variables. Body mass index = weight/height
2
.
 
Total subcutaneous fat mass = biceps + 
triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat 
mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. Fat 
mass index = total fat mass/height
3
. Central-to-total fat mass ratio = trunk fat mass/total fat 
mass. Android-to-gynoid fat mass ratio = android fat mass/gynoid fat mass.   
*P-value<0.05;  **P-value<0.01. 
 
 
 
Fat mass 
measures at 24 
months 
Fat mass measures at 6 years      
Pearson correlation coefficients 
Spearman 
correlation 
coefficients   
Body mass 
index 
Fat mass 
index 
Central-to-
total fat 
mass ratio 
Android-
to- gynoid 
fat mass 
ratio 
 
Preperitoneal 
fat mass area 
Total group       
Body mass index  0.52** 0.36** 0.18** 0.17**  0.11** 
Total  
subcutaneous fat 
mass  
0.32** 0.37** 0.28** 0.24**  0.25** 
Central-to-total  
subcutaneous fat 
mass ratio  
0.11** 0.17** 0.14** 0.12**  0.13** 
Boys       
Body mass index  0.47** 0.33** 0.14** 0.08  0.06 
Total  
subcutaneous fat 
mass  
0.26** 0.32** 0.20** 0.11  0.18** 
Central-to-total 
subcutaneous fat 
mass ratio  
-0.01 0.00 0.01 0.03  0.13* 
Girls       
Body mass index  0.57** 0.48** 0.28** 0.25**  0.21** 
Total  
subcutaneous fat 
mass  
0.36** 0.39** 0.32** 0.32**  0.30** 
Central-to-total  
subcutaneous fat 
mass ratio  
0.21** 0.23** 0.18** 0.18**  0.08 
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CHAPTER 3.3 
 
Subcutaneous fat mass in infancy and cardiovascular 
risk factors at school-age  
 
Susana Santos, Romy Gaillard, Andreia Oliveira, Henrique Barros, Albert Hofman, 
Oscar H. Franco, Vincent W.V. Jaddoe 
 
Adapted from Obesity (Silver Spring) 2016;24(2):424-429. 
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Abstract 
 
Objective: To examine the associations of infant subcutaneous fat with cardiovascular risk 
factors at school-age. 
 
Methods: In a population-based prospective cohort study among 808 children, total 
subcutaneous fat (sum of biceps, triceps, suprailiacal and subscapular skinfold thicknesses) and 
central-to-total subcutaneous fat ratio (sum of suprailiacal and subscapular skinfold 
thicknesses/total subcutaneous fat) at 1.5 and 24 months were estimated. At 6 years, body mass 
index, blood pressure, cholesterol, triglycerides, and insulin levels were measured. 
 
Results: Infant subcutaneous fat measures were not associated with childhood blood pressure, 
triglycerides or insulin levels. A 1-standard-deviation score (SDS) higher total subcutaneous fat 
at 1.5 months was, independently of body mass index, associated with lower low-density 
lipoprotein (LDL)-cholesterol levels at 6 years. In contrast, a 1-SDS higher total subcutaneous 
fat at 24 months was associated with higher total-cholesterol (difference 0.13 (95% Confidence 
Interval (CI) 0.03, 0.23) SDS) and LDL-cholesterol levels (difference 0.12 (95% CI 0.02, 0.21) 
SDS) at 6 years. There were no associations of central-to-total subcutaneous fat ratio with 
childhood cholesterol levels. 
 
Conclusions: These results suggest that infant total subcutaneous fat is weakly associated with 
cholesterol levels at school-age. Further studies are needed to assess the long-term 
cardiometabolic consequences of infant body fat. 
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Introduction 
Early infant and childhood growth rates are associated with cardiovascular disease risk in later 
life.
1
 Results from longitudinal studies suggest that rapid weight gain in infancy or gain in body 
mass index in childhood are associated with an adverse cardiovascular risk profile in adulthood.
2-
4
 Weight or body mass index are suboptimal measures of fat mass development and provide no 
information about body fat distribution.
5
 Several studies have shown that as compared to body 
mass index, body fat distribution plays a greater role in the development of risk factors for 
cardiovascular disease.
6
 We have previously reported in a cross-sectional study among 6-year-
old children that both general and abdominal fat mass measures are associated with 
cardiovascular risk factors, independently of body mass index.
7
 Also, previous studies have 
shown that high total subcutaneous fat mass measured by the sum of skinfold thicknesses is 
associated with high blood pressure, an unfavorable blood lipids profile and high glucose and 
insulin levels in childhood.
8-12
 Currently, it is not known whether, next to rapid weight gain, total 
and regional subcutaneous fat mass development in infancy is associated with cardiovascular risk 
factors in later life. Assessing the contribution of fatness in infancy to later cardiovascular risk 
status is particularly relevant to identify early critical periods of fat development that influence 
the risk for cardiovascular disease.  
 Therefore, we examined, in a population-based prospective cohort study among 808 
children, the associations of infant subcutaneous fat mass measures with cardiovascular risk 
factors at school-age. We used skinfold thickness measurements at 1.5 and 24 months to estimate 
total subcutaneous fat mass and central-to-total subcutaneous fat mass ratio. Cardiovascular risk 
factors of interest include blood pressure, total-, high-density lipoprotein (HDL)-, and low-
density lipoprotein (LDL)-cholesterol levels, triglycerides levels and insulin levels at 6 years. 
 
Methods 
 
Study design 
This study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards among 9,778 mothers and their children living in 
Rotterdam, the Netherlands.
13, 14
 The study protocol was approved by the local Medical Ethical 
Committee. Written informed consent was obtained from all mothers. Additional detailed 
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assessments of fetal and postnatal growth and development were conducted in a subgroup of 
Dutch mothers and their children from late pregnancy onwards. Of all approached women, 80% 
agreed to participate. Of the total of 1,205 singleton children participating in the subgroup study, 
965 children had body mass index or skinfold thicknesses measured at the age of 1.5 or 24 
months. Of these children, 808 children had cardiovascular risk factors measurements at the age 
of 6 years (Flow chart is given in Supplemental Figure S1). Missing measurements were due to 
loss to follow-up, crying behavior or non-consent for venous puncture at 6 years old. 
 
Body fat measurements during infancy  
We measured weight to the nearest gram in naked infants at the age of 1.5 months by using an 
electronic infant scale and at 24 months by using a mechanical personal scale (SECA, Almere, 
the Netherlands). Body length at the age of 1.5 months was measured in supine position to the 
nearest millimeter by using a neonatometer and body height at 24 months was measured in 
standing position by using a Harpenden stadiometer (Holtain Limited, Dyfed, UK). Body mass 
index (kg/m
2
) was calculated. 
We measured skinfold thicknesses at the ages of 1.5 and 24 months on the left side of the 
body at the biceps, triceps, suprailiacal and subscapular area by using a skinfold caliper (Slim 
Guide, Creative Health Products) according to standard procedures described in detail 
previously.
15
 We calculated total subcutaneous fat mass from the sum of all four skinfold 
thicknesses, and central subcutaneous fat mass from the sum of suprailiacal and subscapular 
skinfold thicknesses.
16
 Measurements of body fat quantity and distribution require appropriate 
adjustment for body size or total fat mass, respectively, in order to undertake informative 
comparisons between children and within children over time. To create total subcutaneous fat 
mass independent of length or height and central subcutaneous fat mass independent of total 
subcutaneous fat mass, we estimated the optimal adjustment by log-log regression analyses.
17
 
Details of these regressions are given in the Supplemental Methods. Based on these analyses, 
total subcutaneous fat mass was only weakly correlated with length at 1.5 months or height at 24 
months, and was not adjusted for height whereas a central-to-total subcutaneous fat mass ratio 
was calculated as central divided by total subcutaneous fat mass.  
  
Cardiovascular risk factors at school-age  
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Blood pressure was measured at the right brachial artery four times with one-minute intervals, 
using the validated automatic sphygmanometer Datascope Accutor Plus (Paramus, NJ).
18
 We 
calculated the mean value for systolic and diastolic blood pressure using the last three blood 
pressure measurements of each participant. Thirty-minutes fasting blood samples were collected 
to measure total-, HDL-, and LDL-cholesterol, triglycerides, and insulin concentrations, using 
Cobas 8000 analyzer (Roche, Almere, the Netherlands). Quality control samples demonstrated 
intra- and interassay coefficients of variation ranging from 0.77 to 1.39%, and 0.87 to 2.40%, 
respectively.  
 
Covariates 
Information on maternal age, educational level, parity, pre-pregnancy weight and smoking habits 
during pregnancy was assessed using self-reported questionnaires during pregnancy. We 
measured maternal height at enrollment and calculated pre-pregnancy body mass index (kg/m
2
). 
First trimester maternal nutritional information was obtained by food frequency questionnaire.
19
 
Gestational weight gain was calculated as the difference between maternal weight measured at 
30 weeks of gestation and pre-pregnancy weight. Information about gestational diabetes and 
gestational hypertensive disorders, child’s sex, gestational age and weight at birth was obtained 
from medical records. Information about breastfeeding duration, timing of introduction of solid 
foods and average TV watching time at 6 years old was obtained by questionnaires. At the age of 
6 years, we measured child’s height and weight in standing position without shoes and heavy 
clothing, and calculated body mass index (kg/m
2
). 
 
Statistical analysis 
We assessed the associations of body mass index, total subcutaneous fat mass and central-to-total 
subcutaneous fat mass ratio at 1.5 and 24 months and the change between these ages, with 
cardiovascular risk factors (blood pressure, total-, HDL-, and LDL-cholesterol, triglycerides and 
insulin levels) at school-age using linear regression models. The regression models were adjusted 
for maternal age, educational level, parity, pre-pregnancy body mass index, maternal total energy 
intake, smoking habits and total weight gain during pregnancy, gestational diabetes, gestational 
hypertensive disorders, and child’s sex, gestational age-adjusted birth weight standard-deviation 
scores (SDS), breastfeeding duration, timing of introduction of solid foods, and TV watching 
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time. We included covariates in the models when they were strongly associated with body fat 
mass and cardiovascular risk factors in our or previous studies, or when they changed the effect 
estimates substantially (>10%). Additionally, we adjusted these models for childhood body mass 
index to assess whether any association of infant fat mass measures with childhood 
cardiovascular risk factors was independent of body mass index at 6 years. For the models with 
body mass index as main exposure, we constructed a conditional body mass index variable at 6 
years that was statistically independent of body mass index at 1.5 and 24 months, allowing 
simultaneous inclusion in multiple regression models.
20
 Details of these models are given in the 
Supplemental Methods. For the models with subcutaneous fat mass measures as exposures, body 
mass index at 6 years was simultaneously included in the regression models since no collinearity 
was observed. We did not observe significant interactions between infant fat mass measures and 
sex, breastfeeding groups (never, ever) and body mass index categories at 1.5 or 24 months in 
the associations with childhood cardiovascular risk factors. For all analyses, we log-transformed 
not normally distributed cardiovascular risk factors (triglycerides and insulin levels). We 
constructed SDS [(observed value - mean)/SD] of the sample distribution for all variables to 
enable comparisons in effect size. Missing values in covariates were multiple-imputed, by using 
Markov chain Monte Carlo approach. Five imputed datasets were created and analyzed together. 
We performed statistical analyses using the Statistical Package of Social Sciences version 21.0 
for Windows (SPSS Inc, Chicago, IL, USA). 
 
Results 
 
Subject characteristics 
Tables 1 and 2 show the subject characteristics. Of all participating children, 50.1% were boys, 
the mean (SD) birth weight was 3535 (517) g and the median (95% range) gestational age at 
birth was 40.3 (36.4-42.4) weeks.  
Non-response analyses showed that as compared to mothers who did not participate in the 
follow-up studies, those who did participate were slightly older, had a higher educational level 
and pre-pregnancy body mass index and were more likely to be nulliparous and non-smokers 
(p<0.05). Their children were born with a higher weight and gestational age at birth and were 
breastfed for a longer period (p<0.05) (Supplemental Table S1). 
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Infant body fat and cardiovascular risk factors at school-age 
Table 3 shows that, after adjustment for potential confounders, body mass index at 1.5 and 24 
months or its change over infancy was not associated with cardiovascular risk factors at school-
age. Similarly, total subcutaneous fat mass and central-to-total subcutaneous fat mass ratio at 1.5 
and 24 months or its change over infancy were not associated with childhood blood pressure and 
triglycerides or insulin levels. A 1-SDS higher total subcutaneous fat mass at 1.5 months was 
associated with lower LDL-cholesterol levels at the age of 6 years (difference -0.10 (95% 
Confidence Interval (CI) -0.20, -0.01) SDS), whereas 1-SDS higher total subcutaneous fat mass 
at 24 months was associated with higher childhood total- and LDL-cholesterol levels (differences 
0.15 (95% CI 0.05, 0.24) SDS and 0.14 (95% CI 0.04, 0.23) SDS, respectively). Also, 1-SDS 
increase in total subcutaneous fat mass from 1.5 to 24 months was associated with higher 
childhood total- and LDL-cholesterol levels (differences 0.10 (95% CI 0.03, 0.18) SDS and 0.11 
(95% CI 0.04, 0.19) SDS, respectively). These results were not materially affected by additional 
adjustment for childhood body mass index (Table 3). Results from the unadjusted analyses are 
given in Supplemental Table S2.  
 
Discussion 
We observed in this population-based prospective cohort study that infant subcutaneous fat mass 
measures at 1.5 and 24 months were not associated with childhood blood pressure and 
triglycerides or insulin levels, but were weakly associated with childhood cholesterol levels at 6 
years, independently of body mass index. 
 
Methodological considerations 
Major strengths of this study are the population-based prospective design with detailed infant 
body fat and childhood cardiovascular risk factors measurements available. Some 
methodological issues need to be considered. Of the 965 singleton children with information on 
body fat mass measures at the age of 1.5 or 24 months, 84% (808) participated in the adiposity 
and cardiovascular follow-up study at 6 years old. The non-response could lead to biased effect 
estimates if the associations of infant subcutaneous fat mass with cardiovascular risk factors at 
school-age differ between children included and not included in the present analyses. However, 
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this seems unlikely since children that did not participate in the follow-up studies did not differ 
from those who did participate regarding body mass index and subcutaneous fat mass measures 
at 1.5 and 24 months. Our study group was ethnically homogeneous (Dutch only), which may 
limit the generalizability of our results to other ethnic groups.
21
 We used skinfold thickness as a 
measure of subcutaneous fat mass and therefore we were not able to measure intra-abdominal 
depots. However, during the first months of life approximately 90% of body fat is located 
subcutaneously
22
 and preperitoneal fat mass seems to increase only from the second year of life 
onwards.
23
 Previous studies have shown that skinfold thickness is a valid measurement of fat 
mass in children, but in extremely overweight children the measurement error is larger.
24
 The 
inter- and intra-observer measurement error is also larger as compared to other anthropometric 
measurements.
25, 26
 The use of thirty-minutes fasting blood samples may have resulted in 
misclassification and thus may have led to underestimation of the observed associations. 
However, it has been shown in adults that non-fasting blood lipid levels can accurately predict 
increased risks of cardiovascular events in later life.
27
 Finally, we adjusted for a large number of 
potential confounders but residual confounding in the observed associations might still occur, as 
in any observational study. For example, in our study, we were unable to adjust our results for 
detailed nutritional information during infancy and at school-age. 
 
Interpretation of main findings 
A high body mass index is an important risk factor for an adverse cardiovascular risk profile in 
late childhood.
7, 12, 28
 Also, a high body mass index gain during childhood has been associated 
with cardiovascular risk in adolescence and adulthood.
3, 29
 Few studies have assessed the relation 
of body mass index and cardiovascular risk in preschool children and have found weak or no 
associations with blood lipid and insulin levels.
30-32
 Rapid weight gain in the first 3 months of 
life has been associated with increased adiposity and an unfavorable cardiovascular profile in 
later life.
2
 However, it remains unknown whether gain in body mass index or ponderal index in 
infancy predisposes individuals to cardiovascular risk. A study among 4,601 UK subjects has 
shown that changes in ponderal index from 0 to 2 years were not associated with cardiovascular 
risk factors in adolescence.
29
 In the present study, we observed no associations of body mass 
index at the ages of 1.5 and 24 months or its change in this period with cardiovascular risk 
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factors at school-age. Also, we did not observe differences in results when we used ponderal 
index calculated as weight/height
3
 at 1.5 months (data not shown).
33
 
Body mass index may not be an accurate measure of total fat mass and provides no 
information on body fat distribution.
5
 An accumulating body of evidence has suggested that body 
fat distribution is more strongly associated with cardiovascular disease and type 2 diabetes than 
body mass index.
6
 We have previously reported in a cross-sectional study among 6-year-old 
children that high fat mass percentage and android-to-gynoid fat mass ratio measured by dual-
energy X-ray absorptiometry were associated with adverse levels of cardiovascular risk factors, 
independently of body mass index. The associations of these more detailed body fat mass 
measures with blood lipid levels tended to be stronger than the associations for body mass 
index.
7 
 
Previous studies have also shown that high total and central subcutaneous fat mass 
measures, estimated from skinfold thicknesses, are associated with an adverse cardiovascular 
risk profile, namely high blood pressure, an unfavorable blood lipids profile and high insulin 
levels, in late childhood.
8-10, 12, 34
 Another study has shown that an increase in total subcutaneous 
fat mass from 8 to 18 years old was associated with an increase in total-cholesterol, LDL-
cholesterol and triglycerides levels and a decrease in HDL-cholesterol levels.
11
 Few studies have 
assessed the associations of subcutaneous fat mass measures with cardiovascular risk in 
preschool children.
31, 35
 Those studies have found that total subcutaneous fat mass was positively 
but weakly related to fasting insulin in children aged 2 to 3 years
31
 while no association was 
found with blood lipid levels in children aged 4 years.
35
 It is not known whether total and 
regional subcutaneous fat mass in infancy is associated with cardiovascular risk factors in later 
life. We observed no associations of infant subcutaneous fat mass measures with childhood 
blood pressure and triglycerides or insulin levels. At 1.5 months, total subcutaneous fat mass was 
inversely associated with LDL-cholesterol at the age of 6 years old. We cannot explain this 
finding. Child’s dietary intake and physical activity may have confounded this association, since 
we had only available information about breastfeeding, age at introduction of solid foods and TV 
watching time at 6 years. At 24 months, total subcutaneous fat mass, but not central-to-total 
subcutaneous fat mass ratio, was positively but also weakly associated with childhood total- and 
LDL-cholesterol, independently of body mass index at 6 years old. LDL-cholesterol is an 
  INFANT ADIPOSITY 
180 
 
important determinant of cardiovascular risk and a causal agent in the atherothrombotic 
process.
36
  
In line with the previous cross-sectional studies performed among preschool children,
31, 35
 
our study suggests that subcutaneous fat mass measures in infancy seem to be poor indicators of 
cardiovascular risk profile in later childhood. These findings may be partially explained by the 
fact that fat mass measures in infancy represent the accumulation of fat mass over a short period 
of time, which may not be long enough to influence cardiovascular risk profile. Further studies 
are needed to assess the long-term cardiovascular consequences of infant total and regional fat 
mass measures. 
 
Conclusion 
Our results suggest that infant subcutaneous fat mass measures do not affect childhood blood 
pressure and triglycerides or insulin levels, and are weakly associated with childhood total- and 
LDL-cholesterol levels at 6 years, independently of body mass index. 
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Table 1. Characteristics of study participants
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total group  
(n = 808) 
Maternal characteristics  
  Age (years), mean (SD) 32.0 (3.8) 
  Highest completed education, n (%)  
     Primary school 10 (1.2) 
     Secondary school 261 (32.5) 
     Higher education 533 (66.3) 
  Parity, n (%) nulliparous 512 (63.4) 
  Pre-pregnancy body mass index (kg/m
2
), mean (SD) 23.6 (4.2) 
  Total energy intake (kcal), mean (SD) 2131 (499) 
  Total weight gain during pregnancy (kg), mean (SD) 10.2 (4.6) 
  Smoking habits during pregnancy, n (%)  
     No 575 (78.7) 
     Yes 156 (21.3) 
  Gestational diabetes, n (%) 9 (1.1) 
  Gestational hypertensive disorders, n (%) 64 (8.1) 
Child’s characteristics  
  Boys, n (%) 405 (50.1) 
  Birth weight (g), mean (SD) 3535 (517) 
  Gestational age at birth (weeks), median (95% range ) 40.3 (36.4-42.4) 
  Breastfeeding duration (months), mean (SD) 4.7 (3.9) 
  Introduction of solid foods, n (%)  
     <3 months 41 (5.5) 
 3 to 6 months 569 (76.6) 
     >6 months 133 (17.9) 
  TV watching time, n (%)  
     < 2 hours/day 668 (91.3) 
     ≥ 2 hours/day 64 (8.7) 
   Body mass index at 6 years (kg/m
2
), mean (SD) 15.9 (1.4) 
   Overweight and obesity at 6 years (IOTF criteria), n (%) 87 (10.8) 
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1
Values are observed data and represent means (SD), medians (95% range) or numbers of 
subjects (valid %). IOTF, International Obesity Task Force; SD, standard deviation.  
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Table 2. Body fat at 1.5 and 24 months by skinfold thicknesses and cardiovascular risk 
factors at 6 years old
1
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Values are expressed as means (SD) or medians (95% range). Body mass index = 
weight/height
2
.
 
Total subcutaneous fat mass = biceps + triceps + suprailiacal + 
subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = 
(suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. HDL-
cholesterol, high-density lipoprotein-cholesterol; LDL-cholesterol, low-density 
lipoprotein-cholesterol; SD, standard deviation. 
  
 
 
Total group 
(n = 808) 
Fat mass measures at 1.5 months  n = 731 
    Age (months), mean (SD) 1.6 (0.4) 
    Body mass index (kg/m
2
), mean (SD) 15.2 (1.4) 
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.0) 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 
Fat mass measures at 24 months  n = 735 
    Age (months), mean (SD) 25.2 (1.1) 
    Body mass index (kg/m
2
), mean (SD) 16.0 (1.3) 
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 
Cardiovascular risk factors at 6 years  n = 808 
    Age (years), mean (SD) 6.0 (0.3) 
    Systolic blood pressure (mm/Hg), mean (SD) 102.4 (7.9) 
    Diastolic blood pressure (mm/Hg), mean (SD) 60.2 (6.4) 
    Total-cholesterol (mmol/l), mean (SD) 4.2 (0.6) 
    HDL-cholesterol (mmol/l), mean (SD) 1.3 (0.3) 
    LDL-cholesterol (mmol/l), mean (SD) 2.3 (0.6) 
    Triglycerides (mmol/l), median (95% range) 1.0 (0.4-2.2) 
    Insulin (U/I), median (95% range) 116 (18-384) 
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Table 3. Associations of infant subcutaneous fat mass measures with cardiovascular risk factors at 6 years old
1-2 
 
 
 
 
Cardiovascular risk factors at 6 years in standard-deviation scores 
 Difference (95% Confidence Interval) 
Fat mass measures 
Systolic blood 
pressure 
Diastolic blood 
pressure 
Total-cholesterol HDL-cholesterol LDL-cholesterol Triglycerides Insulin 
1.5 months        
Body mass index         
      Model 1 0.08 (-0.01,0.16) 0.04 (-0.04,0.12) 0.05 (-0.05,0.16) 0.04 (-0.06,0.14) 0.02 (-0.09,0.12) 0.03 (-0.07,0.13) 0.03 (-0.07,0.14) 
     Model 2 0.08 (0.01,0.16)* 0.04 (-0.04,0.12) 0.06 (-0.05,0.16) 0.04 (-0.06,0.14) 0.02 (-0.08,0.12) 0.03 (-0.07,0.13) 0.04 (-0.06,0.14) 
Total subcutaneous fat mass         
      Model 1 0.06 (-0.02,0.14) -0.01 (-0.08,0.07) -0.03 (-0.13,0.07) 0.05 (-0.05,0.15) -0.10 (-0.20,-0.01)* -0.03 (-0.13,0.06) 0.06 (-0.04,0.16) 
     Model 2 0.05 (-0.03,0.13) -0.01 (-0.09,0.07) -0.04 (-0.14,0.06) 0.05 (-0.05,0.15) -0.11 (-0.21,-0.01)* -0.04 (-0.14,0.06) 0.04 (-0.06,0.14) 
Central-to-total  
subcutaneous fat mass ratio  
       
      Model 1 -0.02 (-0.09,0.06) -0.04 (-0.12,0.04) 0.06 (-0.04,0.15) 0.03 (-0.06,0.13) 0.02 (-0.07,0.12) 0.08 (-0.01,0.17) 0.03 (-0.07,0.12) 
     Model 2 -0.02 (-0.10,0.05) -0.04 (-0.12,0.04) 0.05 (-0.04,0.14) 0.04 (-0.06,0.13) 0.02 (-0.07,0.11) 0.08 (-0.01,0.17) 0.02 (-0.07,0.11) 
24 months        
Body mass index         
      Model 1 -0.01 (-0.09,0.06) -0.03 (-0.11,0.05) -0.03 (-0.13,0.06) -0.09 (-0.19,0.01) 0.01 (-0.09,0.10) 0.01 (-0.08,0.11) -0.05 (-0.14,0.05) 
     Model 2 0.00 (-0.08,0.07) -0.03 (-0.11,0.05) -0.03 (-0.12,0.07) -0.09 (-0.19,0.01) 0.01 (-0.08,0.10) 0.02 (-0.08,0.11) -0.04 (-0.13,0.06) 
Total subcutaneous fat mass         
      Model 1 -0.01 (-0.09,0.06) 0.01 (-0.07,0.09) 0.15 (0.05,0.24)** 0.02 (-0.07,0.11) 0.14 (0.04,0.23)** 0.03 (-0.07,0.12) 0.02 (-0.08,0.12) 
     Model 2 -0.07 (-0.14,0.01) -0.01 (-0.09,0.07) 0.13 (0.03,0.23)** 0.03 (-0.07,0.12) 0.12 (0.02,0.21)* 0.01 (-0.09,0.11) -0.04 (-0.14,0.05) 
Central-to-total  
subcutaneous fat mass ratio  
       
      Model 1 0.02 (-0.06,0.10) 0.02 (-0.06,0.10) 0.05 (-0.05,0.15) -0.08 (-0.18,0.01) 0.09 (-0.01,0.19) 0.03 (-0.07,0.13) -0.02 (-0.12,0.08) 
     Model 2 0.01 (-0.07,0.08) 0.02 (-0.06,0.09) 0.04 (-0.07,0.14) -0.08 (-0.18,0.02) 0.08 (-0.02,0.18) 0.02 (-0.08,0.12) -0.05 (-0.16,0.05) 
Change from 1.5 to 24 
months 
       
Body mass index         
      Model 1 -0.06 (-0.13,0.01) -0.05 (-0.12,0.01) -0.05 (-0.14,0.03) -0.06 (-0.15,0.02) -0.02 (-0.10,0.07) -0.03 (-0.11,0.06) -0.03 (-0.12,0.06) 
     Model 2 -0.07 (-0.14,-0.01)* -0.06 (-0.12,0.01) -0.06 (-0.14,0.03) -0.06 (-0.15,0.02) -0.02 (-0.10,0.07) -0.03 (-0.11,0.06) -0.04 (-0.12,0.05) 
Total subcutaneous fat mass         
      Model 1 -0.02 (-0.08,0.03) 0.01 (-0.05,0.07) 0.10 (0.03,0.18)** -0.01 (-0.08,0.06) 0.11 (0.04,0.19)** 0.03 (-0.04,0.11) 0.00 (-0.08,0.08) 
     Model 2 -0.05 (-0.11,0.01) 0.01 (-0.05,0.07) 0.10 (0.02,0.17)* -0.01 (-0.08,0.07) 0.11 (0.03,0.18)** 0.02 (-0.05,0.10) -0.03 (-0.10,0.05) 
Central-to-total  
subcutaneous fat mass ratio  
       
      Model 1 0.01 (-0.04,0.07) 0.03 (-0.03,0.09) -0.05 (-0.12,0.03) -0.06 (-0.14,0.01) 0.02 (-0.06,0.09) -0.05 (-0.12,0.03) -0.01 (-0.09,0.07) 
     Model 2 0.01 (-0.05,0.07) 0.03 (-0.03,0.09) -0.05 (-0.13,0.02) -0.06 (-0.14,0.01) 0.01 (-0.07,0.09) -0.05 (-0.13,0.02) -0.03 (-0.10,0.05) 
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1
Values are standardized regression coefficients (95% confidence interval) and represent the difference in standard-deviation scores for cardiovascular risk 
factors at 6 years per 1-standard-deviation score increase in body mass index and subcutaneous fat mass measures. Body mass index = weight/height
2
.
 
Total 
subcutaneous fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat mass ratio = (suprailiacal + 
subscapular skinfold thicknesses)/total subcutaneous fat mass. HDL-cholesterol, high-density lipoprotein-cholesterol; LDL-cholesterol, low-density 
lipoprotein-cholesterol. 
2
Model 1 is adjusted for maternal age, educational level, parity, pre-pregnancy body mass index, maternal total energy intake, smoking habits and total weight 
gain during pregnancy, gestational diabetes, gestational hypertensive disorders and child’s sex, gestational age-adjusted birth weight standard-deviation 
scores, breastfeeding duration, timing of introduction of solid foods, and TV watching time. Model 2 is additionally adjusted for body mass index standard-
deviation scores at 6 years. Conditional analysis was used in body mass index models to allow the adjustment for body mass index at 6 years. 
*P-value<0.05;  **P-value<0.01.  
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Supplementary materials 
Figure S1. Flow chart of participants in study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = 1,205 
Eligible children  
 
N = 240 
Excluded: no postnatal visit at the ages of 1.5 
and 24 months or missing data on body mass 
index and skinfold thicknesses at the ages of 
1.5 and 24 months  
 
N = 965  
Children with body mass index or 
skinfold thicknesses measured at 
the age of 1.5 or 24 months 
 
N = 157 
Excluded: no visit at 6 years of age or missing 
data on cardiovascular risk factors at 6 years 
of age 
 
N = 808 
Children with required data 
available 
1.5 months                    n = 731 
24 months                     n = 735  
 
INFANT ADIPOSITY 
190 
 
Supplemental Methods  
 
Log-log regression analyses 
The relationships between total subcutaneous fat mass and length or height, and between 
central subcutaneous fat mass and total subcutaneous fat mass were assessed using log-log 
regression analyses. Total and central subcutaneous fat mass measures as well as length or 
height were all log-transformed. Log-total subcutaneous fat mass was regressed on log-length 
or height. The regression slope corresponds to the power P by which length or height should 
be raised in order to calculate an index uncorrelated with length or height (total subcutaneous 
fat mass/length or height
P
). A similar calculation was undertaken for log-central and -total 
subcutaneous fat mass.
1
 
 
Conditional analysis 
We performed conditional analysis to enable inclusion of body mass index measures at 
different ages in the same linear regression model, without problems regarding the 
correlations between the measures. First, we calculated the expected body mass index at the 
age of 6 years based on body mass index at 1.5 or 24 months by performing a linear 
regression model of body mass index at 1.5 or 24 months regressed on body mass index at 6 
years. The standardized residuals obtained from these regression models correspond to the 
difference between the expected and the actual body mass index at 6 years and thus are 
entirely uncorrelated with body mass index at 1.5 or 24 months. Then, we added the 
standardized residuals to the models in order to assess the associations of infant body mass 
index with childhood cardiovascular risk factors, independently of body mass index at 6 
years.
2 
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Table S1. Comparison of maternal and child’s characteristics between children included and 
not included in the analyses
1
 
 
1Values are observed data and represent means (SD), medians (95% range) or numbers of 
subjects (valid %). Differences were tested using Student’s t-tests and Mann-Whitney tests 
for normally and non-normally distributed variables, respectively and χ2-test for dichotomous 
variables. SD, standard deviation. 
 
 
Participants 
 (n = 808) 
Non-participants 
(n = 157) 
P-value 
Maternal characteristics    
  Age (years), mean (SD) 32.0 (3.8) 30.9 (4.9) 0.008 
  Highest completed education, n (%)    
     Primary school 10 (1.2) 8 (5.2) <0.001 
     Secondary school 261 (32.5) 62 (40.0)  
     Higher education 533 (66.3) 85 (54.8)  
  Parity, n (%) nulliparous 512 (63.4) 84 (53.5) 0.020 
  Pre-pregnancy body mass index (kg/m2), mean (SD) 23.6 (4.2) 22.8 (3.4) 0.040 
  Total energy intake (kcal), mean (SD) 2131 (499) 2091 (533) 0.391 
  Total weight gain during pregnancy (kg), mean (SD) 10.2 (4.6) 10.4 (4.7) 0.477 
  Smoking habits during pregnancy, n (%)    
     No 575 (78.7) 100 (67.6) 0.004 
     Yes 156 (21.3) 48 (32.4)  
  Gestational diabetes, n (%) 9 (1.1) 2 (0.5) 0.318 
  Gestational hypertensive disorders, n (%) 64 (8.1) 19 (5.0) 0.056 
Child’s characteristics    
  Boys, n (%) 405 (50.1) 91 (58.0) 0.072 
  Birth weight (g), mean (SD) 3535 (517) 3403 (624) 0.014 
  Gestational age at birth (weeks), median (95% range) 40.3 (36.4-42.4) 39.9 (34.8-42.4) 0.003 
  Breastfeeding duration (months), mean (SD) 4.7 (3.9) 3.3 (3.5) <0.001 
  Introduction of solid foods, n (%)   
     <3 months 41 (5.5) 7 (6.1) 0.417 
 3 to 6 months 569 (76.6) 81 (71.1)  
     >6 months 133 (17.9) 26 (22.8)  
  TV watching time, n (%)   
     < 2 hours/day 668 (91.3) 64 (92.8) 0.672 
     ≥ 2 hours/day 64 (8.7) 5 (7.2)  
1.5 months     
    Body mass index (kg/m2), mean (SD) 15.2 (1.4) 15.2 (1.3) 0.989 
    Total subcutaneous fat mass (mm), mean (SD) 23.9 (7.0) 24.9 (9.1) 0.235 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.50 (0.05) 0.50 (0.04) 0.297 
24 months    
    Body mass index (kg/m2), mean (SD) 16.0 (1.3) 15.9 (1.2) 0.504 
    Total subcutaneous fat mass (mm), mean (SD) 27.4 (7.5) 26.8 (6.0) 0.488 
    Central-to-total subcutaneous fat mass ratio, mean (SD) 0.43 (0.06) 0.44 (0.07) 0.123 
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Table S2. Associations of infant subcutaneous fat mass measures with cardiovascular risk factors at 
6 years old
1-2
 
 
 
 
1
Values are standardized regression coefficients (95% confidence interval) and represent the difference in 
standard-deviation scores for cardiovascular risk factors at 6 years per 1-standard-deviation scores increase in 
body mass index and subcutaneous fat mass measures. Body mass index = weight/height
2
.
 
Total subcutaneous 
fat mass = biceps + triceps + suprailiacal + subscapular skinfold thicknesses. Central-to-total subcutaneous fat 
mass ratio = (suprailiacal + subscapular skinfold thicknesses)/total subcutaneous fat mass. HDL-cholesterol, 
high-density lipoprotein-cholesterol; LDL-cholesterol, low-density lipoprotein-cholesterol. 
2
Unadjusted model. 
*P-value<0.05; **P-value<0.01. 
 
 
Cardiovascular risk factors at 6 years in standard-deviation scores 
 Difference (95% Confidence Interval) 
Fat mass 
measures 
Systolic 
blood 
pressure 
Diastolic 
blood 
pressure 
Total-
cholesterol 
HDL-
cholesterol 
LDL-
cholesterol 
Triglycerides Insulin 
1.5 months 
  
 
    
Body mass index  
0.03 
(-0.04,0.11) 
-0.01 
(-0.08,0.06) 
0.02 
(-0.07, 0.11) 
0.03 
(-0.06,0.12) 
-0.01 
(-0.10,0.08) 
0.01 
(-0.08,0.10) 
-0.01 
(-0.10,0.08) 
Total  
subcutaneous fat 
mass  
0.03 
(-0.04,0.11) 
-0.02 
(-0.10,0.05) 
-0.05 
(-0.14,0.05) 
0.02 
(-0.08,0.11) 
-0.10 
(-0.19,-0.01)* 
-0.02 
(-0.11,0.08) 
0.05 
(-0.04,0.15) 
Central-to-total 
subcutaneous fat 
mass ratio  
-0.01 
(-0.09,0.06) 
-0.03 
(-0.10,0.05) 
0.06 
(-0.03,0.15) 
0.02 
(-0.06,0.12) 
0.02 
(-0.06,0.12) 
0.09 
(-0.01,0.18) 
0.02 
(-0.07,0.11) 
24 months        
Body mass index  
-0.03 
(-0.10,0.05) 
-0.06 
(-0.14,0.02) 
-0.05 
(-0.15,0.04) 
-0.10 
(-0.19,-0.01)* 
0.00 
(-0.10,0.09) 
-0.01 
(-0.10,0.09) 
-0.06 
(-0.15,0.04) 
Total 
subcutaneous fat 
mass  
0.01 
(-0.07,0.08) 
0.02 
(-0.06,0.09) 
0.14 
(0.05,0.24)** 
0.01 
(-0.08,0.10) 
0.13 
(0.04,0.22)** 
0.03 
(-0.06,0.12) 
0.03 
(-0.06,0.13) 
Central-to-total 
subcutaneous fat 
mass ratio  
0.04 
(-0.04,0.11) 
0.04 
(-0.04,0.11) 
0.05 
(-0.04,0.15) 
-0.10 
(-0.19,-0.01)* 
0.10 
(0.01,0.20)* 
0.04 
(-0.06,0.14) 
-0.01 
(-0.11,0.09) 
Change from 1.5 
to 24 months 
       
Body mass index  
-0.05 
(-0.11,0.02) 
-0.04 
(-0.11,0.02) 
-0.05 
(-0.13,0.03) 
-0.06 
(-0.14,0.02) 
-0.01 
(-0.10,0.07) 
-0.02 
(-0.10,0.06) 
-0.01 
(-0.10,0.07) 
Total  
subcutaneous fat 
mass  
-0.01 
(-0.06,0.05) 
0.02 
(-0.04,0.08) 
0.10 
(0.03,0.17)** 
0.00 
(-0.07,0.07) 
0.10 
(0.03,0.18)** 
0.03 
(-0.04,0.11) 
0.01 
(-0.06,0.09) 
Central-to-total 
subcutaneous fat 
mass ratio  
0.02 
(-0.04,0.08) 
0.04 
(-0.02,0.10) 
-0.04 
(-0.12,0.03) 
-0.06 
(-0.13,0.01) 
0.02 
(-0.06,0.10) 
-0.04 
(-0.12,0.03) 
-0.01 
(-0.09,0.06) 
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Introduction 
Obesity is a major public health problem in adulthood,
1
 and leads to increased risks of 
cardiometabolic diseases, musculoskeletal, respiratory and psychological disorders, and 
cancers.
2,3
 Likewise, obesity is reaching alarming levels in women of reproductive age, 
infants and children,
4,5
 which also has major public health implications. 
Obesity at the start of pregnancy and excessive gestational weight gain may have 
short- and long-term consequences for both mother and child, such as an increased risk of 
pregnancy complications and childhood obesity.
6-13
 A maternal obesogenic environment 
during pregnancy leads to fetal over-nutrition that might cause permanent changes in the 
development of adipocytes and in the appetite control system, resulting in larger 
susceptibility to develop obesity later in life.
14 
Infancy, and especially nutrition and growth 
during this period, also seems to be critical for the development of obesity and 
cardiometabolic diseases.
15-19
 Assessing the influence of maternal pre-pregnancy body mass 
index, gestational weight gain and infant growth and adiposity on detailed offspring fat 
measures and cardiovascular risk factors, already from early infancy onwards, is important to 
obtain a better understanding of the influence of maternal and infant adiposity on health 
outcomes in later life. 
The general aim of this thesis was to clarify the adiposity and cardiovascular health 
related consequences of maternal and infant adiposity. This chapter provides a general 
discussion of the main findings of the studies in this thesis, discusses general methodological 
issues and provides suggestions for future research and implications for clinical practice and 
policy. 
 
Interpretation of main findings 
 
Maternal adiposity during pregnancy 
 
Pre-pregnancy body mass index 
A meta-analysis of observational studies showed that maternal pre-pregnancy overweight and 
obesity were associated with a 2-fold and a 3-fold higher risk of offspring 
overweight/obesity, respectively.
10
 Similarly, maternal overweight and obesity have been 
strongly associated with increased risks of overweight and obesity in children aged 4 and 6 
years within the Generation R Study cohort.
20,21
 Thus far, not much is known about the 
associations of maternal obesity with offspring adiposity status throughout infancy, which is 
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a critical period for adiposity development in later life. In line with previous meta-analysis 
and single studies at older ages, we showed that higher maternal pre-pregnancy body mass 
index was associated with higher body mass index from 6 months onwards in infants from 
the Generation R Study. Body fat is mainly located subcutaneously in the first two years of 
life.
22,23
 Thus, skinfold thickness, which is a valid measure to estimate subcutaneous fat 
mass,
24 
might be particularly relevant in infancy. Also, information on total and regional 
subcutaneous fat mass can be obtained from these measurements, enabling the study of 
different locations of fat at younger ages. We showed that maternal pre-pregnancy body mass 
index was positively associated with total subcutaneous fat mass but not with central-to-total 
subcutaneous fat mass ratio at 24 months. No associations were observed with subcutaneous 
fat mass measures at 1.5 and 6 months. Thus, results from this thesis showed that maternal 
pre-pregnancy obesity seems to influence total body fat mass development already from early 
infancy onwards. 
As compared to total or subcutaneous fat, excess visceral, heart and liver fat has been 
described as better indicators of cardiometabolic risk.
25-27
 In 105 healthy mother-newborn 
pairs, higher maternal body mass index was associated with higher infant abdominal fat, 
independently of weight, and higher intrahepatocellular lipid content.
28
 In another study 
among 25 newborns, infants born to obese mothers with gestational diabetes had higher 
intrahepatocellular fat compared with infants born to normal weight mothers.
29
 Maternal pre-
pregnancy obesity was also associated with higher visceral fat mass levels in 1,228 Greek 
children aged 9-13 years.
30
 These studies have important limitations, such as their small 
sample size and the lack of properly control for confounding by general adiposity in these 
associations. The fat that is accumulated in a specific location is influenced by the general 
adiposity status. Thus, to assess the risk factors for accumulation in specific depots, it is 
important to control for the effect of general adiposity. A previous study in 6-year-old 
children from the Generation R Study reported that maternal pre-pregnancy body mass index 
was not associated with subcutaneous and preperitoneal abdominal fat measured by 
ultrasound, independently of child´s body mass index.
21
 Contrarily, we showed that higher 
maternal body mass index was associated with higher subcutaneous, visceral, pericardial and 
liver fat assessed by magnetic resonance imaging in 10-year-old children from the Generation 
R Study. The associations of maternal body mass index with offspring subcutaneous and 
visceral fat seemed to be independent of offspring body mass index, suggesting that higher 
maternal body mass index is associated with a specific accumulation of fat in abdominal 
depots that is not a result of general adiposity. The different results reported in the studies 
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using data from 6- and 10-year-old children from the Generation R Study might be related to 
the use of different methods for measuring subcutaneous and visceral fat mass. Ultrasound 
has been shown to be a reliable method to differentiate between the abdominal preperitoneal 
and subcutaneous fat compartments but showed poorer accuracy and reproducibility as 
compared to magnetic resonance imaging that has been described as a gold standard 
technique.
31
 Besides this, lower amounts of fat in these specific depots at younger ages might 
lead to lower variability, and might have, at least partly, contributed to the absence of effect 
in the sample of 6-year-old children. Results from this thesis showed that higher maternal 
body mass index is associated with organ fat accumulation, especially abdominal fat, in 10-
year-old children. 
 
Gestational weight gain 
Excessive gestational weight gain has been associated with an increased risk of childhood 
overweight and obesity.
11-13
 In a study among 948 mothers and their children from the 
Southampton Women’s Survey, higher maternal total gestational weight gain was associated 
with higher neonatal total fat mass and higher total fat mass at 6 years but not at 4 years.
32
 In 
a study among 1,044 mother-child pairs from Project Viva, higher weight gain during 
pregnancy was associated with higher sum of subscapular and triceps skinfold thickness.
33
 In 
a retrospective cohort study in Germany of 6,837 mother-child pairs, excessive gestational 
weight gain was associated with higher risk of abdominal adiposity measured using waist 
circumference.
34
 In 313 mother-child pairs, higher maternal body mass index was associated 
with higher childhood subcutaneous and visceral fat, particularly among mothers with 
excessive gestational weight gain.
35
 It has been suggested that the associations of maternal 
weight gain with offspring fat mass outcomes may depend upon the timing of gestational 
weight gain. A prospective cohort study among 5,154 UK mothers and their children showed 
that maternal weight gain during early-pregnancy was positively associated with childhood 
total fat mass.
36
 A study among 977 Greek mothers and their children aged 4 years showed 
that maternal weight gain during early-pregnancy was positively associated with childhood 
sum of skinfold thickness and waist circumference.
37
 In 5,908 mothers and their 6-year-old 
children from the Generation R Study, maternal weight gain in early-, mid- and late-
pregnancy was not associated with childhood subcutaneous and preperitoneal abdominal fat 
mass levels, independently of body mass index.
38
 We showed with results from this thesis 
that maternal total and period-specific gestational weight gain were not consistently 
associated with body mass index, total subcutaneous fat mass and central-to-total 
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subcutaneous fat mass ratio in infants aged 1.5, 6 and 24 months from the Generation R 
Study. Higher maternal total gestational weight gain seems to be associated with higher body 
fat quantity assessed by using a body fat pattern combining body mass index, fat mass index 
and waist-to-height ratio in children aged 7 years from the Generation XXI. However, no 
associations were observed with body fat distribution assessed by using a body fat pattern 
combining waist-to-hip, waist-to-thigh and waist-to-weight ratios. Similarly, higher weight 
gain during pregnancy, especially in early-pregnancy, was associated with higher body mass 
index but no consistent associations were observed with subcutaneous, visceral, pericardial 
and liver fat, independently of body mass index in children aged 10 years from the 
Generation R Study. Results from this thesis showed that the effects of maternal weight gain 
during pregnancy on fat mass development seem to become more apparent at older offspring 
ages and seem to be restricted to the general adiposity and not to the accumulation in specific 
depots. The absence of effect, or less clear effect as compared to maternal pre-pregnancy 
body mass index, might be explained by the fact that gestational weight gain reflects maternal 
nutritional status but also other components such as the fetus, amniotic fluid, placenta, uterine 
and mammary tissue expansion, increased blood volume, and extracellular fluid.
39  
 
 
Underlying mechanisms 
Main findings 
 Higher maternal body mass index was associated with higher body mass index and 
total subcutaneous fat mass from 6 months onwards, but not with central-to-total 
subcutaneous fat mass ratio in infancy.  
 
 Higher maternal body mass index was associated with higher abdominal, pericardial 
and liver fat measures at 10 years. The associations with abdominal subcutaneous and 
visceral fat were independent of body mass index. 
 
 Maternal total and period-specific gestational weight gain were not associated with 
body mass index and subcutaneous fat mass measures in infancy. 
 
 Maternal gestational weight gain was positively associated with body fat quantity but 
not with body fat distribution at 7 years. 
 
 Maternal total and period-specific gestational weight gain were not consistently 
associated with subcutaneous, visceral, pericardial and liver fat measures, 
independently of body mass index at 10 years. 
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It remains unclear whether the associations of maternal adiposity during pregnancy with 
infant and childhood adiposity are explained by direct intrauterine mechanisms or 
confounded by environmental, lifestyle or genetic characteristics. To help disentangling the 
underlying mechanisms, previous studies have compared the strength of associations of 
maternal and paternal body mass index with infant and childhood adiposity measures. 
Although studies comparing associations of maternal and paternal body mass index with 
childhood body mass index have shown conflicting results,
40
 other studies have shown that 
maternal pre-pregnancy body mass index tends to be more strongly associated with childhood 
total fat mass than paternal body mass index.
21,41
 In this thesis, we showed stronger 
associations for paternal body mass index with infant body mass index at 1.5 months but 
stronger associations for maternal pre-pregnancy body mass index with infant body mass 
index and total subcutaneous fat mass from the age of 6 months onwards. These results 
suggest that intrauterine programming effects may become more apparent at later ages. We 
also showed a tendency for stronger associations of maternal pre-pregnancy body mass index 
with general and abdominal fat at 10 years. Even though there is a tendency in this thesis for 
stronger associations of maternal body mass index with infant and childhood adiposity 
measures, the confidence intervals of the maternal and paternal effect estimates were not 
statistically different and thus no clear conclusions can be drawn. In this thesis, we also 
showed, by using a path analysis, that the positive although small effect of gestational weight 
gain on child´s body fat quantity seemed to be mainly through intrauterine programming 
effects instead of indirect effects through birth weight. 
The mechanisms by which maternal adiposity during pregnancy might affect 
offspring´s general, abdominal and organ fat accumulation are not fully known yet. A 
maternal obesogenic environment during pregnancy leads to higher maternal plasma 
concentrations of glucose, amino acids and free fatty acids that are transferred to the 
developing fetus. Fetal over-nutrition has been associated with a permanent increase in the 
capacity of adipocytes to store lipids.
42
 Moreover, intrauterine exposure to a high-fat diet
43,44 
and/or to hyperglycemia
45
 is thought to induce excessive appetite postnatally due to a 
dysregulation in the expression of appetite-regulating genes and a reduced sensitivity of 
central hypothalamic neuropeptides to peripheral satiety signals (specifically leptin and 
insulin). Maternal over-nutrition might also lead to accumulation of fat in the liver and other 
developing organs of the fetus, especially during early- and mid-pregnancy due to the 
absence of adipose tissue.
46
 The postnatal persistence of increased fat in these depots might 
be related to reduced fatty acid oxidation, changes in lipogenesis and lipoprotein export.
46
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Infant adiposity  
 
Infant adiposity and childhood adiposity 
Body mass index tends to track from infancy onwards.
47,48
 Although total and central fat 
mass track moderately from childhood into adulthood,
49-55
 the stability of these measures 
already from early infancy onwards is not known. We showed a moderate tracking of body 
mass index from 1.5 and 24 months to 6 years in children from the Generation R Study. Also, 
total subcutaneous fat mass at 24 months was positively associated with fat mass index at 6 
years, suggesting tracking of total fat mass from infancy into school-age. Higher total 
subcutaneous fat mass and central-to-total subcutaneous fat mass ratio in infancy were 
associated with higher central-to-total and android-to-gynoid fat mass ratios measured by 
dual energy X-ray absorptiometry and preperitoneal fat mass area measured by abdominal 
ultrasound at 6 years old.  We observed stronger effect estimates for infant total subcutaneous 
fat mass than for central-to-total subcutaneous fat mass ratio, in the associations with similar 
measures at school-age, although both showed weaker effect estimates compared with the 
tracking of body mass index from infancy to childhood. Stronger effect estimates were 
observed among girls than boys which might be explained by a more stable body fat 
development, driven by less hormonal fluctuations, during infancy in girls.
56
 Also, the effect 
estimates were stronger for 24 months than for 1.5 months fat mass measures, which might 
be due to the shorter interval between 24 months and 6 years old. Also, 1.5 months might be 
more reflective of fetal growth patterns which seemed to be less predictive, as compared to 
postnatal growth, of later abdominal adiposity.
57 
Thus, results from this thesis showed that 
body mass index and subcutaneous fat mass measures in infancy are positively associated 
with body mass index, total and abdominal fat mass at school-age. Compared with body mass 
index, subcutaneous fat mass measures in infancy add little value to estimate adiposity in 
childhood.  
 
Infant adiposity and childhood cardiovascular risk factors 
Rapid weight gain in the first 3 months of life has been associated with increased adiposity 
and an unfavorable cardiovascular profile in later life.
19
 However, it remains unknown 
whether gain in body mass index or ponderal index (weight/height
3
) in infancy predisposes 
individuals to cardiovascular risk. A study among 4,601 UK subjects has shown that changes 
in ponderal index from 0 to 2 years were not associated with cardiovascular risk factors in 
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adolescence.
58
 Similarly, we observed no associations of body mass index at the ages of 1.5 
and 24 months or its change in this period with cardiovascular risk factors at 6 years. 
Previous studies have also shown that high total and central subcutaneous fat mass measures, 
estimated from skinfold thicknesses, are associated with an adverse cardiovascular risk 
profile in childhood.
59-65
 Currently, it is not known whether total and central subcutaneous fat 
mass measures in infancy are associated with cardiovascular risk factors in later life. We 
observed no associations of infant subcutaneous fat mass measures with childhood blood 
pressure and triglycerides or insulin levels in children from the Generation R Study. At 1.5 
months, total subcutaneous fat mass was inversely associated with low-density lipoprotein 
(LDL)-cholesterol at 6 years old. Residual confounding by children´s dietary intake and 
physical activity might have contributed to this finding, since we had only available 
information about breastfeeding, age at introduction of solid foods and TV watching time at 6 
years. At 24 months, total subcutaneous fat mass, but not central-to-total subcutaneous fat 
mass ratio, was positively but weakly associated with childhood total- and LDL-cholesterol, 
independently of body mass index at 6 years old. Results from this thesis suggest that body 
mass index and subcutaneous fat mass measures in infancy seem to be poor indicators of 
cardiovascular risk profile in later childhood. These findings may be partially explained by 
the fact that fat mass measures in infancy represent the accumulation of fat mass over a short 
period of time, which may not be long enough to influence cardiovascular risk profile. 
 
 
  
Methodological considerations 
Strengths and limitations for each study are described in Chapter 2 and Chapter 3 of this 
thesis. In the following paragraphs, general methodological considerations regarding 
selection bias, information bias, confounding and causality are discussed. 
 
Main findings 
 Infant body mass index and subcutaneous fat mass measures were positively 
associated with body mass index, total and abdominal fat mass at school-age. 
 
 Infant body mass index and subcutaneous fat mass measures were not associated with 
childhood blood pressure and triglycerides or insulin levels. Total subcutaneous fat 
mass was weakly associated with cholesterol levels at 6 years, independently of body 
mass index. 
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Selection bias 
Selection bias is a bias in the estimated association or effect of an exposure on an outcome 
that arises from the procedures used to select individuals into the study or the analysis.
66
 It is 
present when the association between exposure and outcome in study participants is different 
as compared to that in eligible non-participants. Selection bias may occur due to selective 
non-response at baseline or selective loss to follow-up.  
 
Generation XXI 
Of the invited mothers, 91% accepted to participate. When compared to the mothers from the 
catchment area, delivering in 2005 and 2006, cohort participants were slightly younger but 
similar in marital status. The prevalence of caesarean section was slightly higher than the 
prevalence in Portugal in 2004. The cohort had a similar gender proportion but higher 
proportion of multiple fetuses as compared to the national percentages. When compared to 
the Portuguese deliveries in 2005 and 2006, the cohort presented a higher proportion of 
preterm and low birth weight newborns, probably because all the maternities enrolled had 
highly differentiated perinatal support. 
 In this thesis, we used data from the 7-year-old re-evaluation, in which 80% of the 
entire cohort participated. Mothers participating in follow-up studies were slightly older and 
higher educated, although the magnitude of the differences was small. 
 
Generation R Study 
The participation rate at birth was 61%. As compared to the general population in Rotterdam, 
women from the Generation R Study were less likely to be from ethnic minority groups and 
of lower socioeconomic status. Also, participating women were less likely to develop 
gestational hypertensive disorders and have children born preterm or with low birth weight.  
In this thesis, we used data from the subgroup of Dutch mothers and their children 
participating in additional detailed assessments of growth and development from late 
pregnancy onwards, in which the loss to follow-up at 1.5, 6 and 24 months and 6 years old 
was low. We also used data from the follow-up at the age of 10 years, in which 76% of the 
original cohort participated in the study. A lower percentage of children participated in the 
magnetic resonance imaging measurements of abdominal and organ fat at 10 years, which 
was mainly due to non-consent. Compared to the baseline characteristics, mothers who did 
visit the research center in the follow-up evaluations were older, more frequently of Dutch 
nationality and higher educated.
67
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Generation XXI might have included mothers that were more likely to have children born 
preterm or with low birth weight. It is difficult to speculate whether this could have biased 
our effect estimates. On the other hand, the selective non-response at baseline in the 
Generation R Study suggests a selection towards a more affluent and healthy population, 
which may have led to lower prevalence rates of maternal, infant and childhood adiposity and 
cardiovascular risk factors, and subsequently reduced statistical power. Also, it may affect the 
generalizability of our findings to less healthy and affluent populations. However, several 
studies have shown that in cohort studies associations are not strongly influenced by selective 
non-participation at baseline, and therefore it seems unlikely that the results of this thesis are 
biased due to the selection procedures.
68,69
 
Similarly, the selective loss to follow-up in both cohorts suggests a selection towards 
a healthier population. Although difficult to speculate if this might have biased our effect 
estimates, this seems unlikely since participants did not differ from non-participants 
regarding the exposures of interest, such as maternal pre-pregnancy body mass index. 
 
Information bias 
Information bias is a bias in an estimate arising from measurement errors or 
misclassification.
66
 In this thesis, we relied on anthropometric measurements, such as body 
mass index, indices based on waist circumference and skinfold thicknesses, which might have 
greater measurement error and be less accurate, but on the other hand be easier and cheaper 
to obtain in large epidemiological studies as compared to imaging techniques of body 
composition.
24,70,71
 High accuracy and reproducibility have been reported for dual energy X-
ray absorptiometry, abdominal ultrasound and magnetic resonance imaging that were also 
used in this thesis.
24,31,72-74
  
Misclassification can be non-differential or differential. Non-differential 
misclassification occurs when the determinant status is not related to the outcome status, and 
vice-versa and generally leads to an underestimation of the effect estimates. Differential 
misclassification occurs when the determinant status is related to the outcome status, and 
vice-versa and generally leads to biased results, which can be either overestimated or 
underestimated. In this thesis, differential misclassification is unlikely. Exposure data used in 
our studies were collected longitudinally and before assessment of the outcomes, the data 
collectors were blinded to the exposure status when assessing the outcomes and parents as 
well as data collectors were unaware of the specific research questions under study. However, 
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non-differential misclassification might have occurred. In the studies included in this thesis, 
information on maternal pre-pregnancy weight and maximum gestational weight was self-
reported. Women tend to underestimate their weight on self-report,
75
 which might have led to 
an underestimation of observed effects for maternal pre-pregnancy body mass index. Since 
pre-pregnancy weight and maximum gestational weight are both self-reported and probably 
underestimated, the influence on maximum weight gain is likely to be minimal. The 
attendance of prenatal visits could also have made pregnant women more aware of their 
weight status, minimizing the error of self-reported final pre-delivery weight. The bias in the 
results for maternal pre-pregnancy body mass index and maximum gestational weight gain 
seems also unlikely since similar results were observed when using maternal weight 
measured at enrolment and weight gain measured until late-pregnancy. The use of thirty-
minutes fasting blood samples may have resulted in misclassification and thus may have led 
to underestimation of the observed associations. However, it has been shown in adults that 
non-fasting blood lipid levels can accurately predict increased risks of cardiovascular events 
in later life.
76
 
 
Confounding 
Confounding occurs when all or part of the effect between an exposure and an outcome is in 
fact explained by other variables that affect the outcome but are not themselves affected by 
the exposure.
66
 To take account for confounding, we adjusted all analyses for multiple 
potential confounders. We selected covariates based on their associations with the exposures 
and outcomes of interest in our or previous studies or a change in effect estimate of more than 
10%. In this thesis, adjustment for potential confounders only moderately affected the effect 
estimates, which suggests that the observed associations are possibly true associations 
between the exposures and the outcomes. Although information about many potential 
confounders was available in the studies included in this thesis, residual confounding might 
still be present. Also, information about several confounders was self-reported and 
misclassification might have occurred, contributing to residual confounding and an 
overestimation of the observed effect estimates. To help understanding whether the 
associations of maternal obesity with infant and childhood adiposity are explained by direct 
intrauterine mechanisms or confounded by environmental, lifestyle or genetic characteristics, 
we compared the associations of both maternal and paternal body mass index. A similar 
effect size for the maternal and paternal association would suggest that the association of 
maternal obesity with infant and childhood adiposity is explained by unmeasured 
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environmental factors, rather than direct intrauterine mechanisms. A limitation of this 
approach is the assumption that both parents contribute equally to the shared lifestyle-related 
characteristics between parents and their offspring. We also performed a comprehensive path 
analysis to help understanding whether the effects of prenatal exposures (gestational weight 
gain, diabetes and smoking) on child´s body fat are mainly explained by a direct (through 
intrauterine programming) or indirect pathway (through birth weight). Although we included 
the most important paths described to date, and tested several covariates as confounders, we 
cannot exclude the possibility of existing other paths not considered in this thesis and also 
residual confounding by lifestyles or genetics that might have biased our estimates for the 
intrauterine programming effects.  
 
Causality 
The causality of the associations observed in this thesis remains to be established. The 
Bradford Hill criteria, that can be useful for providing evidence of a causal relationship 
between an exposure and an outcome, include strength, consistency, specificity, temporality, 
dose-response relationship, biological plausibility, coherence, experiment and analogy.
66
 
Overall, our associations may be relatively small. Although stronger associations are more 
likely to be causal, weak relationships may also be causal. The main findings of this thesis 
were consistent with previous studies, our studies were longitudinal supporting the 
temporality between exposures and outcomes, several potential biological mechanisms for 
these associations have been described, and our findings were coherent with animal studies. 
Although not explored in all studies presented in this thesis, we did observe some dose-
response effects between maternal body mass index and general and organ fat at 10 years. 
The specificity, experiment and analogy criteria were not addressed in this thesis. Although 
this thesis was not designed to fully clarify the causality of these associations, our 
observational studies seem to provide some evidence for causal relationships based on the 
Bradford Hill criteria. 
 
Future research 
Although findings from this thesis suggest that maternal adiposity during pregnancy and 
infant adiposity adversely affect infant and childhood adiposity and cardiovascular health, the 
following major issues remain to be addressed in future studies. 
 
Causality 
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We performed an extensive adjustment for potential confounding factors, used parental body 
mass index comparison analyses and path analyses and found some evidence for causality in 
our studies based on the Bradford Hill criteria. However, the causality of the associations for 
maternal adiposity during pregnancy observed in this thesis remains unclear. Randomized 
controlled trials, sibling comparison studies, and Mendelian randomization studies can be 
used to obtain further insight into the causality of the associations. 
Randomized controlled trials are the gold standard study design to establish causality. 
Previous randomized controlled trials focused on controlling obesity in pregnant women or 
reducing the risk of excessive gestational weight gain by improving diet and physical activity 
showed small reductions in maternal pre-pregnancy weight and gestational weight gain.
77-79
 
The effect of these interventions on infant and childhood outcomes remains to be explored. A 
small randomized controlled trial that provided dietary advice and exercise to obese pregnant 
women showed no differences in their infant body mass index or metabolic risk factors.
80
 
Long-term follow-up of participants in these randomized controlled trials might provide a 
unique opportunity to examine whether maternal obesity and excessive gestational weight 
gain are causally related to childhood adiposity status and cardiovascular risk. It will also 
provide insight into the effectiveness of these interventions for improving health outcomes in 
the offspring. Many randomized controlled trials have started their interventions from the 
second trimester onwards.
79,81
 Considering the findings of this thesis that suggest that 
promoting a healthy maternal pre-pregnancy body mass index might be of greater importance 
than influencing gestational weight gain, randomized controlled trials focused on the 
preconception or early pregnancy period are needed. 
 Sibling comparison studies allow control for environmental characteristics as well as 
maternal genotype that are shared among siblings. However, besides major exposures of 
interest, other lifestyle-related characteristics may also differ between siblings, limiting the 
potential of this study design to assess causality.
82
 Mendelian randomization studies use 
genetic variants, known to be robustly associated with the exposure of interest and not 
affected by confounding, to examine whether the exposure is causally related to the 
outcome.
83
 Mendelian randomization studies with large sample sizes to have adequate 
statistical power, using multiple maternal genetic variants as instruments and focused on 
childhood outcomes are needed. 
 
Assessment of exposures and outcomes 
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In this thesis, information on self-reported maternal pre-pregnancy body mass index, 
measured early-, mid-, and late-pregnancy weight and self-reported maximum gestational 
weight was available. Studies with measured pre-pregnancy weight and maximum gestational 
weight might reduce the risk for misclassification and bias. Studies with serial repeated 
maternal weight measurements during pregnancy are also needed to allow a more thorough 
identification of critical time points for adiposity and cardiovascular development. 
Gestational weight gain reflects multiple components, which might complicate the 
interpretation of the associations. Studies disentangling the different components of 
gestational weight gain might provide further insight into the underlying mechanisms. Infant 
and childhood outcomes studied in this thesis included total, abdominal and organ fat, blood 
pressure, lipids and insulin levels. We used magnetic resonance imaging that is a gold 
standard technique for measuring intra-abdominal and ectopic fat deposition.
31,72-74
 However, 
we only have magnetic resonance imaging measurements available at 10 years. Future studies 
should measure these body fat compartments, which have important adverse metabolic 
consequences, at younger ages to obtain further insight into its development and related risk 
factors and health consequences. Additional measurements of childhood cardiovascular 
development might also provide further insight into the underlying mechanisms linking early 
life exposures to cardiovascular events in later life. Measures of endothelial function, intima 
media thickness, insulin/glucose metabolism and coronary circulation imaging in children 
might be of interest to gain more knowledge about the cardiovascular development. To obtain 
further insight into the underlying mechanisms for the associations addressed in this thesis, 
large population-based studies focused on epigenetics and metabolomics are needed. Further 
research needs to explore whether and which critical periods are involved in these 
associations. 
  
Implications for clinical practice and policy 
Maternal adiposity during pregnancy and infant adiposity might influence the adiposity status 
and cardiovascular profile in later life. The observed effect estimates were small to moderate, 
but are of interest from a developmental perspective since obesity and cardiovascular risk 
factors tend to track into adulthood. Also, even subclinical differences in cardiovascular risk 
factors during childhood are related to the development of cardiovascular disease in later life. 
Thus, prevention of maternal adiposity during pregnancy and infant adiposity is important to 
reduce the burden of obesity and cardiovascular disease throughout the life course and in 
future generations. 
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Preventive strategies or interventions focused on the preconception period or during 
pregnancy should be implemented. Women might be more motivated to make lifestyle 
changes in preconception period and pregnancy and might also keep these new lifestyle 
habits after pregnancy, highlighting the potential for health gains. In particular, based on our 
findings, promoting a healthy body mass index in women when entering pregnancy might be 
of greater importance than influencing gestational weight gain. So, it is essential to promote 
knowledge about the importance of a healthy weight in women of reproductive age. General 
practitioners, gynecologists, and other health professionals should inform and advise young 
women. Also, specific health care programs aiming to encourage healthy eating and physical 
activity for overweight or obese mothers-to-be should be conducted. 
Information about the benefits of an adequate body composition during infancy 
should also be provided to families together with proper recommendations for breastfeeding, 
introduction of solid foods and other environmental and behavioral factors that might impact 
the health of the child later in life. Since the education sector plays a critical role in providing 
nutrition and health education, increasing the opportunities for physical activity and 
promoting healthy school environments is of utmost importance in preventing obesity in 
childhood.
5
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Summary 
 
Chapter 1 provides the background, hypothesis, aims and design for this thesis. Obesity is 
increasing in prevalence worldwide and has large clinical implications in childhood and 
adulthood. An accumulating body of evidence suggests that obesity and cardiometabolic 
diseases in childhood and adulthood at least partly originate in fetal or early postnatal life. 
Adverse exposures, acting during fetal and early postnatal development, lead to permanent 
adaptations in the structure, physiology and function of various organ systems. In particular, 
maternal adiposity during pregnancy might lead to a higher risk of obesity in the offspring 
through intrauterine programming mechanisms. A maternal obesogenic environment during 
pregnancy leads to fetal over-nutrition and might cause permanent changes in the 
development of adipocytes, and in the appetite control system. Infant growth patterns, such as 
rapid postnatal weight gain, seem also to be critical for the development of obesity and 
cardiovascular diseases in later life. Assessing the influence of maternal adiposity during 
pregnancy and infant growth and adiposity on detailed offspring fat measures and 
cardiovascular risk factors is important to obtain a better understanding of the influence of 
mother´s and infant´s health on health outcomes in later life. Therefore, the general aim of 
this thesis was to assess the adiposity and cardiovascular health related consequences of 
maternal and infant adiposity. The studies presented in this thesis used data from the 
Generation XXI, a population-based birth cohort in Porto, Portugal and the Generation R 
Study, a population-based cohort from fetal life onwards in Rotterdam, the Netherlands.  
 In Chapter 2, studies on the influence of maternal adiposity during pregnancy on 
infant and childhood outcomes are described. In Chapter 2.1, we reviewed the childhood 
health consequences of maternal obesity during pregnancy. Evidence from observational 
studies strongly suggests that maternal pre-pregnancy obesity and excessive gestational 
weight gain are associated with increased risks of fetal pregnancy complications and adverse 
childhood cardiometabolic, respiratory and cognitive-related health outcomes. It remains 
unclear whether these associations are due to intrauterine mechanisms or explained by 
confounding. The underlying epigenetic mechanisms have been assessed in animal studies 
and small human studies, but have not been tested yet in large human studies. In Chapter 
2.2, we studied the influence of maternal body mass index, and gestational weight gain on 
body mass index and subcutaneous fat mass measures at the ages of 1.5, 6 and 24 months. 
We observed that higher maternal pre-pregnancy body mass index was associated with higher 
body mass index and total subcutaneous fat mass from 6 months onwards. No associations 
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were observed for central-to-total subcutaneous fat mass ratio in infancy. Maternal total and 
period-specific gestational weight gain were not associated with body mass index and 
subcutaneous fat mass measures at 1.5, 6 and 24 months. Next, we examined the associations 
of maternal gestational weight gain, diabetes and smoking on total and regional adiposity at 
the age of 7 years and explored whether these associations were through direct intrauterine 
mechanisms or through birth weight (Chapter 2.3). We observed a positive total effect of 
maternal gestational weight gain, diabetes and smoking during pregnancy on child´s body fat 
quantity. Maternal smoking was also associated with a central fat distribution in children. 
These effects seem to be mainly through intrauterine programming rather than indirect effects 
through birth weight. In Chapter 2.4, we assessed the associations of maternal body mass 
index, and gestational weight gain with general, abdominal, pericardial and liver fat at the age 
of 10 years. We observed that higher maternal body mass index was associated with higher 
body mass index, fat mass index, and subcutaneous, visceral, pericardial and liver fat. The 
associations with abdominal fat were independent of child´s body mass index. Higher weight 
gain during pregnancy, especially in early-pregnancy, was associated with higher body mass 
index but no consistent associations were observed with subcutaneous, visceral, pericardial 
and liver fat, independently of body mass index. In summary, findings from Chapter 2 
suggest that maternal obesity and excessive gestational weight gain are important modifiable 
factors during pregnancy that are associated with adverse health outcomes in the offspring. 
In Chapter 3, studies on the influence of infant adiposity on childhood outcomes are 
described. In Chapter 3.1, we compared the accuracy of body fat patterns and single 
measures for assessing body fat and clarified the use of indices based on waist circumference 
as measures of adiposity in children. Pattern 1 (body mass index, fat mass index from tetra-
polar bioelectric impedance and waist-to-height ratio) showed stronger correlations with dual 
energy X-ray absorptiometry (DXA)-fat mass index and pattern 2 (waist-to-hip, waist-to-
thigh and waist-to-weight ratios) showed stronger correlations with DXA-central fat. We 
observed that as compared to single measures, body fat patterns showed similar correlations 
with DXA-derived measures. Single anthropometric indices seem to be enough to accurately 
estimate body fat. Waist-to-height ratio might be a proxy for total fat, while waist-to-hip, 
waist-to-thigh and waist-to-weight ratios might be proxies for central fat. The influence of 
infant body mass index and subcutaneous fat mass measures on childhood adiposity and 
cardiovascular risk factors is studied in Chapter 3.2 and Chapter 3.3, respectively. We 
observed that infant body mass index and subcutaneous fat mass measures are positively 
associated with body mass index, total and abdominal fat mass at school-age. The effect 
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estimates were stronger for body mass index and total subcutaneous fat mass than for central-
to-total subcutaneous fat mass ratio, and for girls compared with boys. Also, the effect 
estimates were stronger for 24 months than for 1.5 months fat mass measures (Chapter 3.2). 
Infant body mass index and subcutaneous fat mass measures were not associated with 
childhood blood pressure, triglycerides or insulin levels. Higher total subcutaneous fat mass 
at 1.5 months was associated with lower low-density lipoprotein (LDL)-cholesterol levels 
while higher total subcutaneous fat mass at 24 months was associated with higher total-
cholesterol and LDL-cholesterol levels at 6 years, independently of body mass index. There 
were no associations of body mass index and central-to-total subcutaneous fat mass ratio with 
childhood cholesterol levels (Chapter 3.3). In summary, findings from Chapter 3 suggest 
that infant adiposity is related to childhood adiposity and weakly related to childhood 
cholesterol levels. Finally, in Chapter 4, a general discussion of all studies included in this 
thesis, suggestions for future research and implications for clinical practice and policy are 
presented. 
In conclusion, findings from this thesis suggest that maternal adiposity during 
pregnancy and infant adiposity are associated with infant and childhood adiposity and 
cardiovascular health outcomes. The observed associations are relatively small, but may be 
important for the burden of obesity and cardiovascular disease on a population level. 
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Resumo 
 
O Capítulo 1 inclui a introdução, os objetivos e a população em estudo desta tese. A 
prevalência de obesidade está a aumentar em todo o mundo e tem importantes implicações 
clínicas nas crianças e nos adultos. Evidência científica sugere que a obesidade e as doenças 
cardiometabólicas nas crianças e nos adultos têm origem, pelo menos parcialmente, no 
período pré- e pós-natal. Exposições adversas, durante o período pré- e pós-natal, podem 
resultar em adaptações permanentes na estrutura, fisiologia e função de vários sistemas de 
órgãos. Em particular, a adiposidade das mães durante a gravidez pode aumentar o risco de 
obesidade nos seus filhos através de mecanismos de programação intrauterina. Um ambiente 
materno obesogénico durante a gravidez está associado a sobrenutrição fetal e pode causar 
alterações permanentes no desenvolvimento dos adipócitos e no sistema de controlo do 
apetite. Os padrões de crescimento na infância, tais como um rápido ganho de peso pós-natal, 
parecem ser críticos para o desenvolvimento de obesidade e doenças cardiovasculares na vida 
adulta. Estudar a influência da adiposidade materna durante a gravidez e do crescimento e 
adiposidade infantil em medidas de adiposidade e em fatores de risco cardiovascular ao longo 
da vida é importante para melhorar o conhecimento sobre a influência da saúde materna e 
infantil na saúde futura. Por isso, o objetivo geral desta tese foi estudar as consequências 
relacionadas com a adiposidade e com a saúde cardiovascular da adiposidade materna e 
infantil. Os estudos apresentados nesta tese usaram dados da Geração XXI, uma coorte de 
nascimento de base populacional no Porto, Portugal e da Generation R, uma coorte de base 
populacional desde a vida fetal em Roterdão, Holanda. 
  No Capítulo 2, os estudos sobre a influência da adiposidade materna durante a 
gravidez na saúde das crianças foram descritos. No Capítulo 2.1, as consequências na saúde 
das crianças relacionadas com a obesidade materna durante a gravidez foram sumariadas 
numa revisão. Evidência de estudos observacionais sugere que a obesidade materna e o ganho 
de peso excessivo durante a gravidez estão associados com um aumento do risco de 
complicações da gravidez e de problemas de saúde cardiometabólicos, respiratórios e 
cognitivos nas crianças. Permanece por clarificar se as associações são resultado de 
mecanismos intrauterinos ou explicadas por confundimento. Os mecanismos epigenéticos 
subjacentes têm sido explorados em estudos com animais e com amostras pequenas de seres 
humanos, mas ainda não foram testados em estudos com grande tamanho amostral. No 
Capítulo 2.2, nós estudamos a influência do índice de massa corporal materno e ganho de 
peso gestational no índice de massa corporal e medidas de massa gorda subcutânea aos 1,5, 6 
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e 24 meses. Nós observamos que um aumento no índice de massa corporal materno estava 
associado com um aumento no índice de massa corporal e massa gorda subcutânea total a 
partir dos 6 meses. Não foram observadas associações com a razão de massa gorda 
subcutânea central-total na infância. O ganho de peso gestacional total ou por trimestre não 
estava associado com o índice de massa corporal e medidas de massa gorda subcutânea aos 
1,5, 6 e 24 meses. De seguida, nós avaliamos as associações do ganho de peso gestacional, 
diabetes e hábitos tabágicos na adiposidade total e localizada aos 7 anos e exploramos se 
essas associações ocorriam através de mecanismos intrauterinos diretos ou através do peso ao 
nascimento (Capítulo 2.3). Nós observamos um efeito total positivo do ganho de peso, 
diabetes e hábitos tabágicos durante a gravidez na quantidade de gordura corporal da criança. 
Os hábitos tabágicos da mãe estavam também associados com uma distribuição de gordura 
central nas crianças. Estes efeitos parecem ocorrer maioritariamente através de programação 
intrauterina em vez de serem efeitos indiretos através do peso ao nascimento. No Capítulo 
2.4, nós avaliamos as associações do índice de massa corporal materno e ganho de peso 
gestacional com a gordura corporal total, abdominal, do pericárdio e do fígado aos 10 anos. 
Nós observamos que um aumento do índice de massa corporal materno estava associado com 
um aumento do índice de massa corporal, índice de massa gorda e gordura subcutânea, 
visceral, do pericárdio e do fígado. As associações com a gordura abdominal eram 
independentes do índice de massa corporal da criança. Um aumento do ganho de peso 
durante a gravidez, especialmente no início da gravidez, estava associado com um aumento 
do índice de massa corporal mas não foram observadas associações consistentes com a 
gordura subcutânea, visceral, do pericárdio e do fígado, independentemente do índice de 
massa corporal. Em síntese, os resultados do Capítulo 2 sugerem que a obesidade materna e 
o ganho de peso gestacional excessivo são importantes fatores de risco modificáveis que 
estão associados com problemas de saúde nas crianças. 
 No Capítulo 3, os estudos sobre a influência da adiposidade infantil na saúde das 
crianças foram descritos. No Capítulo 3.1, nós comparamos padrões de gordura corporal e 
medidas individuais para avaliar gordura corporal e clarificamos o uso de índices baseados no 
perímetro da cintura como medidas de adiposidade nas crianças. O padrão 1 (índice de massa 
corporal, índice de massa gorda obtido a partir da bioimpedância tetrapolar e razão cintura-
altura) apresentou correlações mais fortes com o índice de massa gorda obtido a partir da 
absorciometria de raios X de dupla energia (DXA) e o padrão 2 (razão cintura-anca, cintura-
coxa e cintura-peso) apresentou correlações mais fortes com a gordura central obtida a partir 
do DXA. Nós observamos que quando comparado com as medidas individuais, os padrões de 
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gordura corporal apresentaram correlações semelhantes com as medidas obtidas a partir do 
DXA. Os índices antropométricos individuais parecem ser suficientes para estimar a gordura 
corporal. A razão cintura-altura pode ser usada para estimar gordura total, enquanto as razões 
cintura-anca, cintura-coxa e cintura-peso podem ser usadas para estimar gordura central. A 
influência do índice de massa corporal e medidas de massa gorda subcutânea durante os 
primeiros 2 anos de vida na adiposidade e fatores de risco cardiovascular nas crianças foi 
estudada no Capítulo 3.2 e Capítulo 3.3, respetivamente. Nós observamos que o índice de 
massa corporal e as medidas de massa gorda subcutânea nos primeiros 2 anos de vida estão 
positivamente associadas com o índice de massa corporal, e com a massa gorda total e 
abdominal em idade escolar. As estimativas de efeito eram mais fortes para o índice de massa 
corporal e massa gorda subcutânea total do que para a razão de massa gorda subcutânea 
central-total, e para as raparigas do que para os rapazes. Além disso, as estimativas de efeito 
eram mais fortes para as medidas de massa gorda aos 24 meses do que aos 1,5 meses 
(Capítulo 3.2). O índice de massa corporal e as medidas de massa gorda subcutânea não 
estavam associados com a pressão arterial, triglicerídeos e insulina nas crianças. Um aumento 
da massa gorda subcutânea total aos 1,5 meses estava associado com uma diminuição dos 
níveis de colesterol da lipoproteína de baixa densidade (LDL) enquanto um aumento da 
massa gorda subcutânea total aos 24 meses estava associado com um aumento dos níveis de 
colesterol total e LDL aos 6 anos, independentemente do índice de massa corporal. Não se 
observaram associações do índice de massa corporal e da razão de massa gorda subcutânea 
central-total com os níveis de colesterol nas crianças (Capítulo 3.3). Em síntese, os 
resultados do Capítulo 3 sugerem que a adiposidade durante os primeiros 2 anos de vida está 
associada com a adiposidade e fracamente associada com os níveis de colesterol nas crianças. 
Finalmente, no Capítulo 4, apresentamos uma discussão geral de todos os estudos incluídos 
nesta tese, sugestões para investigação futura e implicações para a prática clínica e políticas 
de saúde. 
 Em conclusão, os resultados desta tese sugerem que a adiposidade materna durante a 
gravidez e a adiposidade durante os primeiros 2 anos de vida estão associadas com a 
adiposidade e saúde cardiovascular nas crianças. As associações observadas são 
relativamente pequenas, mas podem ser importantes para o impacto da obesidade e da doença 
cardiovascular ao nível populacional.  
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Samenvatting 
 
Hoofdstuk 1 beschrijft de achtergrond, hypothese, de doelstelling en de opzet van het onderzoek 
beschreven in dit proefschrift. De wereldwijde prevalentie van obesitas neemt toe. Obesitas heeft 
belangrijke gevolgen voor de gezondheid van zowel kinderen als volwassenen. Eerder onderzoek 
suggereert dat obesitas en cardiometabole ziekten in de kindertijd en op volwassen leeftijd hun 
grondslag deels al vinden in de foetale en vroege postnatale ontwikkeling. Blootstelling aan 
ongunstige factoren tijdens deze foetale of vroeg postnatale periode leidt tot blijvende 
aanpassingen in de structuur, fysiologie en functie van verschillende orgaansystemen. In het 
bijzonder zou maternale adipositas tijdens de zwangerschap via intra-uteriene programmering 
kunnen leiden tot een hoger risico op obesitas bij het kind. Een obesogene omgeving tijdens de 
zwangerschap leidt tot foetale overvoeding en zou kunnen leiden tot blijvende verandering in de 
ontwikkeling van adipocyten en het verzadigingssysteem. Groeipatronen tijdens de peutertijd, 
zoals een snelle postnatale gewichtstoename, lijken ook belangrijk te zijn voor de ontwikkeling 
van obesitas en cardiovasculaire ziekten later in het leven. Het is van belang om meer inzicht te 
verkrijgen in de invloed van maternale adipositas tijdens de zwangerschap en de groei en 
adipositas van het kind tijdens de peutertijd op gedetailleerde maten van lichaamssamenstelling 
en cardiovasculaire risicofactoren op latere leeftijd. Het doel van dit proefschrift was daarom om 
de gevolgen te onderzoeken van adipositas bij de moeder en in de peutertijd met betrekking tot 
adipositas en cardiovasculaire gezondheid later in het leven. Voor de studies beschreven in dit 
proefschrift zijn gegevens gebruikt van de Generation XXI, een populatie-gebaseerd 
geboortecohort in Porto, Portugal, en van de Generation R Studie, een populatie-gebaseerd 
cohort dat gevolgd wordt vanaf het vroege foetale leven in Rotterdam, Nederland. 
 In Hoofdstuk 2 worden studies beschreven betreffende de invloed van maternale 
adipositas tijdens de zwangerschap op gezondheidsuitkomsten tijdens de peuter- en kindertijd. In 
Hoofdstuk 2.1 hebben we het bestaande onderzoek naar de gevolgen van maternale obesitas 
tijdens de zwangerschap op de gezondheid van het kind samengevat. Observationele studies 
stellen dat maternale obesitas vooraf aan de zwangerschap en een verhoogde gewichtstoename 
tijdens de zwangerschap geassocieerd zijn met een verhoogd risico op complicaties bij de foetus 
tijdens de zwangerschap en ongunstige cardiometabole, respiratoire en cognitieve 
gezondheidsuitkomsten op de kinderleeftijd. Het is niet duidelijk of deze associaties het gevolg 
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zijn van intra-uteriene mechanismen of verklaard kunnen worden door confounding. De epi-
genetische mechanismen onderliggend aan deze associaties zijn bestudeerd in dierstudies en 
kleine studies bij mensen, maar zijn nog niet onderzocht in grotere populatie gebaseerde studies. 
In Hoofdstuk 2.2 hebben we de invloed van maternale body mass index en gewichtstoename 
tijdens de zwangerschap op de body mass index en maten voor subcutaan vet bij het kind op de 
leeftijden van 1.5, 6 en 24 maanden onderzocht. We lieten zien dat hogere maternale body mass 
index was geassocieerd met een hogere body mass index en totale subcutane vetmassa vanaf de 
leeftijd van 6 maanden. Maternale body mass index was niet geassocieerd met de centraal/totaal 
subcutaan vet ratio tijdens de peutertijd. Maternale totale en periode-specifieke gewichtstoename 
tijdens de zwangerschap waren niet geassocieerd met body mass index en maten van subcutaan 
vet op de leeftijden van 1.5, 6 en 24 maanden. Daarnaast hebben we gekeken naar de associaties 
van gewichtstoename tijdens de zwangerschap, diabetes, en roken met totale en regionale 
adipositas op de leeftijd van 7 jaar, en hebben we onderzocht of deze associaties verklaard 
werden door directe intra-uteriene mechanismen of door het geboortegewicht (Hoofdstuk 2.3). 
We zagen een positief totaal effect van gewichtstoename, diabetes en roken tijdens de 
zwangerschap op de hoeveelheid lichaamsvet bij het kind. Roken tijdens de zwangerschap was 
ook geassocieerd met een centrale vetverdeling bij kinderen. Deze effecten lijken vooral 
verklaard te worden door intra-uteriene programmering en niet door indirecte effecten via 
geboortegewicht. In Hoofdstuk 2.4 onderzochten we de associaties van maternale body mass 
index en gewichtstoename tijdens de zwangerschap met totaal-, abdominaal-, pericardiaal- en 
levervet op de leeftijd van 10 jaar. We observeerden dat een hogere body mass index van de 
moeder was geassocieerd met een hogere body mass index en  een hogere massa van het 
subcutane-,viscerale-, pericardiale- en levervet.De associaties met abdominaalvet waren 
onafhankelijk van de body mass index van het kind. Meer  gewichtstoename tijdens de 
zwangerschap, vooral tijdens de vroege zwangerschap, was geassocieerd met een hogere body 
mass index, maar er waren geen consistente associaties met subcutaan-, visceraal-, pericardiaal- 
en levervet, onafhankelijk van de body mass index. Samengevat, de bevindingen beschreven in 
Hoofdstuk 2 suggereren dat maternale obesitas en meer gewichtstoename tijdens de 
zwangerschap belangrijke factoren zijn die geassocieerd zijn met ongunstige 
gezondheidsuitkomsten bij kinderen. 
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 In Hoofdstuk 3 worden studies naar de invloed van adipositas tijdens de peutertijd op 
gezondheidsuitkomsten op de kinderleeftijd beschreven. In Hoofdstuk 3.1 vergeleken we de 
patronen van lichaamsvet met enkelvoudige maten van lichaamsvet en beschreven we het 
gebruik van indexen gebaseerd op middelomtrek als maten van adipositas bij kinderen. Patroon 1 
(body mass index, vetmassa index verkregen met tetra-polar bioelectric impedance, en 
middelomtrek/lengte ratio) was sterker gecorreleerd aan vetmassa index verkregen met dual 
energy X-ray absorptiometry (DXA) scans en patroon 2 (middelomtrek/heupomtrek, 
middelomtrek/dijomtrek en middelomtrek/gewicht ratio’s) was sterker gecorreleerd met centraal 
vet, verkregen met DXA scans. De correlaties van lichaamsvetpatronen met maten verkregen 
met DXA scans waren gelijk aan die van de enkelvoudige maten van lichaamsvet. Enkelvoudige 
antropometrische indexen lijken voldoende te zijn om de hoeveelheid lichaamsvet te schatten. 
Middelomtrek/lengte ratio zou een proxy kunnen zijn voor totaal vet, terwijl 
middelomtrek/heupomtrek, middelomtrek/dijomtrek en middelomtrek/gewicht ratio’s proxies 
zouden kunnen zijn voor centraal vet. De invloed van body mass index en maten voor subcutaan 
vet tijdens de peutertijd op adipositas en cardiovasculaire risicofactoren tijdens de kindertijd zijn 
onderzocht in respectievelijk  Hoofdstuk 3.2 en Hoofdstuk 3.3. We hebben laten zien dat body 
mass index en maten voor subcutaan vet tijdens de peutertijd positief geassocieerd zijn met body 
mass index en totale en abdominale vetmassa op schoolgaande leeftijd. De associaties waren 
sterker voor body mass index en totaal subcutaan vet dan voor de centraal/totaal subcutaan vet 
ratio en waren ook sterker voor meisjes dan voor jongens. Daarnaast waren de effecten sterker op 
de leeftijd van 24 maanden dan op de leeftijd van 1.5 maand (Hoofdstuk 3.2). Body mass index 
en maten voor subcutaan vet waren niet geassocieerd met bloeddruk, triglyceriden of insuline 
waarden op de kinderleeftijd. Een hogere totale subcutane vetmassa op de leeftijd van 1.5 maand 
was geassocieerd met lagere LDL-cholesterol waarden, terwijl een hogere totale subcutane 
vetmassa op de leeftijd van 24 maanden geassocieerd was met hogere totaal-cholesterol waarden 
en LDL-cholesterol waarden op de leeftijd van 6 jaar, onafhankelijk van body mass index. Body 
mass index en centraal/totaal vetmassa ratio waren niet geassocieerd met cholesterol waarden op 
de kinderleeftijd (Hoofdstuk 3.3). Samengevat, de bevindingen beschreven in Hoofdstuk 3 
suggereren dat adipositas op de peuterleeftijd gerelateerd is aan adipositas op de kinderleeftijd en 
zwak gerelateerd is aan cholesterol waarden op de kinderleeftijd. In Hoofdstuk 4 is een 
algemene discussie gegeven van alle studies beschreven in dit proefschrift. Daarnaast worden er 
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suggesties gedaan voor verder onderzoek en worden de implicaties voor de klinische praktijk en 
beleid beschreven. 
  Concluderend, de bevindingen van dit proefschrift suggereren dat maternale adipositas 
tijdens de zwangerschap en adipositas tijdens de peutertijd geassocieerd zijn met adipositas 
tijdens de peuter- en kindertijd en cardiovasculaire gezondheidsuitkomsten tijdens de kindertijd. 
Hoewel de gevonden effecten relatief klein zijn, zijn ze van belang voor de impact van obesitas 
en cardiovasculaire zieken op populatieniveau. 
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Genetic Epidemiology 2012/13 4.0 
Epidemiology of cancer 2012/13 4.0 
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Year 
Workload 
(ECTS) 
Mental Health 2012/13 2.0 
Ethics, Solidarity and Public Health 2012 0.3 
   
Meetings   
Generation R Research Meetings 2014-17 1.0 
Maternal and Child Health meetings 2014-17 1.0 
ISPUP internal scientific meetings 2012-14 1.0 
Nutrition and Obesity Research group meetings 2012-14 1.0 
ISPUP Scientific Committee meetings 2012-14 1.0 
National public health PhD students meeting 2013 0.2 
   
Communications in scientific meetings   
Oral communications   
Porto Birth Cohorts Meeting, Porto, Portugal 2016 0.7 
The Power of Programming, Munich, Germany 2016 1.4 
III World Congress of Public Health Nutrition, Las Palmas de Gran Canaria, 
Spain 
2014 1.4 
10
th
 International Symposium on Body Composition, Cascais, Portugal 2014 1.4 
International Society for Behavioral Nutrition and Physical Activity Annual 
Meeting, San Diego, California, USA 
2014 1.4 
54
th 
Annual Meeting European Society for Paediatric Research, Porto, 
Portugal 
2013 1.4 
XII Congress of Food and Nutrition, Lisbon, Portugal 2013 0.7 
XI Congress of Food and Nutrition, Porto, Portugal 2012 0.7 
   
Poster/Poster-oral communications   
9th World Congress on Developmental Origins of Health and Disease, Cape 
Town, South Africa 
2015 1.0 
European Congress of Epidemiology, Aarhus, Denmark 2013 1.0 
European Congress of Epidemiology, Porto, Portugal 2012 1.0 
IX Congress of Portuguese Society of Nutrition and Food Sciences, Porto, 
Portugal 
2012 0.7 
   
Communications by invitation   
European Birth Cohorts Network meeting, Barcelona, Spain 2017 1.4 
XIV Congress of Food and Nutrition, Lisbon, Portugal 2015 0.7 
   
Prizes and awards   
New investigator award. The Power of Programming 2016, Munich, 
Germany 
2016  
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Year 
Workload 
(ECTS) 
1st prize for best poster-oral communication. 9th World Congress on 
Developmental Origins of Health and Disease, Cape Town, South Africa 
2015  
1st prize for best oral communication. XII Congress of Food and Nutrition, 
Lisbon, Portugal 
2013  
1st prize for best oral communication. XI Congress of Food and Nutrition, 
Porto, Portugal 
2012  
   
Grants   
Individual doctoral grant (SFRH/BD/81123/2011) by Foundation for Science 
and Technology, Portugal 
2012-16  
Vereniging Trustfonds Erasmus Universiteit Rotterdam, several travel grants 2015-16  
   
Other activities   
Co-chair session:    
European Birth Cohorts Network meeting, Barcelona, Spain 2017  
The Power of Programming, Munich, Germany 2016  
Peer review of articles for scientific journals 2012-17  
Participation in an international collaboration of pregnancy and birth cohorts 
focused on maternal obesity and childhood outcomes (MOCO) 
2015-17  
Collaboration in the ultrasound measurements and analyses of abdominal fat 
in a randomized controlled trial (Venus study, Danone) 
2016-17  
   
2. Teaching activities 
Varsha Jharap, Master in Clinical Epidemiology, NIHES, the Netherlands, 
Project title: Associations of maternal obesity and excessive weight gain 
during pregnancy with subcutaneous fat mass in infancy 
2015-16 4.0 
Teaching assistant in Biostatistical Methods I, NIHES, the Netherlands 2016 0.5 
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The ultimate measure of a man is not where he stands in moments of comfort and convenience, 
but where he stands at times of challenge and controversy. 
Martin Luther King, Jr. 
 
